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ABSTRACT 
Membrane repair can be modulated by the association of an S100A10 dimer 
with the calcium- and phospholipid-binding protein annexin A2. This heterotetrameric 
complex has the ability to form larger multiprotein assemblies such as those with the 
enlargeosome protein AHNAK and members of the transmembrane ferlin family. The 
main goals of this thesis were to design, synthesize and characterize a molecule that 
would facilitate assembly of larger S100 multiprotein complexes, investigate the 
arrangement of the proteins, stoichiometry and affinity of AHNAK for the S100A10-
annexin A2 complex and identify structural details of the ternary complex formed 
between S100A10, annexin A2 and AHNAK. 
Successful expression, purification and characterization of two S100-target 
peptide hybrid proteins comprised of S100A10 and S100B linked in tandem to annexin 
A2 (residues 1-15) (referred to as A10A2) and CapZ (TRTK12) (referred to as BT12), 
respectively, was achieved. Different protease cleavage sites were incorporated into the 
linkers of the hybrid proteins. Since in situ proteolytic cleavage showed the linker did not 
perturb the structures of the S100A10-annexin A2 or S100B-TRTK12 complexes, this 
approach was used as a scaffold for larger S100 complexes. 
Peptide array experiments identified the regions of interaction within the C-
terminus of AHNAK. Of the eight consensus regions observed, one of the sequences of 
AHNAK (AHNAK5) which showed the strongest interaction was used as a synthetic 
peptide to identify the binding region(s), stoichiometry and affinity with the A10A2 
complex. Using NMR, fluorescence and non-denaturing electrospray mass 
   iv 
spectrometries, a novel asymmetric arrangement between a single AHNAK5 peptide and 
the A10A2 dimer having an affinity near 3 nM was identified.   
The binding region of AHNAK5 on A10A2 was determined by NMR 
spectroscopy and X-ray crystallography. X-ray crystallography of the A10A2-AHNAK5 
complex showed that the backbone structure of A10A2-AHNAK5 is similar to that of 
S100A10 bound to the N-terminal peptide of annexin A2 (Rety et al. 1999). From the 
structure, it was clear that only one AHNAK5 was bound to a dimeric A10A2 through 
helix IV in S100A10 and the C-terminal portion from the annexin A2 peptide. These 
results provide a novel mode of interaction for AHNAK5 in an S100-target complex.  
 
 
Keywords: S100; Annexin A2; AHNAK; membrane repair; hybrid protein; protein 
interactions; NMR spectroscopy; peptide array; non-denaturing electrospray mass 
spectrometry; fluorescence spectroscopy; X-ray crystallography; stoichiometry. 
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Chapter 1 
Introduction 
1.1          Role of Calcium in the Cell 
There are at least 1,400 grams of calcium inside the human body (Carafoli 
2003). While the majority of calcium resides in the skeleton and teeth, less than 1% of the 
ion circulates in the body cells (Carafoli 2002; 2003). The importance of calcium ions in 
the cell was first noted by Ringer (Ringer 1883) 128 years ago, when the heart muscle 
continued contracting in the presence of calcium in saline medium. Since then, the 
implication of calcium ion in many biological processes such as cell growth and 
proliferation, fertilization, neurotransmitter release, and memory have been identified 
(Berridge et al. 2000).  
In a resting cell, the cytosolic concentration of free calcium ions is 
approximately 100-300 nM (Tsien 1981), which is approximately 10,000 fold lower than 
the concentration of the ion in the extracellular space (1 mM). This calcium concentration 
is also about 1,000 fold lower than that found within intracellular storage compartments 
such as the sarcoplasmic reticulum (SR), endoplasmic reticulum (ER), the golgi apparatus 
and mitochondria (Pozzan et al. 1994; Pinton et al. 1998) (Figure 1.1A). Maintaining this  
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Rintala-Dempsey, A. C., Rezvanpour, A., and Shaw, G. S. 2008. S100-annexin 
complexes—structural insights. FEBS J. 275: 4956-4966. 
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Figure 1.1. Generation of calcium signal through the inositol-lipid pathway. 
 
Calcium homeostasis in a resting cell is illustrated in (A). To maintain the low level calcium concentration of approximately 100 
nM within the cell, calcium ions must be actively transported out of the cell or into intracellular organelles (ER, SR, 
mitochondria, golgi apparatus). Various calcium pumps such as plasma membrane calcium ATPase (PMCA) and sarco-
endoplasmic reticulum calcium ATPase pumps transfer the calcium ions to the exterior of the cell or to the intracellular 
organelles, respectively. In addition to the pumps, Na+/Ca2+ exchangers, transport calcium ions while sodium ions are entering 
the cell. An excitable cell (B) can become stimulated by a first messenger such as hormones. This results in the activation of the 
G protein coupled receptor and subseqently phospholipase C (PLC) which cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) 
into 1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG). IP3 binding to the IP3-sensitive calcium channels (IP3R) on 
intracellular storage compartments leads to the opening of the channel and release of calcium into the cytosol. A local increase 
in the calcium concentration in the cytosol triggers a physiological response through interaction with a large number of calcium-
binding proteins. (This figure was adapted and modified from Missiaen et. al. 2000 and  Molecular Cell Biology 3rd Edition by 
Lodish et al. 1995). 
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tight regulation of calcium concentration is essential for sustaining life, as calcium ions 
act as “second messengers” in various signaling pathways.  
The type of a cell designates the type of receptors located on the plasma 
membrane. In an excitable cell, first messengers such as neurotransmitters, nerve 
impulses or ligands stimulate these receptors, resulting in the release and increase of the 
local calcium ion concentration (~1 µM) in the cytoplasm. Figure 1.1B illustrates a signal 
transduction cascade initiated by an agonist binding to the cell-surface G protein-linked 
receptor. This results in the activation of phospholipase C (PLC) by the G protein and 
subsequent cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-
triphosphate (IP3) and 1,2-diacylglycerol (DAG) (Clapham 2007). IP3 splits off from PIP2 
and diffuses through the cytoplasm to bind to the IP3-sensitive calcium channels (IP3R) 
on the intracellular storage compartments. This leads to the opening of the channel and 
release of calcium into the cytosol (Figure 1.1B). At this point calcium acts as a second 
messenger and triggers a physiological response through interaction with a large number 
of calcium-binding proteins (CaBP) such as the EF-hand calcium-binding family of 
proteins.  
In order to prepare for the next signal, the cell must actively remove the calcium 
ions. Calcium is taken up through calcium pumps to the extracellular space or 
intracellular compartments through plasma membrane calcium-ATPase (PMCA) and 
sarco-endoplasmic reticulum ATPase (SERCA) pumps (Pozzan et al. 1994; Pinton et al. 
1998), respectively (Figure 1.1A). Na+/Ca2+ exchangers also remove calcium ions to the 
exterior of the cell.     
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1.2          The EF-Hand Calcium-Binding Motif 
With at least 600 identified members in the human genome, the EF-hand 
calcium-binding family of proteins comprises the largest subfamily of CaBP (Kawasaki et 
al. 1998). The name EF-hand was first introduced by Kretsinger and Nockolds over 30 
years ago with the atomic resolution structure of the crab calcium-buffering protein 
parvalbumin (Kretsinger and Nockolds 1973). As shown in Figure 1.2, an EF-hand motif 
consists of two α-helices that are connected by a calcium-binding loop. The term EF-hand 
is used as the shape of this domain resembles a right hand with an extended index finger 
and thumb, depicting the N-terminal helix (helix E) and the C-terminal helix (helix F), 
respectively (Tufty and Kretsinger 1975). The remaining curled fingers represent the 10-
12 amino acid calcium-binding loop. A CaBP may contain between 2-12 EF-hand loops 
to maximize the calcium capacity (Carafoli 2002).  
The classical, canonical EF-hand loop is characterized by a sequence of 12 
amino acids with the pattern X * Y * Z * -Y * -X * * -Z, where the letters are the residues 
that participate in metal coordination and the asterisks are the intervening residues 
(Strynadka and James 1989). The amino acids at positions 1, 3, 5, 9 (via water) and 12 of 
this sequence provide the oxygen ligand to the calcium ion by sidechain carboxyl groups, 
and position 7 coordinates the ion through the main chain carbonyl group. Consequently, 
the calcium ion is coordinated in a pentagonal bipyramidal arrangement with preferences 
for aspartate, glycine and glutamate in positions 1, 6, and 12, respectively (Marsden et al. 
1989). 
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Figure 1.2. The structure of an EF-hand motif. 
 
(A) The EF-hand calcium-binding motif is comprised of an entering helix (pink) and an 
exiting helix (aqua) that are connected by the calcium binding loop (grey). (B) The motif 
was called an EF-hand as the N-terminal helix E corresponds to the index finger and the 
C-terminal helix F represents the extended thumb. The remaining flexed fingers form the 
calcium binding loop. The movements of the C-terminal helix (helix F) in the closed 
conformation (light grey) before binding to calcium and after calcium-binding in the open 
conformation (dark grey) are also presented. (Figure adapted and modified from Lewit-
Bentley et al. 2000). 
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Another type of EF-hand motif contains 14 amino acids within the calcium-
binding loop and has the X * * Y * Z * * -Y * -X * * -Z pattern (Strynadka and James 
1989). In this case, extra residues are introduced between the X and Y, as well as the Z 
and –Y positions and the calcium coordination occurs with the main chain carbonyl 
groups at positions X, Y, and Z. The EF-hand motif with this type of calcium 
coordination is referred to as a pseudo EF-hand loop (Strynadka and James 1989). 
 
1.3          Overview of EF-Hand Calcium Binding Proteins 
CaBPs can be divided into two distinct classes: 1) calcium buffers (or calcium 
signal modulators) and 2) calcium sensors (da Silva and Reinach 1991). Calcium buffers 
are acidic proteins that can be found in the cytosol, organelles or integrated in membranes 
(Carafoli 2003). They have a high affinity for calcium and can store large amounts of 
calcium. By doing so, these proteins can regulate the intracellular calcium concentration 
or transport the calcium throughout the cell. Members of the calcium buffering proteins 
include calbindin D9K found in the cytosol and calsequestrin found in the SR. Calbindin 
D9K is a small protein of 75 residues and is composed of a pair of EF-hand loops 
connected by a linker. While calcium binding occurs with positive cooperativity (Linse et 
al. 1987), it does not result in major conformational changes, therefore the calcium-bound 
protein maintains a “closed” conformation (Skelton et al. 1994; Gifford et al. 2007). 
Consequently, with no identified binding partner, calbindin D9K functions as a transporter 
for calcium ions within the cell. 
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Calcium sensors, on the other hand, have moderate affinities in the range of 1 
to 10 µM for calcium (Schaub and Heizmann 2008), and exist in the calcium-free (apo) 
state at resting concentrations of the ion. A local increase in calcium concentration 
beyond the resting level results in the calcium-binding by the calcium-sensor proteins. 
This leads to a significant calcium-induced conformational change and thus the exposure 
of previously buried hydrophobic surface for interaction with biological targets. Some 
members of the calcium-sensor family include calmodulin (Han and Campbell 2007), 
troponin-C (TnC) and the S100 protein family.  
Calmodulin is a small (148 amino acids), highly conserved protein found 
ubiquitously in eukaryotes. This protein binds to a large number of targets (more than 
350) such as myosin light chain kinase and calcineurin in a calcium-dependent manner 
(Yap et al. 2000) and regulates a vast number of cellular activities such as cell growth, 
muscle contraction, and secretion. Calmodulin is comprised of two lobes of EF-hand 
pairs that are connected through a flexible linker (Kuboniwa et al. 1995; Shao et al. 
2006), giving it a “dumbbell-like” overall shape (Babu et al. 1988) (Figure 1.3). The two 
N- and C-terminal EF-hand loops in each lobe are arranged in a four-helix bundle. 
Consequently, calmodulin is able to bind a total of four calcium ions (Kdcalcium ~ 1-10 µM) 
in response to an increase in intracellular calcium concentration (Teo and Wang 1973). 
Upon calcium-binding, the α-helices of each EF-hand motif modify their interhelical 
angle such that the position of each helix pair changes from an anti-parallel arrangement 
(130-140º) to an almost perpendicular conformation (89º) (Shao et al. 2006). These 
structural changes allow the “closed” helical bundles of the two lobes to obtain an
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Figure 1.3. Calcium-induced conformational changes of calmodulin.  
 
Ribbon diagrams of (A) apo-calmodulin (1DMO) (Zhang et al. 1995), and (B) calcium-
bound calmodulin (3CLN) (Babu, et al. 1988) showing calcium induced conformational 
changes in the two lobes of EF-hand pairs. Calmodulin has an overall “dumbbell-like” 
appearance (Kuboniwa et al. 1995). Upon calcium-binding, the α-helices of each EF-
hand motif modify their interhelical angle such that the position of each helix pair 
changes from an anti-parallel arrangement (130-140º) to an almost perpendicular 
conformation (89º) (Zhang et al. 1995). Increased exposure of the hydrophobic surface 
allows for interaction with target protein. In both diagrams, the helices in the N-terminal 
lobes are coloured, while the helices in the C-terminal lobes are in grey.   
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“open” conformation with an exposed hydrophobic surface for interaction with target 
proteins.  
 
1.4          Structures of S100 Proteins 
The S100 protein family is a group of 25 members, found solely in vertebrates. 
These proteins undergo a calcium-induced structural change during signalling events. As 
a result, the calcium-bound forms of S100 proteins are able to interact with target 
molecules, giving rise to a variety of biological responses including protein 
phosphorylation, cell growth, motility and gene transcription (Rintala-Dempsey et al. 
2006). The structures of several S100 proteins have been determined using NMR 
spectroscopy and x-ray crystallography and show the details of the calcium-binding sites, 
dimerization motif and structural changes upon calcium binding. Unlike the dumbbell 
shapes of well-studied EF-hand calcium-binding proteins such as calmodulin (Babu et al. 
1988) and troponin-C (Herzberg and James 1985), the S100 proteins have a more 
compact, globular structure. As shown for S100A11 (Figure 1.4) each S100 protomer is 
comprised of two helix-loop-helix motifs, or EF-hands, connected by a flexible linker. 
The N-terminal calcium-binding site (site I) is a “pseudo” EF-hand, while the tighter 
binding C-terminal site (site II) is a canonical EF-hand. The majority of S100 proteins 
form symmetric non-covalent homodimers, a feature that is unique to these proteins 
within the EF-hand family of calcium-binding proteins. S100 proteins have also shown 
the formation of heterodimers, such as that formed between S100A8 and S100A9 
(Korndorfer et al. 2007). The dimer interface is composed of the antiparallel arrangement 
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Figure 1.4. Calcium-induced conformational changes of S100 proteins.  
 
Ribbon diagrams of (A) apo-S100A11 (1NSH) (Dempsey et al. 2003) and (B) Ca2+-
S100A11 (1QLS) (Rety et al. 2000) are shown in similar orientations to demonstrate the 
conformational changes that occur upon calcium-binding. The helices are numbered I-IV 
for one monomer and I’-IV’ for the other. Helix I is shown in pink, helix II in aqua, helix 
III in purple and helix IV in blue. The β-sheets in the calcium-binding loops are shown in 
light purple and the calcium ions as yellow spheres. When calcium binds to S100A11 the 
largest conformational changes occur in the C-terminal EF-hand. Helix III moves ~ 40º 
with respect to helix IV, exposing a hydrophobic cleft between helix IV and the linker of 
one monomer and helix I’ of the second monomer. (C) Binding of the N-terminal region 
of annexin A1 (green) is mediated by hydrophobic residues of the binding cleft on either 
side of S100A11 dimer (1QLS) (Rety et al. 2000) making contacts with helices III and IV 
from one monomer and helix I’ of the partner monomer simultaneously. (D) The structure 
of S100A10 bound to the N-terminal region of annexin A2 (1BT6) (Rety et al. 1999) is 
shown to illustrate the similarity to the Ca2+-S100A11-annexin A1 structure. When the 
two S100-annexin structures are superimposed, the backbone RMSD is 0.85. 
   
11 
of helices I and IV of each protomer. The two calcium-binding loops are held in close 
proximity via a short antiparallel β-sheet and are on the opposite side of the molecule 
relative to the N- and C-termini. 
In the calcium-free (apo) structures of several S100 proteins, including apo-
S100A11, helices III and IV are nearly parallel to one another, resulting in a number of 
residues at their interface that are inaccessible to solvent and giving the protein a more 
“closed” structure (Dempsey et al. 2003). Upon calcium-binding, the N-terminus of helix 
III moves by almost 40° relative to helix IV and becomes nearly perpendicular to helix 
IV, exposing hydrophobic residues on both helices (V57, M61, L85, A88, F93 in 
S100A11), as well as on helix I (I12, I16) and the linker region (L45, A47, F48), that 
were previously buried in the apo state (Figure 1.4).  In S100A11 it has also been noted 
that helix IV becomes elongated upon calcium binding. The large conformational change 
of helix III and exposure of hydrophobic residues, first shown for S100B (Drohat et al. 
1998; Matsumura et al. 1998; Smith and Shaw 1998) and S100A6 (Otterbein and 
Dominguez 2002) has become a trademark of the S100 calcium-binding event and is 
responsible for the interactions of these proteins with a diverse array of target proteins 
(Rintala-Dempsey et al. 2006). One member of the S100 family, S100A10, differs from 
others as it is unable to bind calcium ions due to a three-residue deletion in site I (N28, 
N29, T30 of S100A11 are absent in S100A10) and mutations of acidic calcium-
coordinating residues in site II (D68 and E77 of S100A11 are substituted with C61 and 
S70 in S100A10) (see sequences in Figure 1.6A). Remarkably, the structure of calcium-
free S100A10 (Rety et al. 1999) is nearly identical (rmsd 0.85 Å) in structure to that of 
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calcium-bound S100A11 (Ca2+-S100A11) (Rety et al. 2000) despite the presence (or 
absence) of calcium ions in their calcium-binding loops (Figure 1.4).  
In S100A10 and Ca2+-S100A11, helices I and IV comprise the dimer interface 
as in the other S100 structures, however helix IV is markedly longer in apo-S100A11, 
extending nearly to the C-terminus. Helix III has a similar orientation in both S100A10 
and in Ca2+-S100A11, thus exposing very similar hydrophobic regions and residue 
composition (Figure 1.4).  
 
1.5          Structures of the Annexin Proteins 
In humans there are 12 different annexin proteins, annexins A1-A11 and A13 
that have orthologs in most vertebrates (Fernandez and Morgan 2003). As of April 2011, 
there were 69 three-dimensional structures of annexin proteins, most from x-ray 
crystallographic methods, deposited to the Protein Data Bank (www.rcsb.org). These 
structures include full-length, truncated and mutant forms of the annexins (particularly 
annexin A5), as well as annexin-protein complexes. In particular, vertebrate structures of 
human annexins A1, A2, A3, A5, A8 and bovine annexins A4 and A6 have been 
determined, some in both the calcium-free and calcium-bound forms. 
Consistent with the first annexin structure determined, annexin A5 (Huber et al. 
1990a; Huber et al. 1990b; Concha et al. 1993; Sopkova et al. 1993), all annexins except 
annexin A6, form a core domain consisting of four conserved structural repeat sequences 
(I-IV), each about 70-75 residues in length. Annexin A6 is a unique member of the 
annexin family possessing two four-repeat core domains connected by a linker region 
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(Avila-Sakar et al. 1998), a result of a gene duplication event. As shown in Figure 1.5 
for annexin A1 (Rosengarth et al. 2001), each repeat unit is formed from five α-helices 
(A-E) arranged such that helices A, B, D and E are roughly anti-parallel to each other 
while helix C is nearly perpendicular to these helices. The repeats pack into two distinct 
arrangements within the core domain. The repeat pairs I/IV and II/III pack together 
mostly due to hydrophobic interactions between helices B and E in each repeat, arranged 
in a near antiparallel fashion (Weng et al. 1993; Rosengarth et al. 2001). For example, in 
annexin A2 (Shao et al. 2006) residues in helices B and E from repeat I (V54, V57 and 
V98, L102) and repeat IV (I289, V293 and A330, Y333, L334) form a tight non-polar 
network between these two repeat units. In general the hydrophobic nature of these 
residues in the annexin sequences is highly conserved. 
Calcium binding to the annexins promotes their binding to phospholipid-
containing membranes. Most structures of annexins show that coordination of calcium 
ions by the annexins occurs via three residues in the A/B loop that ligate the calcium ion 
using their backbone carbonyl atoms and the bidentate side chain of either an aspartic or 
glutamic acid 38 residues downstream in the D/E loop (Figure 1.5) (Seaton 1996). Water 
molecules satisfy the remaining two coordination sites for each calcium ion. In this 
manner, each annexin protein coordinates one calcium ion per repeat giving rise to the 
trademark annexin sequence pattern GXGT-(38)-D/E (Geisow et al. 1986). In addition, 
secondary coordination of calcium ions with lower affinity have also been noted within 
the D/E loops of repeats I and III as in annexin A1 (Rosengarth and Luecke 2003) and A2 
(Shao et al. 2006) or in the A/B loop near the primary calcium site in this region. In 
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Figure 1.5. Extrusion of the N-terminal helix in annexin A1 upon calcium binding.  
 
Ribbon representations of (A) apo-annexin A1 (1HM6) (Rosengarth et al. 2001) and (B) 
Ca2+-annexin A1 (1MCX) (Rosengarth et al. 2003). The core domain repeats are colored 
pink for repeat I, blue for repeat II, yellow for repeat III and green for repeat IV. The 
helices of repeat III are labeled A-E. The N-terminus of apo-annexin A1 was resolved in 
the calcium-free crystal structure and is shown in teal. The extreme N-terminal helix of 
annexin A1 is associated with repeat III in the absence of calcium and essentially takes 
the place of helix D. In the presence of calcium the N-terminal helix is not visible in the 
structure and is presumed to be expelled from the core domain. The calcium ions are 
shown as orange spheres. 
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both these cases a greater number of water molecules are used to satisfy the calcium 
coordination. Further, these sites appear to have a greater variability within the annexin 
structures, likely due to differences in crystallization conditions. Remarkably, the calcium 
ions all lie on the same curved side of the annexin structures (Swairjo et al. 1995) forming 
a convex surface proposed to interact with phospholipids (Figure 1.5).  
Unlike the structures of EF-hand signalling proteins such as troponin-C 
(Herzberg and James 1985) or members of the S100 protein family (Nelson and Chazin 
1998; Maler et al. 2002), the annexins do not appear to undergo a significant structural 
change within their core domains upon calcium binding. For example, a comparison of 
the calcium-free and calcium-bound forms of annexins A1 and A2 show only 1.56 and 
0.72 Å differences between the backbone arrangements of these structures. The most 
significant difference between these structures is a disruption of the packing of the helices 
in repeat III of calcium-free annexin A1 due to the presence of an N-terminal helix. The 
N-terminal extension ranges between eleven (annexin A6) and more than 50 residues 
(annexin A7, A11) and is only found in some annexins (A1, A2, A6, A7, A9, A11). 
However, annexin A1 is the only member of the group where the intact N-terminal 
sequence is visible in the x-ray structure (Rosengarth et al. 2001). In the calcium-free 
state this structure shows that the N-terminus of annexin A1 forms a kinked α-helix where 
residues A2-A11 from this helix are buried against helix E (D259-A271) of repeat III and 
backing on to helix C. The unique feature of this N-terminal helix is that it has essentially 
replaced helix D from the helical packing arrangement in repeat III found in the calcium-
bound form of annexin A2 or in other annexin structures. In the presence of calcium, the 
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N-terminal helix is absent from the annexin A1 structure suggesting it has been 
extruded from the core structure (Rosengarth and Luecke 2003). This calcium-sensitive 
extrusion is reminiscent of that exhibited by the EF-hand protein recoverin which releases 
an N-terminal myristoyl group upon calcium binding (Ames et al. 1995a; Ames et al. 
1995b). Studies of peptides derived from the N-terminus of annexin A1 reveal that an 
extruded N-terminus likely has little regular secondary structure but undergoes a coil-
helix transition upon protein or membrane binding (Yoon et al. 2000; Hu et al. 2008). 
 
1.6          Structures of S100 Proteins in Complex with the Annexins  
The first structure of an S100 protein in complex with an annexin protein was 
solved by Rety et al. (Rety et al. 1999) and comprised S100A10 bound to the first 13 
residues of the N-terminus of annexin A2. One year later, the structure of Ca2+-S100A11 
bound to the 14 N-terminal residues of annexin A1 was determined (Rety et al. 2000). 
These two structures (Figure 1.4) provide valuable information regarding how these two 
protein families physically interact with one another, and how these interactions give rise 
to the biological functions that have been observed in the cell. S100s have long been 
known to interact with members of the annexin family and that these interactions play a 
role in membrane fusion events (Harder and Gerke 1993; Mayorga et al. 1994; Jost et al. 
1997). In particular, the structures reveal a common mode of interaction among these two 
protein families as well as key elements for target specificity. 
Early studies showed that the binding of annexins A1 and A2 to Ca2+-S100A11 
and S100A10 respectively was strongly dependent on the unique N-terminal regions of 
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the annexin proteins (Johnsson et al. 1986; Johnsson et al. 1988; Mailliard et al. 1996; 
Jost et al. 1997). This was confirmed from crystal structures of Ca2+-S100A11 and 
S100A10 (Rety et al. 1999) in the presence of N-terminal annexin peptides. Despite the 
differences between the sequences of the S100 proteins (Figure 1.6), their calcium-bound 
state and the sources of the two annexin peptides, both structures show two annexin 
peptides per S100 dimer, located in near-identical binding sites on either side of the S100 
molecule (Figure 1.4). Each peptide makes contacts with both S100 protomers resulting 
in the bridging together of the two protomers by the annexin protein. In each case, the 
peptides form α-helical structures when bound to their S100 binding partners, as had been 
previously predicted based on their sequences (Acetyl-AMVSEFLKQAWFID and 
Acetyl-STVHEILSKLSLEG for annexin A1 and A2, respectively) (Johnsson et al. 1988; 
Becker et al. 1990; Mailliard et al. 1996) and the structure of this region in the calcium-
free form of annexin A1 (Rosengarth et al. 2001). Furthermore, N-acetylation of the 
peptides is a requirement for the S100-annexin interactions (Johnsson et al. 1988; Becker 
et al. 1990; Rety et al. 2000) since removal of the acetyl group in annexin A2 results in a 
2700-fold decrease in binding affinity to S100A10 (Becker et al. 1990). Although no 
direct contacts are made between the acetyl groups and the S100 proteins, it has been 
suggested that the acetyl group aids in stabilizing the helix dipole of the annexin N-
terminus and therefore the required helical conformation of the peptide. The backbone 
RMSD for the entire Ca2+-S100A11-annexin A1 and S100A10-annexin A2 complexes is 
0.85 Å. This is a clear indication of a common mode of interaction between these 
members of the S100 and annexin families. 
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Figure 1.6. Similarity of sequences and protein-protein contacts in S100-annexin 
structures.  
 
(A) A sequence alignment of S100A11 (pig) and S100A10 (human) is shown to allow 
comparison of the residues involved in interactions with the annexin peptides. The helices 
are shaded in similar colours to those used in Figure 1.4 and the calcium-binding loop 
residues are underlined. Schematic representations of the contacts between S100A11 and 
the annexin A1 peptide (B) and between S100A10 and annexin A2 (C) are shown to 
illustrate the similarities in the two complexes. The annexin peptides are shown as helical 
wheels to show the relative positions of the amino acids in the helices, with the key 
hydrophobic residues shaded in light purple forming a XOOXXOOX motif. The residues 
of the respective S100 binding partners that make contacts (< 6 Å) with each of the 
hydrophobic residues are labeled. For example, the side chain of L7 of annexin A1 is 
within 6 Å of the side chains of L45, A47, F48 within the linker of S100A11, L85 and 
C89 of helix IV and E9’ and I12’ of helix I’ of the other monomer. L7 of annexin A2 
makes nearly identical contacts with F38, F41, L78, C82, E5’ and M8’ of S100A10 as 
can be seen when the residues are compared in the sequence alignment of the two 
proteins. 
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Hydrophobic surface plays a major role in the interactions between the 
annexin N-termini and the S100 proteins. The amphipathic nature of the annexin 
sequences presents a series of hydrophobic residues on one face of the α-helix that 
interact with S100A10 or Ca2+-S100A11. In annexin A1, the hydrophobic surface is made 
up of V3, F6, L7 and A10 and in annexin A2 it is made up of residues V3, I6, L7 and L10 
(Figure 1.6). This representation clearly indicates a strong conservation of hydrophobic 
residues at these positions (XOOXXOOX; X=hydrophobic residue, O=polar residue) that 
make the largest number of contacts with the S100 proteins. In the S100A10-annexin A2 
structure, V3 of the annexin A2 peptide interacts with a large number of residues in helix 
I’ (E5’, M8’, E9’, M12’). Similarly, E9’, I12’, E13’ and I16’ of S100A11 are in close 
proximity to V3 of annexin A1 (Figure 1.6B). The importance of this residue was further 
illustrated by its substitution with a polar amino acid, that lead to a complete loss of 
binding between annexin A2 and S100A10 (Becker et al. 1990). However, the Ca2+-
S100A11-annexin A1 complex formation seems less sensitive to substitution since 
replacement of V3 with alanine results in little change in binding affinity (Rintala-
Dempsey et al. 2006). The residue at position 6 (I or F) makes numerous contacts with 
helix IV (C82, Y85, F86, M90 in S100A10 and L85, A88, C89, S92 in S100A11). The 
sidechain of L7 makes the largest number of contacts with the S100 proteins by 
interacting with residues in the linker (F38, F41 in S100A10 and L45, A47, F48 in 
S100A11), helix IV (L78, C82 in S100A10 and L85, C89 in S100A11) and helix I’ (E5’, 
M8’ in S100A10 and E9’, I12’ in S100A11). Reduction of the size of the hydrophobic 
sidechain at positions 6 and 7 by substitution with either an alanine or valine in both 
   
20 
annexins A1 and A2 dramatically reduces binding, indicating the close packing of the 
S100-annexin interaction (Becker et al. 1990; Rintala-Dempsey et al. 2006). The residue 
at position 10 (A or L) is near helix IV (A81, C82, Y85 in S100A10 and A88, S92 in 
S100A11). Several hydrogen bonds between the peptides and the S100 proteins stabilize 
the interaction. 
The structures of the S100A10-annexin A2 and Ca2+-S100A11–annexin A1 
heterotetramers show how a single S100 protein might interact with two annexin proteins 
(Rety et al. 1999; Lewit-Bentley et al. 2000; Rety et al. 2000). As proposed by Gerke and 
Moss (Gerke and Moss 2002) this would provide an elegant mechanism whereby 
calcium-binding by an annexin protein not only promotes its association with a 
phospholipid membrane but also facilitates interaction with either S100A10 or Ca2+-
S100A11 allowing two membrane surfaces to be brought within close proximity for a 
fusion or vesiculation event. 
 
1.7          Insights into other S100-Annexin Interactions 
Other interactions between the S100 and annexin families have been reported. 
Consistent with the calcium-induced conformational change observed in S100A11, most 
of these complexes require the calcium form of the S100 protein although there are a few 
calcium-independent interactions, including S100A4 and annexin A2 (Semov et al. 2005). 
Some annexins, such as annexin A6, have many possible S100 binding partners: S100A1 
(Garbuglia et al. 2000), S100A6 (Zeng et al. 1993), S100A11 (Chang et al. 2007) and 
S100B (Garbuglia et al. 2000), while other S100 proteins can interact with several 
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different annexins. For example, S100A6 has been shown to bind annexins A2 (Filipek 
et al. 1995), A6 (Zeng et al. 1993) and A11 (Tokumitsu et al. 1992). The S100A6-
annexin A11 interaction appears to involve a similar pattern of hydrophobic residues 
(XOOXXOOX) from the N-terminal extension of annexin A11 (L52, M55, A56 and 
M59) (Sudo and Hidaka 1999) as observed for annexins A1 and A2 and this region is 
predicted to adopt an amphipathic helix. Similar to the S100A10-annexin A2 complex, 
S100A4 also interacts with the N-terminus of annexin A2 in a calcium-independent 
manner (Semov et al. 2005). Alternatively, the interaction between S100A11 and annexin 
A6 involves residues within each of the two core domains of annexin A6 (Chang et al. 
2007). A similar conclusion has been reached for the interaction of S100A1 and S100B 
with annexin A6 (Garbuglia et al. 2000). In this latter case, and for the S100A12-annexin 
A5 interaction (Hatakeyama et al. 2004) it has also been observed that the extreme C-
terminus of the S100 protein is not involved in the annexin interaction. This is in contrast 
to observations for the S100A10-annexin A2 and Ca2+-S100A11-annexin A1 complexes 
(Figures 1.4 and 1.6) where the C-termini of the S100 proteins are indispensable, likely 
due to the elongated nature of helix IV which extends nearly to last residue in each 
protein. Together, these results indicate that multiple modes of binding between S100 
proteins and annexins are possible. 
Uncovering the potential binding sites in the core domains of annexins A1, A2 
and A5 for S100 proteins have not yet been attempted. Other than the calcium-sensitive 
extrusion of the N-terminal helix from annexin A1 and A2, the most significant structural 
change observed in the annexins is the exposure of Trp187 in annexin A5 at high calcium 
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ion concentrations (Huber et al. 1992; Concha et al. 1993; Sopkova et al. 1993). The 
exposure of this residue facilitates binding to the phospholipid membrane so is unlikely to 
also be used for interactions with an S100 protein. In addition, this residue is not 
conserved in annexins A1 and A2 where lysine residues exist. Rather, the most obvious 
choice for S100 protein binding with the annexins is the opposite “side” of the core 
domain from the membrane-binding region. An attractive site might be helix C from 
domain IV as this helix sits near the bottom of the structure (Figure 1.4). In the absence of 
calcium, helix C is protected by the N-terminal helix in annexins A1 and A2. Upon 
calcium binding to the annexin protein, several residues near helix C become mostly 
exposed (E305, N309, D310, A313, K317 in annexin A1). Several of the analogous 
residues are also exposed in annexin A5. However, analysis of this helix does not reveal 
the XOOXXOOX motif used in the N-terminal helix, suggesting a different mode of 
interaction may be occurring. It is also interesting that residues V287-V298 in annexin 
A2 match the TRTK-12 consensus motif observed for peptide binding to S100B 
(McClintock and Shaw 2000). However, most of these residues appear to be buried in 
annexin A2. Further experiments will be needed to confirm whether this or some 
alternative site on the annexin proteins is used to interact with other S100 proteins. 
While the structures of Ca2+-S100A11 and S100A10 clearly show the surfaces 
used to interact with annexins A1 and A2 respectively, models of other S100-annexin 
complexes such as Ca2+-S100A11 with annexin A6 are not available. However, some 
information about potential binding sites can be gleaned by examination of S100 protein 
structures in the apo- and calcium-bound states. For example, S100A11 utilizes several 
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residues in helices I (E9, I12, I13, I16), the linker (L45, A47, F48) and the extreme C-
terminus of helix IV (L85, A88, C89, S92) to interact with annexin A1 (Figure 1.6). 
Many of these residues are inaccessible in the calcium-free state and would be expected 
to provide an interactive surface not only for annexin A1 but for other annexin proteins. It 
will be important to complete site directed mutagenesis experiments on S100 proteins 
such as S100A11 to understand the roles of these residues on the affinities for different 
annexin proteins.  
 
1.8          Different Modes of Recognition for S100 Target Protein Complexes 
The three-dimensional structures of several S100 proteins have been determined 
in complex with a variety of peptides derived from their parent proteins. These include 
calcium- bound  S100B  (Ca2+-S100B) in  complex  with  peptides  from  the C-terminal  
region  of p53 (Rustandi et al. 2000), the N-terminal regulatory domain from Ndr kinase 
(Bhattacharya et al. 2003) and the actin-capping protein CapZ (TRTK12) (Inman et al. 
2002; McClintock and Shaw 2003; Charpentier et al. 2010); calcium-bound S100A1 
(Ca2+-S100A1) in complex with peptides from CapZ (Wright et al. 2009) and  the  
cytosolic region of the ryanodine receptor (RyR) (Wright et al. 2008); calcium-bound 
S100A6 (Ca2+-S100A6) in complex with a C-terminal region from the Siah-1 interacting 
Protein (SIP) (Lee et al. 2008) and, Ca2+-S100A11 in complex with the N-terminus of the 
phospholipid-binding protein annexin A1 (Rety et al. 2000). In addition, the structure of 
S100A10, an S100 protein unable to bind calcium due to substitutions in both calcium-
binding loops, is available in complex with the N-terminal region from annexin A2 (Rety 
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et al. 1999). In general these structures show there are at least three distinct modes a 
target protein adopts when binding to an S100 protein (Figure 1.7), all showing a 
symmetric relationship and 1:1 stoichiometry for the target:S100 protomer. 
The first mode of binding involves the interaction between the target protein and 
the hydrophobic surface exposed between helices III and IV due to calcium binding to the 
S100 protein. In this case, all interactions between the target and the S100 protein occur 
at the S100 protomer level. This type of interaction is exhibited in the Ca2+-S100B 
structures with TRTK12 (Protein Data Bank accession codes - 1MWN, 1MQ1, 3IQO), 
Ndr kinase (1PSB, Figure 1.7A) and p53 (1DT7), and the Ca2+-S100A1 structures with 
TRTK12 (2KBM, Figure 1.7A) and the ryanodine receptor (2KF2). In the p53 (Rustandi 
et al., 2000) and Ndr kinase (Bhattacharya et al. 2003) structures, each bound peptide 
forms a three-turn α-helix such that its N-terminus lies near the N-terminus of helix III 
and its C-terminus has key interactions with the C-terminus of helix IV of Ca2+-S100B. In 
contrast, the  TRTK12 structures with Ca2+-S100A1 (Wright et al., 2009) and Ca2+-
S100B (Inman et al., 2002) form 1.5 turn α-helices and are aligned nearly perpendicular 
to the orientations of the p53 and Ndr peptides such that the C-terminus of TRTK12 is 
closer to the middle of helix IV (Figure 1.7A). Even though the TRTK12 peptide binds 
within the helix III-IV cleft in both structures the presentation of the peptide is different 
when bound to Ca2+-S100A1 compared to Ca2+-S100B. In Ca2+-S100A1 the anchoring 
tryptophan (W7) of TRTK12 interacts with residues towards the C-terminus of helix IV 
(L81, A84, C85, F88) whereas in Ca2+-S100B, this same tryptophan interacts with 
residues in the linker (L44, E45, I47) and helix III (V53, V56). These differences have the  
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Figure 1.7. Different modes for target protein interaction with S100 proteins.  
 
(A) Binding to the helix III-IV hydrophobic displayed by TRTK12 (pink) bound to Ca2+-S100A1 (2KBM) 
(Wright et al. 2009) and NDR kinase (cyan) bound to Ca2+-S100B (1PSB) (Bhattacharya et al. 2003). (B) 
Binding near helix I’ at the dimer interface displayed by the N-terminal region of annexin A1 (pink) and Ca2+-
S100A11 (1QLS) (Rety et al. 2000). (C) Two- site surface mode displayed by the C-terminal region of SIP 
bound to Ca2+-S100A6 (2JTT) (Lee et al. 2008). Ribbon diagrams of the calcium-saturated S100 proteins are 
presented with one of the protomers shaded in black (helices labeled as I-IV) and the other protomer shown in 
light grey (helices labeled as I’-IV’). Calcium ions are illustrated in yellow spheres. 
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effect of rotating the entire TRTK12 peptide by about 60˚ and “tipping” the peptide by 
about 20˚ towards helix III in the Ca2+-S100B structure. Pictorially the binding of a 
peptide representing the cytosolic region from the ryanodine receptor to Ca2+-S100A1 
(Wright et al. 2008) appears to be quite similar to that described for TRTK12. However, 
major differences exist as the RyR peptide forms a three-turn α-helix and is oriented 
nearly 180˚ with respect to TRTK12 such that its C-terminus is proximal to the N-
terminus of helix III in Ca2+-S100A1. An anchoring tryptophan (W5) in the RyR peptide 
interacts with residues near the middle of helix IV (L77, A80, L81) but also with I57 in 
helix III. The diversity of the interactions exhibited by these five S100-target peptide 
structures can be attributed to the binding surfaces in S100A1 and S100B that are broader 
and flatter than other calcium-sensor proteins (i.e. calmodulin) and have different 
distributions of hydrophobic and charged residues (Lee et al. 2008). This observation 
likely accounts for the broad spectrum of target proteins that interact with the S100 
proteins and makes prediction of target binding based on protein sequence somewhat 
problematic. 
The second mode of interaction utilized by the S100 proteins is displayed by 
structures of Ca2+-S100A11 (1QLS, Figure 1.7B) and S100A10 (1BT6) in complexes 
with the N-terminal peptides from annexins A1 and A2 respectively (Rety et al. 1999; 
Rety et al. 2000). Unlike the diversity displayed by Ca2+-S100A1 and Ca2+-S100B, these 
structures show nearly identical locations and orientations for peptide binding such that < 
1 Å rmsd exists between structures. In both structures the annexin peptide bridges the two 
S100 protomers such that its C-terminus interacts with the linker and helix IV of one 
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protomer while the annexin N-terminus has contacts near the N-terminus of helix I’ of 
the partner protomer. The similarity of these S100-annexin structures is not surprising 
given the conservation of hydrophobic residues in both annexin peptides. The interacting 
residues correspond to V3, F6, L7 and L10 in annexin A1 and V3, I6, L7 and L10 in 
annexin A2 forming a XOOXXOOX interaction motif (X=hydrophobic residue, 
O=variable). This level of conservation does not exist between the TRTK12, RyR, p53 
and Ndr sequences described earlier in complex with Ca2+-S100A1 or Ca2+-S100B 
proteins. Some similarity also exists in the annexins contacting residues in S100A10 and 
Ca2+-S100A11, especially in helix I’ and helix IV. 
Although it has been shown that N-terminal peptides from annexins A1 and A2 
both interact with Ca2+-S100A11 (Rintala-Dempsey et al. 2006), it is interesting to note 
that annexin A1 does not form a tight complex with S100A10 (Streicher et al. 2009). 
Further, a strong level of specificity has been shown for S100 recognition of annexins A1 
and A2. Other than S100A10 and Ca2+-S100A11, the only other S100  protein that 
displays a tight calcium-dependent interaction with annexin A1 is S100A6 (Streicher et 
al. 2009). 
Whereas both the previous modes of target peptide binding with S100 proteins 
utilized different albeit contiguous surfaces, the recent structure (Lee et al. 2008) of the 
C-terminal domain from the Siah-1 Interacting Protein (2JTT) shows a hybrid two-site 
surface (Figure 1.7C). In this structure the SIP peptide forms two distinct three-turn α-
helices oriented nearly perpendicular to each other upon binding to Ca2+-S100A6. The 
first helix (Helix A) occupies a position and orientation similar to that observed for the 
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RyR peptide utilizing the hydrophobic groove between helices III and IV. Helix A of 
SIP lies diagonally across helix III in Ca2+-S100A6 with L196 and I199 anchoring the 
peptide through interactions with residues in helix IV and the C-terminus of helix III 
respectively. The second helix in SIP (helix B) lies across helix I’ of the adjacent 
protomer, in effect bridging the two S100A6 subunits analogous to the S100-annexin 
complexes. Whereas the annexin structures only contact the N-terminus of helix I’ in 
either S100A10 or Ca2+-S100A11, helix B in SIP has interactions towards the more 
central portion of helix I’ (I9’, I13’ and K18’). This results in helix B of SIP and helix I of 
Ca2+-S100A6 running along opposite faces of helix I’ forming a near mirror image of 
each other, albeit helices I and B are oriented in opposite directions. The two binding 
regions for SIP to Ca2+-S100A6 could in part be due to the length of the SIP fragment 
(189-219; 30 residues) that is significantly longer than any of the other target peptides for 
which structures are available. Lee and co-workers show that the two helices in SIP are 
not equivalent  in their abilities to coordinate S100A6 with helix A having a much tighter 
binding,  while the less hydrophobic helix B enhances the affinity by about 4-fold. 
The three modes of target binding to the S100 proteins utilize two distinct 
binding regions – the helix III-IV hydrophobic groove and the dimer interface near helix 
I’ on the partner protomer. It has been suggested that the combination of these two 
regions might represent the full interaction surface for single or multiple protein 
interactions with the S100 proteins. Otterbein proposed this idea by superimposing the 
peptide binding regions for annexins A1 or A2, and p53 on the surface of Ca2+-S100A6 
showing these peptides occupied distinct regions of the surface with no observable steric 
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clashes between the peptides (Otterbein et al. 2002). Subsequently, it was shown for 
TRTK12 binding to Ca2+-S100B that a region similar to the annexin binding site was left 
exposed, and that a larger target protein might be accommodated (McClintock and Shaw 
2003). The structure of SIP bound to Ca2+-S100A6 (~1100 Å) provides the first structural 
evidence for a target protein that occupies both the helix III-IV groove and helix I’ 
interface, a binding surface that is nearly twice the size of other S100 target protein 
surfaces (500-700 Å). Amongst the questions raised by this important structure and 
earlier hypotheses are – is there evidence for other S100 protein complexes that might 
utilize this larger target protein binding surface or can this surface possibly accommodate 
simultaneous binding for two distinct target proteins? 
 
1.9          Evidence for Multiprotein S100 Complexes Involving Annexin Proteins 
A variety of S100 protein interactions have been shown to be more complicated 
than a single target interacting per S100 protomer molecule. For example multiprotein 
complexes between S100A10 and annexin A2 and either AHNAK (Benaud et al. 2004; 
De Seranno et al. 2006), TRPV5/6 (van de Graaf et al. 2003; Borthwick et al. 2008) or 
plasminogen (MacLeod et al. 2003) have been identified from two- and three-hybrid or 
direct binding experiments. The S100A10-annexin A2 complex is thought to be necessary 
to recruit an additional target, or allow both targets to bind simultaneously indicating that 
the binding sites for AHNAK, TRPV5/6 and plasminogen on S100A10 are likely distinct 
from those of annexin A2. The complexes described here focus on those for S100A10, 
largely because it functions well in yeast two-hybrid experiments. Other S100 proteins 
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(S100B, S100A1, S100A6) do not respond well in this method due to the calcium-
sensitivity of their protein interactions, although homo- and heterodimeric S100 
complexes can be identified using two-hybrid experiments (Deloulme et al. 2000; 
Deloulme et al. 2003). 
The interaction between the transient receptor potential cation channel proteins 
TRPV5 and TRPV6 with S100A10 has been shown using two-hybrid and co-
immunoprecipitation experiments (Figure 1.8A) (van de Graaf et al. 2003; Borthwick et 
al. 2008). In this role, the S100A10-annexin A2 complex is thought to mediate trafficking 
of the TRPV5 and TRPV6 proteins to the plasma membrane where they act as calcium-
selective channels. The site of interaction on TRPV5 and TRPV6 for S100A10 has been 
localized to its intracellular C-terminal tail. Using a series of truncated and substituted 
proteins this has been refined to contain residues 598-603 (VATTV), a highly conserved 
region in both channel proteins. Although S100A10 forms a ternary complex with 
annexin A2 and either TRPV5 or TRPV6, there does not appear to be a direct interaction 
between the annexin and TRPV proteins based on negative results from 
immunoprecipitation experiments. Rather, S100A10 seems to bridge the two proteins 
indicative of different binding sites for annexin A2 and TRPV5/TRPV6, although this has 
not been demonstrated yet. Since S100A10 and annexin A2 co-localize with 
TRPV5/TRPV6, the S100A10-annexin A2 complex has been proposed to traffic these 
calcium channels to the plasma membrane. 
S100A10 has been shown to interact with the potassium channel TASK-1 using 
two-hybrid, GST pull-down and co-immunoprecipitation experiments, and has a role in 
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the trafficking of TASK-1 to the plasma membrane (Girard et al. 2002; Renigunta et al. 
2006). TASK-1 is an important regulator of membrane potential that can be affected by a 
variety of factors including pH, hormone and neurotransmitter binding. Two studies show 
binding of S100A10 to the C-terminus of TASK-1 albeit to different regions of the 
channel protein. In one study, S100A10 was observed to interact with the extreme C-
terminal sequence (SSV) of TASK-1 previously established as a site for 14-3-3 binding 
(Girard et al. 2002). In more recent work, the S100A10 site was localized to a more 
central region in the C-terminus (residues 292-331) of TASK-1 (Renigunta et al. 2006).  
A portion of this sequence is highly conserved in TASK-1 orthologs, but not in TASK-3, 
which exhibits little binding to S100A10. Further, a segment of this sequence 
(FRNVYAEML) bears a strong similarity to the interaction motif (XOOXXOOX) used 
by annexins A1 and A2 upon binding to S100A11 and S100A10, respectively (Mailliard 
et al. 1996; Rintala-Dempsey et al. 2008). An interaction between S100A10 and annexin 
A2 in the presence of TASK-1 can not be shown suggesting the S100A10 binding regions 
for TASK-1 and annexin A2 at least partly overlap. It has further been shown that the 
S100A10 interaction promotes retention of TASK-1 in the endoplasmic reticulum due to 
the presence of a retention signal at the extreme C-terminus of S100A10 (KQKGKK) 
(Renigunta et al. 2006). Alternatively, binding of S100A10 to TASK-1 has been 
suggested to mask an endoplasmic retention signal near the C-terminus of TASK-1 
(KRR) and promote trafficking of the potassium channel to the plasma membrane (Girard 
et al. 2002). 
S100A10 interacts with the bluetongue virus protein NS3 (Beaton et al. 2002), a 
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Figure 1.8. Possible involvement of S100A10 in multiprotein complexes.  
 
(A) Possible complexes formed by membrane channel proteins such as TRPV5, TRPV6 or Nav1.8 and S100A10-
annexin A2 for trafficking to the plasma membrane. Once inserted into the membrane, the S100A10-annexin A2 
could dissociate or become associated with phospholipids in the membrane. (B) Proposed interactions in the 
dysferlin complex are based on multiple biochemical experiments. The C-terminus of AHNAK is shown to 
interact with S100A10 and annexin A2, while the dysferlin C2A domain is near annexin A2 (adapted from Huang 
et al. 2007). In all cases, dimeric S100A10 could coordinate two annexin A2 proteins although for simplicity only 
one is shown. 
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membrane spanning protein thought to have a role in the export of virus particles from 
infected cells. Two-hybrid and affinity experiments show that residues at the N-terminus 
of NS3 (1-13) are most important for its interaction with S100A10. This region has the 
potential for α-helix formation and possesses a sequence (LSGLIQRF) corresponding to 
the annexin binding motif (XOOXXOOX) suggesting these two proteins likely share the 
same binding region on S100A10 (Figure 1.7B). Using synthetic peptides corresponding 
to the N-terminus of NS3, it was shown that a peptide comprising residues 1-14 could 
compete with annexin A2 for S100A10 binding. Whereas annexin A2 could displace NS3 
from an S100A10-NS3 complex, NS3 could only partially displace annexin A2 from an 
S100A10-annexin A2 complex indicating annexin A2 has a tighter binding to S100A10 
than does NS3. It was suggested that NS3 might play a role in localizing a virus particle 
to the interior of the plasma membrane by bridging S100A10 and the virus particle 
providing an efficient route for extrusion from the cell. 
The voltage-gated sodium channel Nav1.8 has been observed, using two-hybrid 
experiments, to interact with S100A10 (Figure 1.8A) (Okuse et al. 2002; Poon et al. 
2004). Further, this interaction facilitates trafficking of the channel protein to the plasma 
membrane resulting in functional Na+ currents. Other voltage-gated channels such as 
Nav1.2, Nav1.5, Nav1.7 and Nav1.9 have much poorer affinity for S100A10 providing 
evidence that some degree of specificity for the voltage-gated sodium channel Nav1.8 
exists. The site of interaction with S100A10 has been localized to the N-terminus of the 
sodium channel. In particular residues 74-103 of the voltage-gated sodium channel 
Nav1.8 are sufficient to bind to S100A10 in GST pull-down assays. Reciprocal 
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experiments using segments of S100A10 show that a region spanning much of the C-
terminal half of the protein is able to interact with the N-terminal region of the voltage-
gated sodium channel. This region does not include the extreme N- or C-termini of 
S100A10, known to interact with the annexin proteins so would appear to be a unique 
binding surface. However, it has not been shown whether annexin A2 can also bind to 
S100A10 in the presence of the sodium channel, an event that could facilitate association 
with the plasma membrane. 
A multiprotein complex has been identified between S100A10, annexin A2 and 
AHNAK (Figure 1.8B) (Benaud et al. 2004; De Seranno et al. 2006), a protein found in 
the lumen of enlargeosome and trafficked to the plasma membrane in response to calcium 
flux. Recruitment of AHNAK to the plasma membrane by S100A10 in complex with 
annexin A2 is also proposed to maintain the proper cytoarchitecture of epithelial cells 
(Benaud et al. 2004). AHNAK is an important protein for cell membrane differentiation 
and membrane repair (Kouno et al. 2004), is expressed in epithelial cells and localizes 
near the plasma membrane. The protein contains three main structural domains; an amino 
terminus (251 aa), a central region containing thirty-six repeats and a C-terminus (1002 
aa) (Shtivelman and Bishop 1993). The interaction between S100A10 and annexin A2 
utilizes the N-terminus of annexin A2 similar to that observed in the S100A10-annexin 
A2 tetramer crystal structure (Rety et al. 1999). In the absence of annexin A2, a weak 
interaction between S100A10 and the C-terminal portion of AHNAK is present. 
However, the strength of this interaction was increased more than 150-fold in the 
presence of annexin A2. Further, in vitro binding assays showed no detectable 
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interactions between annexin A2 and the C-terminus of AHNAK, in the absence of 
S100A10, or S100A10 with AHNAK in the absence of annexin A2. These observations 
suggest that S100A10-annexin A2 tetramer formation is likely a prerequisite for the 
interaction with AHNAK. Using a series of GST pull-down assays, a 20-residue region in 
AHNAK corresponding to residues 5654-5673 was found to be sufficient to bind to 
S100A10-annexin A2 and can compete for binding to the complex with the entire 
AHNAK C-terminus having a Kd of about 30 nM (De Seranno et al. 2006). The AHNAK 
interaction appears to be specific for annexin A2 since other annexins (A4, A11) are not 
recovered from immunoprecipitation experiments. However, given the similarity of the 
binding surfaces and interacting residues for annexins A1 and A2 (Rintala-Dempsey et al. 
2008), it is possible that an S100A10-annexin A1 or Ca2+-S100A11-annexin A1/A2 may 
also participate in the AHNAK complex. Interestingly, Ca2+-S100B is able to compete 
with S100A10-annexin A2 for binding to the AHNAK C-terminus. Further, it has been 
observed that Zn2+ binding to S100B enhance its association with AHNAK (Gentil et al. 
2001). Unlike the S100A10-annexin A2 interaction that utilizes only the C-terminus of 
AHNAK, several regions in AHNAK are able to interact with Ca2+-S100B. These include 
sequences in the repeat regions in the central portion of AHNAK (820-1330, 2589-3059, 
3730-4188) as well as its C-terminus. 
 
1.10        Role for S100 Proteins in Membrane Repair 
The fusion of cellular phospholipid membranes is an important step during 
membrane repair, vesicular trafficking and exocytosis. A requisite for plasma membrane 
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repair is calcium-regulated exocytosis, controlled by a number of proteins that 
coordinate resealing of the membrane. One exocytotic compartment implicated in 
membrane fusion is the enlargeosome, characterized by the large scaffolding protein 
AHNAK, that relocates to the plasma membrane immediately following membrane 
damage (Zhang, et al. 2004). In addition to AHNAK, calcium-sensors such as members 
from the synaptotagmin, ferlin (dysferlin) and annexin protein families are involved in 
membrane repair. Upon membrane rupture, these sensor proteins respond to the calcium 
influx by localizing near the inner membrane surface. Recent proteomic analyses have 
identified approximately 115 proteins in the dysferlin complex including calpain 3, 
annexin A2 and AHNAK (de Morree et al. 2010; Cacciottolo et al. 2011) that might be 
responsible for the repair process. These studies indicate that large protein complexes are 
likely needed to orchestrate the repair process and restore the integrity of the membrane.  
S100A10, AHNAK and the annexins have been shown to be constituent 
proteins in the dysferlin membrane repair complex (Huang et al. 2007). This multiprotein 
complex is thought to form at the site of muscle, epithelial and auditory cell damage to 
facilitate wound repair. The mechanism of cell membrane repair involves the aggregation 
of vesicles containing dysferlin, a type II membrane spanning protein, near the wound.  
In vivo and in vitro studies show that annexin A2 is a central protein involved in 
membrane transport events such as endo/exocytosis (Sarafian et al. 1991; Emans et al. 
1993; Harder and Gerke 1993; Diakonova et al. 1997; Harder et al. 1997; Jost et al. 1997; 
Merrifield et al. 2001; Knop et al. 2004; Ayala-Sanmartin et al. 2008; Zibouche et al. 
2008; Illien et al. 2010). Calcium-binding to the annexins promotes their localization and 
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association with phospholipid-containing membranes through the convex surface of the 
core domain (Swairjo et al. 1995). In the case of annexins A1 and A2, calcium binding is 
proposed to lead to the release of the previously buried N-terminus to an exposed position 
available for interaction with S100A10 protein (Gerke and Moss 2002). Thus, an 
S100A10 dimer can coordinate a pair of annexin A2 proteins, potentially bridging 
adjacent phospholipid membranes into close proximity during a membrane fusion event 
(Gerke and Moss 2002). This leads to the aggregation of vesicles and formation of an 
endomembrane patch (Figure 1.9). As with S100A10 and annexin A2, the AHNAK 
protein gets located on the plasma membrane (Kouno et al. 2004), where the interaction 
between dysferlin and this complex can mediate the docking and fusion of the patch and 
sealing of the membrane. For instance, a high calcium concentration (extracellular, via 
the wound) causes annexin A1 and A2 association with a dysferlin-containing vesicle and 
damaged plasma membranes. The central protein in this process, dysferlin (Doherty and 
McNally 2003; Shao et al. 2006; Glover and Brown 2007), has been shown to co-localize 
and co-immunoprecipitate with annexins A1 and A2 (Lennon et al. 2003). Recent three-
hybrid and co-immunoprecipitation experiments have also provided some details of the 
dysferlin repair complex. Using a series of truncated AHNAK constructs it has been 
shown that the extreme C-terminal domain of AHNAK is responsible for dysferlin 
binding. Although dysferlin possesses six ~130-residue C2 domains, the AHNAK 
interaction is localized to only the N-terminal C2A domain of dysferlin, a region that 
typically coordinates calcium as a prerequisite for phospholipid binding. Calcium binding 
to the dysferlin C2A domain is not a requirement for its interaction with AHNAK. 
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Figure 1.9. Hypothetical diagram illustrating possible interactions of the dysferlin complex important in membrane 
repair. 
 
(A) Under resting calcium levels (100 nM), apo-S100A10 interacts with the N-terminal region of annexin A2. (B) In the 
case of a lesion in the membrane, calcium influx raises the intracellular calcium concentration locally, triggering the patch 
repair response. Intracellular vesicles get aggregated by calcium-bound annexin A2 that is in complex with the S100A10 to 
form an endo-membrane patch. (C) This complex is trafficked to the site of disruption. Dysferlin and AHNAK molecules 
present on the plasma membrane mediate docking and fusion of the patch and sealing of the membrane. Proposed 
interactions in the dysferlin complex are based on multiple biochemical experiments. The C-terminus of AHNAK is shown 
to interact with S100A10-annexin A2 complex, while the dysferlin C2A domain is near annexin A2.  
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Although the exact mechanisms whereby AHNAK is recruited for plasma  membrane 
repair are not clear, annexin A2 and S100A10 co-localize with AHNAK at the plasma 
membrane along with dysferlin providing some evidence this multiprotein complex 
functions in the repair process.  
 
1.11        Scope of Thesis 
The multiple binding modes used by the S100 proteins to interact with a diverse 
array of target proteins suggest a great deal of flexibility in the manner an S100 protein 
recognizes a partner protein. This may prove useful to simultaneously coordinate more 
than a single target protein by some S100 proteins. Recent in vivo and in vitro 
experiments suggest that S100A10-annexin A2 can form multiprotein complexes with 
other proteins such as AHNAK and dysferlin that are important in plasma membrane 
repair.  
Lack of structural information on the arrangement, affinities and structures of 
these proteins in the complex does not allow understanding the mechanisms of membrane 
repair. Consequently, further biochemical and structural experiments will be needed to 
ascertain the general role of S100 proteins in larger multiprotein complexes. 
The main goals of this thesis were 1) design, synthesize and characterize a 
molecule that would facilitate assembly of larger S100 multiprotein complexes, 2) 
investigate the arrangement of the proteins, stoichiometry and affinity of AHNAK for the 
S100A10-annexin A2 complex and 3) identify structural details of the ternary complex 
formed between S100A10, annexin A2 and AHNAK complex. 
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The first objective was achieved by designing a hybrid protein in which 
S100A10 was linked in tandem to the N-terminus of annexin A2 (residues 1-15). The 
generality of this method was demonstrated by synthesizing a similar hybrid molecule 
between S100B and the central region of CapZ (TRTK12; residues 1-12). Using NMR 
spectroscopy, it was shown that the spectra for the S100A10-annexin A2 and S100B-
TRTK12 hybrid proteins are nearly identical to those obtained for the complexes formed 
between the individual S100 proteins and synthetic peptides. The hybrid S100A10-
annexin A2 protein was used in the peptide array experiments to uncover the binding 
region of this protein on AHNAK. The identified 20-residue C-terminal region of 
AHNAK with the strongest interaction to the S100A10-annexin A2 complex was then 
used in the remaining experiments. NMR spectrometry, non-denaturing electro-spray 
mass spectrometry (ES-MS) and fluorescence spectroscopy provided the evidence for a 
novel 1:1 interaction between an S100A10-annexin A2 dimer and an AHNAK peptide. 
The dissociation constant of the interaction between the AHNAK peptide and S100A10-
annexin A2 was determined by fluorescence spectroscopy. Finally, NMR spectroscopy 
and X-ray crystallography confirmed that the interaction of AHNAK to the S100A10-
annexin A2 complex utilizes residues from both, the S100A10 protein and annexin A2 
peptide. Chemical shift mapping produced a binding surface for the S100A10-annexin 
A2-AHNAK complex. These results provided a novel model of a larger protein assembly 
required during the membrane repair process. 
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Chapter 2 
Design of High-Affinity S100-Target Hybrid Proteins 
 
2.1          Introduction 
Although some structures of different S100 proteins bound to target peptides 
have been determined, only three crystal structures are available (S100A10-annexin A2, 
Ca2+-S100A11-annexin A1, Ca2+-S100B-TRTK12) (Rety et al. 1999; Rety et al. 2000; 
Charpentier et al. 2010). This is likely due to the difficulties associated with crystal 
formation of the S100-target complexes. Better progress has been made for S100-target 
complexes by NMR spectroscopy where structures such as calcium-bound S100B (Ca2+-
S100B) with peptide binding regions from p53 (Rustandi et al. 2000), Ndr kinase 
(Bhattacharya et al. 2003) and CapZ (Inman et al. 2002; McClintock and Shaw 2003) 
have been determined. However, some of these structures suffer from imprecision of the 
side chains, especially at the protein-peptide interface making details of the interaction 
difficult to characterize. This could be improved by 15N, 13C-labeling of the target peptide 
although this is very costly for a synthetic peptide and can suffer from low yields and 
proteolysis when expressed as a fusion protein. Only one example of a biosynthetic, 
isotopically-labeled peptide exists for the 30-residue Siah-1 interacting region for Ca2+-
S100A6 (Lee et al. 2008).  
 
Parts of this chapter have been taken from the published article: Rezvanpour, A., Phillips, 
J. M., and Shaw, G. S. 2009. Design of high-affinity S100-target hybrid proteins. Protein 
Sci. 18: 2528-2536. 
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In this chapter, a method is described in which S100B and S100A10 are used 
as the carrier proteins for target peptides from CapZ and annexin A2, respectively.  The 
premise is that the S100 protein will protect the target peptide from degradation during 
biosynthesis and purification. S100A10 and S100B proteins were linked to the N-terminal 
region of annexin A2 (residues 1-15) and the central region of CapZ (TRTK12; residues 
1-12) using linkers containing different protease cleavage sites to facilitate isolation of the 
target peptides. NMR spectroscopy has been used to show that the spectra for the 
S100A10-annexin A2 (A10A2) and S100B-TRTK12 (BT12) hybrid proteins are nearly 
identical to those obtained for the complexes formed between the individual S100 
proteins and synthetic peptides. 
 
2.2          Materials and Methods 
2.2.1       Source of Materials 
The expression vector for human S100A10 (pGEX-6P-1-derived vector, GE 
Healthcare) was generously provided by Dr. Michael Walsh (University of Calgary, 
Alberta, Canada). For expression vectors with an in-frame N-terminal GB1 fusion of 
TRTK12, annexin A2 and AHNAK, pSAF2 vector was obtained from Dr. Susan Safadi 
(University of Western Ontario). All forward and reverse oligonucleotides described 
within this chapter were synthesized by Sigma-Genosys (Mississauga, ON, Canada). T4 
DNA ligase was purchased from Fermentas Life Sciences (Burlington, ON, Canada). Pfu 
Turbo DNA polymerase was purchased from Stratagene (La Jolla, CA, USA). All other 
chemicals used in cloning were purchased from BioShop Canada (Burlington, ON, 
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Canada). PreScission protease was obtained from GE Healthcare (Buckinghamshire, 
UK). All DNA sequencing were performed at Robarts Research Institute Sequencing 
Facility (London, ON, Canada). 
15NH4Cl and 13C6-glucose were obtained from Cambridge Isotope Laboratories, 
Inc. (Andover, MA). Puratronic grade CaCl2 (99.9995% purity) was purchased from 
Johnson-Matthey (Ward Hill, MA). Annexin A2 (STVHEILSKLSLEG) and TRTK12 
(TRTKIDWNKILSLE) peptides were synthesized as previously described (McClintock 
and Shaw 2003; Rintala-Dempsey et al. 2006). All other reagents used in the following 
experiments were of the highest purity commercially available. 
 
2.2.2       Construction of GB1-TRTK12, -annexin A2, and –AHNAK in E. coli Expression 
Vectors 
pSAF2 plasmid, a derivative of the pGEV1 expression vector, containing an in-
frame N-terminal GB1 gene was used to construct the GB1-TRTK12 (residues 1-12), -
annexin A2 (residues 1-15), and –AHNAK (residues 5654-5673) genes. The genes were 
under control of a T7 RNA polymerase promoter and were used for inducible expression 
of them in E. coli. In these vectors the N-terminal GB1 gene was linked to the TRTK12, 
annexin A2, and AHNAK through a linker containing a thrombin protease cleavage site. 
Five glycine residues were added to enhance the accessibility of the protease cut site, 
which would be used to remove the GB1 tag following purification. There was also a His6 
tag at the C-terminus which was separated from TRTK12, annexin A2, and AHNAK by a 
tobacco etch virus (TEV) cleavage site.  
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The entire DNA sequences coding for TRTK12, annexin A2, and AHNAK 
were created using 5’-phosphorylated, one forward and one reverse single-stranded (ss), 
complementary primers (Table 2.1). The forward and reverse primers were designed such 
that following annealing, the double-stranded (ds) DNA fragment would have BamHI and 
XhoI over-hangs at the N- and C-terminus, respectively. 1 µL of 1 µg/µL stock solutions 
of the forward and reverse primers were mixed with 2 µL of Buffer 3 (50 mM Tris-HCl, 
100 mM NaCl, 10 mM MgCl2, 1 mM DTT, pH 7.9) and the total volume was adjusted to 
20 µL with ddH2O. The mixture was heated to 100 ºC for 2 minutes in a water bath to 
eliminate the secondary structure of the single-stranded oligonucleotides and slowly 
cooled down to room temperature to facilitate the proper annealing of the complementary 
oligonucleotides. The annealed reaction (5 µL) was mixed with 1 µL of Bromophenol 
blue and run on a 8 % native polyacrylamide gel in TBE (Tris-borate-EDTA) buffer. The 
gel was then stained in TBE buffer with ethidium bromide. The double-stranded DNA 
fragment was ligated with the BamHI and XhoI digested pSAF2 vector (Safadi and Shaw 
2007) using T4 DNA ligase and then transformed into E. coli strain JM-109. Single 
colonies were selected and the correct constructs were confirmed by DNA sequencing.  
 
2.2.3       Expression and Purification of GB1-TRTK12, -annexin A2, and -AHNAK 
The GB1-TRTK12, -annexin A2 and -AHNAK vectors were transformed into 
E. coli strain BL21 (DE3)-RIL expression cells (Invitrogen), which contain extra copies 
of the argU, ileY, and leuW tRNA genes to recognize AGA, AGG, AUA, and CUA 
codons. Overnight cultures (25 mL) were used to inoculate 1 L of pre-warmed LB  
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Table 2.1. Oligonucleotides used in synthesis of GB1-TRTK12, -annexin A2 and 
AHNAK expression vectors. 
Parental 
Vector 
Oligonucleotide  
Name 
Oligonucleotide  Sequence (5’-3’) Length 
 
TRTK (F2) 
 
GATCCATGACTCGTACTAAGATAGATTGGAACA 
AGATACTGTCTC 
 
 
45 
 
TRTK (R2) 
 
TCGAGAGACAGTATCTTGTTCCAATCTATCTTAG 
TACGAGTCATG 
 
 
45 
 
AnnexinII (F2) 
 
GATCCATGAGCACCGTACACGAAATCTTGAGCA 
AACTGTCCCTGGAAGGGC 
 
 
51 
 
AnnexinII (R2) 
 
TCGAGCCCTTCCAGGGACAGTTTGCTCAAGATTT 
CGTGTACGGTGCTCATG 
 
 
51 
 
AHNAK (F2) 
 
GATCCATGGGCAAAGTCACGTTCCCCAAAATGAA 
GATCCCTAAATTCACGTTCTCCGGCAGAGAGTTAC 
 
 
69 
 
 
 
 
 
 
 
pSAF1 
 
AHNAK (F2) 
 
TCGAGTAACTCTCTGCCGGAGAACGTGAATTTAG 
GGATCTTCATTTTGGGGAACGTGACTTTGCCCATG 
 
 
69 
   
57 
medium supplemented with 50 µg/mL ampicillin. The cultures were grown at 37 ºC to 
a density of (A600) 0.8 AU, when they were induced with 1 mM IPTG. Induction 
continued for another 4 h with constant shaking at 37 ºC. Cells were harvested by 
centrifugation at 6,000 rpm for 15 min at 4 ºC. Following addition of one complete-mini 
protease inhibitor tablet and PMSF (1 mM final concentration), the cells were lysed by 
French Pressure at 20,000 psi. Ultracentrifugation of the lysed cells was performed to 
remove cell debris on a Beckman ultracentrifuge at 38,000 rpm for 90 min. All 
fractionation steps were performed at 4 °C. The supernatant was filtered through 0.45 
micron low protein binding Millipore syringe filters (Millipore) to remove the particulate 
matter. The protein was subsequently applied to a 5 mL Ni-NTA column pre-equilibrated 
in 20 mM Tris-HCl, 10 mM imidazole, 300 mM NaCl, pH 8.0. The column was washed 
with the same buffer containing 20 mM imidazole until the OD280 returned to baseline. 
Bound protein was then eluted with a 30 mL, 20-250 mM imidazole gradient in the 
elution buffer. Fractions containing the protein were pooled and extensively dialyzed 
against TEV protease cleavage buffer (20 mM Tris-HCl, 150 mM NaCl, 10 mM 
imidazole, 1 mM DTT, pH 7.5) for 6 h with multiple buffer exchange. GB1-peptide was 
cleaved from the His6 tag using 250 units of TEV protease in 24 h with gentle agitation. 
Cleaved protein was purified on a 20 mL IgG Sepharose fast flow column (Amersham) in 
binding buffer to remove the His6 tag. Bound protein was eluted with 0.5 M acetic acid, 
pH 3.4. Protein fractions were pooled, dialyzed against thrombin cleavage buffer (20 mM 
Tris-HCl, 150 mM NaCl, 2.5 mM CaCl2, pH 8.4) and cleaved with a 1:2000 wt:wt ratio 
of thrombin to protein for 14 h at 20 ºC.  Cleaved GB1 was then isolated from the 
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peptides utilizing an IgG Sepharose column as described above. The integrity of all 
proteins was verified on 16.6% SDS-PAGE gel and electrospray ionization mass 
spectrometry (Biological Mass Spectrometry Laboratory, University of Western Ontario).  
 
2.2.4       Molecular Modeling of Hybrid S100 Proteins 
The lengths of the linker connecting S100A10 to annexin A2 or S100B to 
TRTK12 were determined using Swiss-PDB Viewer (Guex and Peitsch 1997). The 
coordinates for S100A10 bound to annexin A2 (PDB code: 1BT6) (Rety et al. 1999) and 
Ca2+-S100B complexed with TRTK12 (PDB codes: 1MQ1, 1MWN) (Inman et al. 2002; 
McClintock and Shaw 2003) were obtained from the Protein Data Bank (Berman et al. 
2000). The last four residues at the C-terminus of S100A10 were disordered and not 
visible in the structure. Initial linkers were built using glycine spacers with moderate 
rotations of φ,ψ angles. A total of nine glycine residues was required to connect the 
observed C-terminus of S100A10 (K91) to the N-terminus of the annexin A2 peptide 
(STVHEILSKLSLEG). Eleven glycine residues were added in the S100B-TRTK12 
(BT12) hybrid from the C-terminus of the S100B (E91) to the N-terminus of the TRTK12 
peptide (TRTKIDWNKILS). Each structure was energy minimized using steepest descent 
minimization. Upon completion, glycine residues were swapped to those corresponding 
to the TEV (S100A10) or PreScission (S100B) cleavage sites. Subsequent energy 
minimization and visualization was used to insure the absence of bad contacts between 
the linker residues and the corresponding S100 protein.  
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2.2.5       Construction of the S100A10-annexin A2 Hybrid Gene 
A derivative of the pGEX-6P-1 expression vector containing the human 
homologue of S100A10 was used to construct the A10A2 hybrid gene. The QuikChange 
method (Stratagene, La Jolla, CA) was used in three consecutive steps to a) substitute the 
last four amino acid residues of S100A10; K93E, G94N, K95L, K96Y, b) insert a TEV 
protease cleave site, and c) generate the annexin A2 hybrid DNA fragment. Forward and 
reverse primers used in these procedures are shown in Table 2.2. The resulting vectors at 
each step of the cloning were confirmed by DNA sequencing. 
 
2.2.6       Expression and Purification of S100A10 and S100A10-Annexin A2 
Uniformly 15N, 13C-labeled GST-S100A10 and GST-S100A10-annexin A2 
(A10A2) were over-expressed in the BL21 (DE3) Codon Plus E. coli strain using M9 
minimal medium supplemented with 1 g 15NH4Cl and 2 g 13C6-glucose as the sole 
nitrogen and carbon sources, respectively. The cultures were grown at 37 ºC in the 
presence of ampicillin (50 µg/mL) to a density of (A600) 0.8 AU, then induced by adding 
1 mM IPTG. Induction continued for another 8 h with constant shaking at 37 ºC. Cells 
were harvested by centrifugation at 6,000 rpm for 15 min and lysed by French Pressure at 
20,000 psi. Cell debris was removed by centrifugation at 38,000 rpm for 90 min. All 
fractionation steps were performed at 4 °C. The supernatant was applied to a 5 mL 
glutathione-linked Sepharose column equilibrated in PBS buffer (140 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.3). The 15N, 13C-labeled GST-S100A10 or 
GST-A10A2 were eluted in elution buffer (50 mM Tris-HCl, 20 mM reduced glutathione, 
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Table 2.2. Oligonucleotides used in synthesis of A10A2 expression vector. 
 
 
 
Parental 
Vector 
Oligonucleotide  
Name 
Oligonucleotide  Sequence (5’-3’) Length 
 
S100A10-
AnX(F1) 
 
GTGCACATGAAGCAGGAGAACCTGTACTGACTCGA
GCGGCCG 
 
 
42 
 
S100A10-
AnX(R1) 
 
CGGCCGCTCGAGTCAGTACAGGTTCTCCTGCTTCAT
GTGCAC 
 
 
42 
 
S100A10-
AnX(F2) 
 
CAGGAGAACCTGTACTTTCAAGGGGATTCCACAGTT
TGACTCGAGCGGCCG 
 
 
51 
 
S100A10-
AnX(R2) 
 
CGGCCGCTCGAGTCAAACTGTGGAATCCCCTTGAAA
GTACAGGTTCTCCTG 
 
 
51 
 
S100A10-
AnX(F3) 
 
GGGGATTCCACAGTTCACGAGATTCTGTCGAAATGA
CTCGAGCGGCCG 
 
 
48 
 
S100A10-
AnX(R3) 
 
CGGCCGCTCGAGTCATTTCGACAGAATCTCGTGAAC
TGTGGAATCCCC 
 
 
48 
 
S100A10-
AnX(F4) 
 
CACGAGATTCTGTCGAAACTATCTCTAGAAGGGGAC
TGACTCGAGCGGCCG 
 
 
51 
 
S100A10 
 
S100A10-
AnX(R4) 
 
CGGCCGCTCGAGTCAGTCCCCTTCTAGAGATAGTTT
CGACAGAATCTCGTG 
 
 
51 
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pH 8.0). Fractions containing the protein were pooled and extensively dialyzed against 
PreScission protease cleavage buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 
mM DTT, pH 7.0) overnight. S100A10 or A10A2 were cleaved from the glutathione S-
transferase protein using 150 units of PreScission protease in 48 h. The cleaved protein 
was applied to a GST column in binding buffer and the flow-through fractions were 
collected. MALDI-TOF mass data for A10A2 (MWcalc = 14517.9 Da; MWobs = 14507.2 
Da for 15N, 13C-labeled protein) confirmed the protein identities. 
 
2.2.7       Construction of the S100B-TRTK12 Hybrid Gene 
The pSS2 expression vector containing human S100B was utilized to construct 
the S100B-TRTK12 (BT12) hybrid gene (Smith et al. 1996). In the first step, a unique 
XhoI reporter cut site (5’ C↓TCGAG 3’) was generated directly adjacent to the stop codon 
of the S100B coding sequence using the QuikChange kit (Stratagene, La Jolla, CA). The 
primers used are shown in Table 2.3. The PCR reaction was conducted using Pfu Turbo 
DNA polymerase (Stratagene, La Jolla, CA) and the parental DNA was digested with 
DpnI endonuclease (Bostrom et al.). The amplified, nicked PCR product was then 
transformed into the competent E. coli strain JM109 to repair the nick of the mutant DNA 
fragment. Single colonies were selected and the correct constructs were confirmed by 
DNA sequencing. The vector was then cleaved with XhoI restriction enzyme and 
dephosphorylated with 1 µL of alkaline phosphatase (Amersham Pharmacia Biotech) to 
prevent religation of the cut vector. The digestion reaction was run on a 1% agarose gel 
and the corresponding band was extracted using QIAquick Gel Extraction Kit (Qiagen).  
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Forward and reverse primers (5’-phosphorylated, Sigma-Aldrich) 
corresponding to residues from the linker region, the entire TRTK12 peptide and 
appropriate XhoI site over-hangs (Table 2.3) were annealed together as described in 
Section 1.2.2. The double-stranded DNA fragment was ligated with the unique XhoI site 
of the dephosphorylated vector containing the S100B gene using T4 DNA ligase and then 
transformed into E. coli strain JM-109. Single colonies were selected and the correct 
orientation and a single insertion of the annealed primers in the resulting vectors were 
confirmed by DNA sequencing.  
 
2.2.8        Expression and Purification of S100B and S100B-TRTK12 
Expression and purification of uniformly 15N, 13C-labeled BT12 in Escherichia 
coli strain N99 were conducted as described for human S100B (Smith et al. 1996). The 
protocol was modified by reducing the (NH4)2SO4 concentration to 50% saturation due to 
the decreased solubility of BT12 compared to S100B. Following dialysis (25 mM Tris-
HCl, 100 mM NaCl, 1 mM DTT, and 5 mM CaCl2, pH 7.5), BT12 was applied to a 
phenyl-Sepharose (Amersham Biosciences) column equilibrated in the same buffer. The 
column was washed (25 mM Tris-HCl, 100 mM NaCl, 1 mM DTT, 1 mM CaCl2, pH 7.5) 
and BT12 was eluted with EGTA buffer (25 mM Tris-HCl, 100 mM NaCl, 1 mM DTT, 
and 1 mM EGTA, pH 7.5). MALDI-TOF mass data for 15N-labeled BT12 
(desformylmethionine MWcalc = 13430.2 Da; MWobs = 13427.3 Da,  desformyl MWcalc = 
13563.2 Da; MWobs = 13559.5 Da, and formylmethionine MWcalc = 13591.2 Da; MWobs = 
13587.6 Da) confirmed the presence of the three chemically different forms of BT12 at 
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Table 2.3. Oligonucleotides used in synthesis of BT12 expression vector. 
 
 
 
 
Parental 
Vector 
Oligonucleotide  
Name 
Oligonucleotide  Sequence (5’-3’) Length 
 
XhoIfor 
 
GGCTGCTTTCTAATCTCACTCGAGCTCATGTTCAAA
GAACTCG 
 
 
43 
 
 
S100B 
 
 
 
 
XhoIrev 
 
CGAGTTCTTTGAACATGAGCTCGAGTGAGATTAGAA
AGCAGCC 
 
43 
 
Linker  
TRTK-for 
 
 
TCGACCTCTTCCAAGGCCCAGGCGGCGGCGGCACTC
GTACTAAAATAGATTGGAACAAGATACTCTCTC 
 
 
69 
 
 
S100B-
XhoI 
 
Linker 
TRTK-rev 
 
 
TCGAGAGAGAGTATCTTGTTCCAATCTATTTTAGTA
CGAGTGCCGCCGCCGCCTGGGCCTTGGAAGAGG 
 
 
69 
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 its N-terminus similar to those previously characterized for S100B (Smith et al. 1997).   
 
2.2.9       NMR Spectroscopy 
All NMR experiments were acquired at 35 ºC on a Varian INOVA 600 MHz 
spectrometer equipped with a 13C-enhanced triple resonance cold probe.  NMR samples 
of 0.5 mM (monomer) uniformly 15N, 13C-labeled S100A10 and A10A2 were prepared in 
10% D2O, 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic 
acid, and 100 mM NaCl buffer at pH 7.0, and 100 µM DSS as an internal standard. 
Uniformly 15N, 13C-labeled NMR samples of 0.7 mM S100B and BT12 were prepared in 
a similar buffer using either 20 mM CaCl2 or 1 mM EDTA. Sequential 1H, 13C, and 15N 
resonance assignments of A10A2 and calcium saturated BT12 were completed using 
HNCACB (Wittekind and Mueller 1993), CBCA(CO)NH (Grzesiek and Bax 1992a), 
HNCO (Kay et al. 1990), HNCA (Grzesiek and Bax 1992b), and C(CO)NH experiments 
(Kay 1993). Sensitivity-enhanced 1H-15N HSQC spectra (Kay et al. 1992) for A10A2 
were acquired using carrier frequencies of 4.705 (1H) and 114.0 ppm (15N) and spectral 
widths of 8000.0 and 1700.0 Hz, respectively. Similar spectra were generated for Ca2+-
BT12 using carrier frequencies of 4.702 (1H) and 120.0 ppm (15N) and spectral widths of 
8000.0 and 2000.0 Hz, respectively. All data were processed using NMRPipe and 
NMRDraw (Delaglio et al. 1995) and spectra were analyzed by NMRView (Johnson and 
Belvins 1994). The 1H-15N HSQC spectra of the 15N, 13C-labeled A10A2, and BT12 
hybrid proteins cleaved with TEV and PreScission proteases were acquired 48 h 
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following the addition of 16 units of each of the enzymes respectively. The presence of 
the fully cleaved product in the NMR sample was verified by SDS-PAGE.  
 
2.2.10     NMR Titration Experiments 
The 15N, 13C-labeled S100A10 in complex with annexin A2 peptide was 
prepared by the titration of 0.5 mM (monomer) S100A10 with a 20 mM stock solution of 
annexin A2 peptide under constant buffer conditions. A final peptide concentration of 0.8 
mM was used. The pH of the sample remained at 7.0 throughout the titration. The sample 
was mixed after each addition and equilibrated for 15 minutes. The total volume increase 
of the NMR sample was 24 µL (4%). 1H-15N HSQC spectra were recorded at each point 
to monitor the titration. A sample of 0.7 mM (monomer) apo-S100B was prepared in 12 
mM CaCl2 and titrated with a 20 mM stock solution of TRTK12 peptide in the same 
buffer (above) to a final peptide concentration of 0.9 mM. The pH of the sample remained 
at 7.0 throughout the titration. 
 
2.3          Results  
2.3.1       Cloning of GB1-TRTK12, -annexin A2, and -AHNAK in Expression Vectors 
In order to obtain pure bacterially expressed peptides, the peptide sequence was 
fused to a larger, stable and soluble protein which would not only protect it from 
proteolysis in the cell but also improve its solubility. Previous attempts to biosynthetically 
prepare annexin A1 and A2 peptides using GST-tagged constructs lead to <1 mg 
peptide/L culture and the isolated peptide was prone to proteolysis (Rintala-Dempsey, 
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unpublished results). The approach opted here involved expression of TRTK12 
(TRTKIDWNKILS), annexin A2 (STVHEILSKLSLEG), and AHNAK 
(GKVTFPKMKIPKFTFSGREL) peptides as GB1 fusion proteins. The B1 
immunoglobulin binding domain of streptococcal protein G (GB1) is a smaller, N-
terminal protein of about 56 residues (Huth et al. 1997; Safadi and Shaw 2007), which 
was linked to the peptides through 5 glycine residues and a thrombin cleavage site 
(LVPR/GS) as outlined in Figure 2.1. To further protect the C-terminus of the peptides 
from degradation by proteases and to facilitate the isolation of untagged peptides, the 
peptides were linked to a C-terminal His6 tag through a TEV cleavage site (ENLYFQ/S).  
The insert for each cloning reaction was designed as single-stranded primers 
(forward and reverse) encoding the entire sequence of each one of the peptides with a 
minimum of 41 complementary bases (Figure 2.1). Proper annealing of the two primers 
would generate a double-stranded DNA fragment containing over-hangs compatible with 
those created by Bam HI and Xho I endonucleases at the N- and C-terminus, respectively. 
The double-stranded DNA fragments were readily inserted with the correct orientation 
into the Bam HI and Xho I endonucleases cut sites of digested pSAF2 vector (Figure 2.2). 
 
2.3.2       Expression and Purification of GB1-TRTK12, -annexin A2, and -AHNAK 
In order to obtain unlabeled, 15N-labeled and 15N, 13C-labeled TRTK12, annexin 
A2 and AHNAK peptides, bacterial overexpression of GB1 fusion peptides was 
examined in 1 L of LB. High levels of expression of unlabeled GB1-TRTK12 after 
induction with 1 mM IPTG are illustrated in Figure 2.3. Similar results were observed
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Figure 2.1. Development of cloning and purification procedures for a GB1-TRTK12 fusion protein.  
 
N-terminal GB1 was linked to TRTK12 through 5 glycine residues and a thrombin cleavage site. A C-terminal His-tag 
was also connected to the peptide by a TEV cleavage site. The forward and reverse single-stranded oligonucleotides 
were designed encoding the entire amino acid sequence of the TRTK12 peptide with 41 complementary bases. Annealed 
primers would generate a double-stranded DNA fragment containing Bam HI and Xho I sticky ends at the N- and C-
terminus, respectively. The DNA fragment was then inserted into pSAF2 vector. Expression of pSAF2-TRTK12 in E. 
coli is followed by purification using the Ni-NTA and IgG-Sepharose fast flow columns.  
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Figure 2.2. Cloning of GB1-TRTK12, -annexin A2 and -AHNAK.  
 
The DNA samples (5 uL) are run on a 1% agarose gel stained with ethidium bromide. 
The sizes for the molecular standard bands are indicated on the left. Lane 1 contains the 
molecular weight DNA ladder. Lanes 2, 3 and 4 contain the DNA for GB1-TRTK12, -
annexin A2 and -AHNAK, respectively. 
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for the GB1-annexin A2 and -AHNAK fusion proteins. Following cell lysis, the 
supernatant was loaded onto a Ni-NTA column. Bound protein was then eluted by 
increasing the level of imidazole in the elution buffer. After dialysis of GB1-TRTK12, the 
protein was cleaved from the His6 tag using TEV protease and purified on an IgG 
Sepharose fast flow column that binds to the GB1 domain of the protein. Bound protein 
was eluted at low pH with 0.5 M acetic acid (pH 3.4). A Coomassie-stained SDS-PAGE 
gel of the fractions is presented in Figure 2.4 showing 3 major bands: the first and second 
ones are slightly below and above 10 kDa molecular standard marks respectively, and the 
third one around 15 kDa. To identify the band corresponding to GB1-TRTK12, a sample 
from one of the fractions was sent for electrospray ionization mass spectrometry. Figure 
2.5 shows a mass spectrum of three species in the sample with molecular weights of 
15667.11, 7598.55, and 9294.42 Da. The peak at 9294.42 Da was in good agreement with 
the calculated molecular weight of intact GB1-TRTK12 (MWcal = 9296.2 Da) and 
appeared as the middle band on the SDS-PAGE gel. This band ran slightly above 10 kDa 
molecular standard mark, which is a characteristic of GB1 bound proteins (Safadi and 
Shaw 2007).  The peak with molecular weight of 7598.55 Da represents the proteolytic 
product of GB1-TRTK12 (MWcal = 7600.2 Da), where the entire sequence of TRTK12 
peptide as well as two residues from the linker (S and M) are cleaved from the GB1 
fusion protein. Finally, the contaminating protein at 15667.11 Da is the light chain of the 
IgG protein that is bound to the Sepharose beads of the column and breaks down due to 
the low pH of the elution buffer.  
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Figure 2.3. SDS-PAGE analysis of the overexpression of unlabeled GB1-TRTK12 
fusion protein.  
 
GB1-TRTK12 was expressed as described in Chapter 2 (Section 2.2.3). An aliquot of the 
cells before and after induction with IPTG were suspended in SDS sample buffer, heated 
to 90ºC for 5 min and then subjected to electrophoresis on 16.5% SDS-polyacrylamide 
gels and protein bands were visualized with Coomassie Brilliant Blue stain. Lane 1 
contains the molecular weight standards. The positions and sizes of molecular weight 
standards are indicated on the left. Lane 2 shows total cellular protein prior to induction 
with IPTG of the 1 L culture batch. Lanes 3 contains total cellular protein 5 hours after 
induction of 1 L culture at 37 °C. The arrowhead indicates a high level of expression for 
the GB1-TRTK12 (9.3 kDa) fusion protein.  
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Figure 2.4. Purification of GB1-TRTK12 on IgG Sepharose fast flow column.   
 
The protein was expressed in E. coli strain Bl21 (DE3)-RIL and lysed cells were purified 
as described in Chapter 2 (Section 2.2.3). Following the first purification step on the Ni-
NTA column, fractions containing the protein were dialyzed against TEV protease 
cleavage buffer. GB1-TRTK12 was cleaved from the His6 tag using TEV protease and 
applied to IgG Sepharose fast flow column. Bound protein was eluted with 0.5 M acetic 
acid, pH 3.4. Only lanes of fractions in which GB1-TRTK12 eluted are shown here. Lane 
1 contains the molecular weight standards. The positions and sizes of molecular weight 
standards are indicated to the left of each gel. Lanes 2-13 contain elution profile of every 
fraction. The arrowhead indicates the band for GB1-TRTK12 (9.3 kDa) fusion protein.  
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Figure 2.5. Mass spectrum of unlabeled GB1-TRTK12.  
 
Following purification of the protein, excess salt was removed. The sample was then subjected to mass 
spectrometric analysis. The analysis resulted in three peaks at molecular masses of 7598.55, 9294.42, and 
15667.11 Da. The peak at 9294.42 agrees with the calculated mass of GB1-TRTK12. 
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Changing the order of columns or addition of protease inhibitors did not 
improve the yield, as the TRTK12 peptide was degraded very quickly in solution. Since 
similar results were observed for the GB1-annexin A2 and –AHNAK fusion proteins, a 
different approach was taken to bacterially express the peptides. 
 
2.3.3       Design of Hybrid S100-Target Proteins  
In order to generate hybrid S100-target protein complexes, two systems that 
have been well characterized by structural methods were chosen. The approach taken was 
to analyze the relative positions of the S100 proteins and their target peptides in the 
structures and then incorporate a linker between the two components to create a hybrid 
protein. The first structure employed S100A10 in complex with the N-terminus of 
annexin A2 (1BT6) (Rety et al. 1999), and a second structure utilized Ca2+-S100B 
complexed to a portion of the alpha-1 subunit of F-actin capping protein (TRTK12), 
CapZ (1MWN, 1MQ1) (Inman et al. 2002; McClintock and Shaw 2003). In both these 
structures (Figure 2.6), the C-termini of helix IV in the S100 protein are proximal to the 
N-terminus of the binding peptide. Although S100A10 and Ca2+-S100B are structurally 
similar, the orientations and distances of the annexin A2 and TRTK12 peptides with 
respect to the S100 protein are quite different. Further, in the A10A2 complex the 
distance from the C-terminal carboxyl carbon of S100A10 (K91) to the N-terminal 
nitrogen of annexin A2 is about 16 Å. For the Ca2+-S100B complexed with TRTK12 the 
distance ranges from about 14 - 26 Å in the families of NMR structures. The choice of 
these two proteins allowed for testing this approach with one protein (S100B) that 
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undergoes a calcium-induced conformational change in order to interact with a target, 
and one protein (S100A10) that is calcium-insensitive. Further, the structures of the target 
peptides in both structures are quite different. The annexin A2 peptide adopts an α-helical 
conformation for most of its sequence while the TRTK12 peptide is unstructured at its N-
terminus followed by a single turn of α-helix. 
The A10A2 is comprised of a linker spanning the measured protein-peptide 
distance (16 Å) in the S100A10-annexin A2 complex connecting the two proteins. 
Although this distance is sufficient to accommodate about five amino acid residues linked 
in a linear fashion, modeling showed that a further four residues were required in A10A2 
hybrid protein to allow favorable φ,ψ angles in the linker. Within the nine-residue linker, 
a TEV protease cleavage site (ENLYFQ/G) was introduced. Finally, an aspartic acid at 
the N-terminus of the annexin A2 sequence was added to stabilize its α-helical structure 
(Figure 2.6A) in lieu of the acetyl group found in the native protein (Johnsson et al. 
1988). For the BT12 the maximum linker length observed in the NMR structures (~26 Å) 
allowed approximately 11 residues to bridge the protein and target. Within this region a 
PreScission protease cut site (LFQ/GP) and four glycine residues were included (Figure 
2.6B). The PreScission protease site allowed testing a different protease for the BT12 
hybrid compared to the TEV site in the A10A2 hybrid protein. Since the Ca2+-S100B 
complexes with TRTK12 are ensembles of NMR structures, the N-terminus of TRTK12 
exhibits a wide range of positions with respect to Ca2+-S100B. This may be due to the 
flexibility of this region in TRTK12 not observed for annexin A2 in the S100A10 
complex. The glycine residues were added in BT12 to maintain backbone flexibility of 
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Figure 2.6. Models of the S100A10-annexin A2 (A10A2) and Ca2+-S100B-TRTK12 (BT12) hybrid constructs.  
 
Ribbon representations of S100A10 in complex with (A) annexin A2 (1BT6) (Rety et al. 1999) and (B) Ca2+-S100B 
bound to TRTK12 (1MWN) (Inman et al. 2002) are shown in similar orientations to demonstrate how the annexin A2 
and TRTK12 peptides (magenta) are joined to the S100 proteins through a linker (cyan). In each model one of the 
protomers is presented in light gray (helices labeled as I-IV) and the other protomer shaded in black (helices labeled as 
I’-IV’). Four bound calcium ions are shown as yellow spheres for Ca2+-S100B. The corresponding schematics of the 
constructs used for A10A2 and BT12 hybrid proteins are also illustrated with S100 protein located at the N-terminus 
(grey), annexin A2 and TRTK12 peptides positioned at the C-terminus (magenta), and the linker (cyan) connecting the 
S100 proteins to the target peptides. The amino acid composition of the linker region and the corresponding protease 
cleavage sites are indicated. All numbering is consecutive based on the S100 protein sequences. 
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the linker. During the design process, the linkers for both proteins were incorporated 
into the existing structures by modeling. Energy minimization was used to ensure that the 
hybrid proteins were not constrained or distorted, or that the linker did not make any 
significant contacts with the S100 protein that might mask the protease cleavage sites.  
 
2.3.4       Cloning, Expression and Purification of Hybrid S100-Target Proteins 
Figure 2.7 shows the DNA product of the last cloning step for A10A2 and 
BT12. The DNA band for A10A2 appears higher than the 5000 bp molecular standard 
mark which is close to the correct molecular weight of 5334 bp. However, the BT12 
DNA band ran lower (around 4500 bp) than the expected molecular weight of 6357 bp. 
This is most likely caused by the supercoiling of the BT12 DNA causing the DNA to run 
farther in the gel. Both the A10A2 and BT12 hybrid proteins were expressed using a 
BL21 (DE3) codon-plus E. coli strain. Following purification, the typical yield was 15-25 
mg of 15N, 13C-labeled A10A2 or BT12 protein from 1L M9 minimal media cultures for 
heteronuclear NMR spectroscopy experiments. Based on the molecular weights of the 
peptides, proceeding with the cleavage of the hybrid proteins would approximately yield 
2-4 mg of the isolated peptides. SDS-PAGE (Figure 2.8) and MALDI-TOF mass 
spectroscopy analyses showed that the proteins were homogeneous and free of 
degradation products, similar to the parent S100B and S100A10 proteins. In both A10A2 
and BT12, the accessibility of the protease cleavage sites was tested by proteolysis using 
TEV and PreScission proteases, respectively. In both cases cleavage proceeded to 
completion allowing separation of the S100 protein and peptide partner (Figure 2.8). 
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Figure 2.7. Cloning of A10A2 and BT12.  
  
The DNA samples (5 uL) are run on a 1% agarose gel stained with ethidium bromide. 
The sizes for the molecular standard bands are indicated on the left. Lane 1 contains the 
molecular weight DNA ladder. Lanes 2 and 3 contain the DNA for A10A2 and BT12, 
respectively.  
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Figure 2.8. Coomassie-stained SDS-PAGE gel (16.5%) depicting the purification of 
A10A2 and BT12 constructs.  
 
Lane 1 contains the protein molecular weight markers, with molecular weights labeled on 
the left of the gel. Lanes 2 and 5 contain S100B and S100A10, while BT12 and A10A2 
hybrid constructs are presented in lanes 3 and 6, respectively. Lanes 4 and 7 show S100B 
and S100A10 following cleavage of BT12 and A10A2 by PreScission and TEV 
proteases, respectively. Each of these proteins run at a higher molecular weight than the 
parent due to the presence of the linker that remains appended to the C-terminus of the 
S100 protein. The TRTK12 and annexin A2 peptides are not observed.  
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2.3.5       The S100A10-Annexin A2 Hybrid Protein Adopts an Active Configuration 
The A10A2 hybrid protein was examined by NMR spectroscopy to determine if 
the complex retained the similar structure observed in the crystal structure for S100A10 
in combination with the N-terminal annexin A2 peptide. Using standard heteronuclear 
multiple dimensional NMR spectroscopy (HNCA, HNCACB, and CBCA(CO)NH), 
chemical shift assignments (1H, 15N, and 13C) for A10A2 (Figures 2.9 and 2.10) (Table 
2.4) and BT12 (Figures 2.11 and 2.12) (Table 2.5) proteins were completed. Figure 2.10 
shows a representative 1H-15N HSQC spectrum of A10A2 that is well dispersed and 
characteristic of a folded S100 protein. The spectrum of A10A2 is remarkably similar to 
that of 15N, 13C-labeled S100A10 in complex with the unlabeled annexin A2 peptide 
(Figure 2.13). The 1H-15N correlations for all residues in the annexin A2 segment (S101-
D115) and the TEV cleavage site (E93-G99) were easily identified in A10A2 (Figure 
2.10). These residues are not visible in Figure 2.13 where the annexin A2 peptide is 
unlabeled. The resonances for residues S101-D115 are well separated ranging between 
7.1 (S108) and 8.9 ppm (T102) indicating the annexin A2 portion of the hybrid is well 
folded. In contrast, the linker residues form a tight cluster between 7.9-8.3 ppm indicating 
this region of the A10A2 hybrid adopts little regular secondary structure. Backbone 
assignment of A10A2, and S100A10 in complex with individual annexin A2 peptide 
allowed the chemical shifts of each residue to be compared between the two complexes 
(Figure 2.14) as well as that for other Ca2+-bound S100 proteins, indicating that little 
structural change has occurred in the S100A10 protein by incorporating the C- terminal 
linker and annexin A2 sequences. For BT12 a specific interaction between the S100B and 
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Figure 2.9. Selected regions of 600 MHz NMR spectra used for the backbone 
assignment of the A10A2 complex.  
 
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the 
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of 
the three-dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i) 
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous 
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for 
sequential assignment of residues S111-G114 of A10A2.  
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Figure 2.10. Backbone amide assignments of A10A2 hybrid protein.  
 
1H-15N HSQC spectrum of 0.5 mM (monomer) uniformly 15N, 13C-labeled A10A2 hybrid 
protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was collected 
in 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 100 
mM NaCl, pH 7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated with their 
one letter amino acid code and number. The residues from 15N, 13C-labeled annexin A2 
are presented in pink and those from the linker region in cyan. Pairs of resonances for 
sidechain amide cross peaks are connected by horizontal lines. Peaks visible at lower 
contour levels are indicated by boxes. 
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Table 2.4. 15N, 13C and 1H resonance assignments for human A10A2. 
 
Residue HN N C’ Cα  Cβ Other 
G-5 
  
 
   
P-4 
  
176.09 63.30 32.14 Cγ (27.00), Cδ (49.63) 
L-3 8.492 122.3 178.10 55.49 42.33 Cγ (27.31), Cδ1 (24.82) 
Cδ2 (23.67) 
G-2 8.391 109.6  45.43   
S-1 8.198 115.7  58.07 64.25  
M0 8.190 122.3  53.23 32.83  
P1 
  
176.95 62.46 31.92 Cγ (27.66), Cδ (50.37) 
S2 8.953 118.8 175.25 56.87 65.50  
Q3 9.552 120.6 180.37 59.63 28.19 Cγ (34.83), Cδ (180.53)  
Nε2 (112.78) 
M4 8.960 119.7  56.81 30.84  
E5 
  
179.49 60.18 29.43 Cγ (37.52) 
H6 8.385 117.9 178.02 59.47 29.80  
A7 8.531 124.9 176.62 55.84 18.56  
M8 8.523 118.0 177.91 60.31 35.24 Cγ (30.62) 
E9 8.315 120.2 177.83 60.53 29.92 Cγ (37.43) 
T10 8.599 116.6 178.12 67.36 68.02 Cγ2 (21.43) 
M11 8.069 122.7 177.21 61.30 32.59  
M12 8.178 117.9 177.83 59.99 35.10 Cγ (31.74) 
F13 9.353 117.0  60.09 37.64  
T14 
  
175.24 68.35  Cγ2 (21.17) 
F15 7.440 119.2 176.02 62.81 38.79  
H16 7.592 115.7 178.06 61.16 31.47  
K17 8.467 122.3 177.87 59.40 32.04 Cγ (24.23), Cδ (29.33)  
Cε (42.01) 
F18 7.111 114.5 178.06 60.78 40.39  
A19 8.482 122.3 179.07 53.87 18.72  
G20 7.505 100.9 174.06 44.96   
D21 7.948 111.8  56.04 42.48  
K22 
  
178.38 57.80 31.04 Cγ (23.30) 
G23 7.298 103.5 172.65 46.71   
Y24 6.912 114.1 171.76 55.49 40.13  
L25 8.967 117.5 178.21 52.86 43.36 Cγ (27.15), Cδ1 (23.65)  
Cδ2 (20.36) 
T26 9.286 113.1 175.58 60.53 71.82  
K27 9.136 120.6 178.24 60.77 32.04 Cγ (24.96), Cδ (29.23)  
Cε (41.94) 
E28 8.107 117.5 178.78 59.65 29.01 Cγ (36.65) 
D29 7.635 120.1 177.83 57.02 42.75  
L30 8.465 118.8 177.76 57.77 41.71 Cγ (26.56), Cδ1 (23.99), 
Cδ2 (23.47) 
R31 8.174 119.3 177.80 60.60 29.79 Cγ (27.15), Cδ (43.08) 
V32 7.680 117.9 177.30 66.35 31.66 Cγ2 (22.33), Cγ1 (22.33) 
L33 8.070 122.3 179.33 59.41 42.03 Cγ (28.07), Cδ1 (24.02)  
Cδ2 (24.02) 
M34 8.554 117.5 178.02 59.17 31.83 Cγ (33.11) 
E35 8.337 118.4 178.93 59.32 30.29 Cγ (36.97) 
K36 8.057 115.3 178.72 57.82 33.37 Cγ (25.42), Cδ (28.59)  
   
83 
Cε (42.66) 
E37 8.804 114.9 176.65 56.45 29.93 Cγ (36.34) 
F38 8.110 118.0  54.54 39.44  
P39 
  
179.41 
   
G40 9.112 111.3  46.41   
F41 7.953 121.1 174.61 57.61 39.20  
L42 7.746 126.2  57.60 40.94  
E43 
  
177.53 59.46 29.03 Cγ (36.70) 
N44 7.523 115.3 175.40 53.71 39.19 Cγ (177.14), Nδ2 (113.30) 
Q45 7.411 117.1 177.77 55.26 27.99  
K46 8.147 119.7 176.22 57.26 31.68 Cγ (24.76), Cδ (28.81) 
Cε (42.27) 
D47 7.939 118.4  50.94 42.48  
P48 
  
177.57 64.20 32.21 Cγ (27.09), Cδ (51.07) 
L49 8.403 119.3 177.24 54.11 41.02 Cγ (27.37), Cδ1 (25.34)  
Cδ2 (22.79) 
A50 7.562 122.8 179.69 56.12 18.65  
V51 8.442 115.7 176.57 66.28 31.21 Cγ2 (21.27), Cγ1 (23.56) 
D52 7.744 120.6 178.96 57.57 40.45  
K53 7.964 119.3 178.92 59.73 32.38 Cγ (25.92), Cδ (29.35) 
Cε (42.14) 
I54 7.746 119.7 177.94 64.50 38.26 Cγ1 (28.58), Cδ1 (13.18) 
Cγ2 (17.92) 
M55 8.118 117.1 177.62 57.57 32.16  
K56 7.622 118.3 178.06 59.12 32.12 Cγ (24.64), Cδ (28.86) 
Cε (42.16) 
D57 7.638 117.6 177.32 55.72 41.09  
L58 7.694 118.9 177.67 55.65 42.57 Cγ (26.09), Cδ1 (22.94)  
Cδ2 (22.94) 
D59 8.293 120.9 177.24 54.26 40.41 Cγ (180.23) 
Q60 8.382 120.6 176.75 57.80 28.56 Cγ (34.11), Cδ (180.24)  
Nε2 (111.97) 
C61 8.435 117.1 176.54 58.96 27.21  
R62 8.079 120.6 175.82 57.15 28.47 Cγ (27.15), Cδ (43.43) 
D63 8.655 118.8 176.73 53.76 41.08  
G64 9.255 109.6 173.84 46.11   
K65 7.471 118.4 175.30 55.39 34.36 Cγ (24.55), Cδ (29.12) 
Cε (42.25) 
V66 9.356 124.5 176.25 62.62 32.58 Cγ2 (21.52), Cγ1 (21.52) 
G67 8.485 114.4 174.08 44.29   
F68 9.076 121.0 177.10 62.93 39.42  
Q69 8.912 117.5 178.66 60.44 27.48 Cγ (34.20), Cδ (179.82)  
Nε2 (111.52) 
S70 8.060 117.1 176.38 61.90 63.06  
F71 8.632 123.6 175.98 60.88 39.21  
F72 8.772 120.1 177.62 62.55 38.40  
S73 7.925 114.9 177.05 62.47 62.50  
L74 7.460 125.4 177.82 57.90 41.06 Cγ (25.76), Cδ1 (23.59)  
Cδ2 (23.59) 
I75 7.222 117.9 179.51 62.71 35.56 Cγ1 (26.81), Cγ2 (17.52) 
A76 9.005 125.8 178.58 55.28 18.68  
G77 7.871 104.4 177.60 47.36   
L78 7.833 120.6 178.65 57.58 42.61 Cγ (24.40), Cδ1 (22.17) 
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T79 8.499 118.3 176.85 68.55 68.79  
I80 8.837 123.6 177.78 66.10 38.29 Cγ1 (30.94), Cγ2 (17.29) 
A81 7.555 121.5 181.47 55.41 18.14  
C82 8.296 117.5 176.43 63.74 26.78  
N83 8.595 120.5 176.29 58.05 39.63  
D84 8.497 119.2 174.47 57.80 40.48  
Y85 7.678 119.7 178.05 62.00 39.11  
F86 9.051 121.4 177.39 61.18 40.22  
V87 8.865 117.5 177.57 66.50 31.91 Cγ2 (22.11), Cγ1 (22.11) 
V88 7.400 117.5 177.43 65.40 32.66 Cγ2 (20.39), Cγ1 (22.57) 
H89 7.954 113.8 176.20 57.77 30.81  
M90 7.856 117.1 176.14 57.44 34.90 Cγ (32.54) 
K91 7.620 120.1 177.21 58.58 32.48 Cγ (24.76), Cδ (28.82) 
Q92 8.166 117.6 176.25 56.99 28.93 Cγ (34.04), Cδ (180.18)  
Nε2 (111.06) 
E93 7.838 117.9 175.97 56.75 30.05 Cγ (36.29) 
N94 8.062 117.1 174.58 53.84 (4.518) 38.38 Cγ (177.51), Nδ2 (111.87) 
L95 7.922 120.1 176.30 55.28 (4.248) 42.59 Cγ (27.04), Cδ1 (24.96)  
Cδ2 (23.64) 
Y96 7.862 118.8 175.23 57.48 (4.508) 38.93  
F97 7.946 120.9 175.24 57.71 (4.239) 39.17  
Q98 8.245 121.4 176.04 55.96 (4.293) 29.60 Cγ (33.85), Cδ (180.35)  
Nε2 (111.49) 
G99 8.013 110.0 173.81 45.57  Hα2 (3.941), Hα3 (3.900) 
D100 8.361 120.1 176.34 54.88 (4.750) 41.59  
S101 8.343 113.5  58.15 (4.796) 63.82  
T102 8.921 123.6 176.29 66.64 69.36 Cγ2 (22.14) 
V103 8.823 121.5 179.81 67.84 (3.578) 31.76 Cγ1 (21.61) 
H104 8.533 117.9 176.72 60.35 (3.957) 28.86  
E105 7.710 116.6 179.37 59.05 (3.953) 29.33 Cγ (36.04) 
I106 8.328 121.0 178.14 66.05 (4.151) 38.95 Cγ1 (29.13), Cγ2 (18.33) 
L107 8.623 118.4 178.42 58.27 (4.644) 41.59 Cγ (27.46), Cδ1 (23.97)  
Cδ2 (23.97) 
S108 7.101 111.0 178.28 60.65 (4.164) 63.57  
K109 7.688 119.7 177.32 55.84 (4.304) 33.28 Cγ (24.33), Cδ (28.60) 
Cε (42.62) 
L110 7.373 120.1 177.08 55.84 (4.086) 43.06 Cγ (25.91), Cδ1 (23.39)  
Cδ2 (23.40) 
S111 8.377 116.2 174.75 57.38 (4.608) 64.27  
L112 8.347 124.9 177.21 55.45 (4.331) 42.15 Cγ (27.34), Cδ1 (25.26)  
Cδ2 (23.10) 
E113 8.222 120.1 176.63 56.63 (4.317) 30.69 Cγ (36.34) 
G114 8.195 110.1 172.88 45.31  Hα2 (3.970), Hα3 (3.900) 
D115 7.947 125.8  55.86 (4.424) 42.49  
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Figure 2.11. Selected regions of 600 MHz NMR spectra used for the backbone 
assignment of the BT12 complex.  
 
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the 
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of 
the three-dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i) 
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous 
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for 
sequential assignment of residues G64-E67 of the BT12. 
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Figure 2.12. Backbone amide assignments of BT12 hybrid protein. 
 
1H-15N HSQC spectrum of 0.7 mM (monomer) uniformly 15N, 13C-labeled BT12 hybrid 
protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was collected 
in 20 mM MOPS, 20 mM CaCl2, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 
100 mM NaCl, pH 7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated with 
their one letter amino acid code and number. The residues from 15N, 13C-labeled TRTK12 
are presented in pink and those from the linker region in cyan. Pairs of resonances for 
sidechain amide cross peaks are connected by horizontal lines. 
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Table 2.5. 15N, 13C and 1H resonance assignments for human BT12. 
 
Residue HN N C Cα Cβ Other 
S1  121.9 174.72 57.50 65.56  
E2 9.243 119.6 179.68 59.80 29.22  
L3 8.699 121.5 177.70 58.20 42.52  
E4 8.228 120.0 178.70 59.68 29.37  
K5 8.687 117.0 179.80 60.17 32.74  
A6 8.047 123.4 178.83 55.14 18.05  
M7 8.061 116.6 178.22 60.81 33.34  
V8 8.026 116.9 177.73 67.00 31.60  
A9 8.148 122.6 179.06 55.48 18.52  
L10 8.064 117.3 178.56 58.68 42.05  
I11 7.473 118.1 178.00 66.05 38.86  
D12 8.751 120.0 179.74 57.77 41.34  
V13 8.914 120.0 177.05 66.15 31.18  
F14 7.685 119.6 177.46 62.82 38.98  
H15 7.993 116.2 178.07 58.57 29.00  
Q16 8.349 121.6 177.72 58.58 28.29 Cγ (33.57), Nε2 (110.5), 
Hε21 (6.81), Hε22 (7.19) 
Y17 7.210 115.4 176.26 60.93 40.59  
S18 8.943 115.4 177.44 61.05   
G19 7.605 110.1 173.69 45.51   
R20 7.134 121.1 177.38 59.90 30.94  
E21 9.428 116.2  54.78 35.06  
G22       
D23       
K24   176.59 58.08 31.40  
H25 9.483 118.9 173.35 55.48 31.11  
K26 7.057 114.6 174.95 55.29 39.18  
L27 9.536 125.7 175.95 52.74 43.65  
K28 9.690 124.2 177.71 55.07 33.08  
K29 9.046 121.5 177.70 62.55 32.00  
S30 8.113 110.5 177.29 61.11 61.11  
E31 6.542 123.1 177.72 58.68 31.44  
L32 8.444 119.6  57.67 42.13  
K33 8.318 118.1 177.05 60.40 32.63  
E34 7.345 116.2 177.99 59.35 29.36  
L35 7.894 123.0 179.06 59.51 41.93  
I36 8.325 120.4 178.37 66.21 38.82  
N37 8.407 117.3 177.53 54.71 37.26 Nδ2 (106.6), Hδ21 (7.108) 
Hδ22 (7.501) 
N38 8.219 114.7 177.13 55.03 40.53  
E39 8.511 113.5 178.13 55.34 30.90  
L40 7.717 120.0 177.31 54.41 42.04  
S41 7.272 112.8 175.80 60.01 64.27  
H42 10.254 121.9 176.15 59.28 28.69  
F43 7.543 115.5 174.68 56.85 41.09  
L44 8.237 118.1 176.36 53.13 44.33  
E45 8.130 120.7 175.61 56.67 30.78  
E46 8.270 123.4 177.32 56.67 30.86  
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I47 9.832 125.7 176.23 62.20 38.31  
K48 8.861 126.8 176.07 56.39 34.60  
E49 7.580 118.5  55.35 31.51 Cδ (180.42) 
Q50   177.07 58.25 28.15 Cγ (32.85), Nε2 (112.9) 
Hε21 (6.497), Hε22 (7.974) 
E51 9.219 116.6 178.65 59.66 29.23  
V52 7.094 117.8 177.26 66.35 31.28  
V53 6.929 118.5 177.28 66.24 31.20  
D54 8.360 120.0 178.64 57.94 39.80  
K55 7.580 120.7 179.69 58.63 32.23  
V56 8.452 121.9 177.55 67.19 31.49  
M57 8.345 118.1 177.28 57.82 30.74  
E58 8.216 117.3 178.81 59.16 29.72  
T59 7.641 114.0 175.15 66.06 69.16  
L60 7.673 119.6 178.04 55.63 43.21  
D61 8.120 116.1 176.29 54.56 39.92 Cγ (176.05) 
N62 9.087 127.6 176.28 54.49 40.20 Nδ2 (113.2), Hδ21 (6.934) 
Hδ22 (7.767) 
D63 8.234 116.3 178.00 53.35 40.14  
G64 7.639 108.6 175.18 47.47   
D65 8.338 120.4 177.37 53.61 40.17  
G66 10.094 113.1 172.68 45.78   
E67 7.880 118.1 175.05 55.07 34.45  
C68 9.452 124.2 174.77 56.97 27.93  
D69 9.790 131.4 175.52 53.04 40.28  
F70 8.939 118.5 176.63 63.35 38.66  
Q71 8.016 119.2 179.79 59.61 28.30 Cγ (34.27), Nε2 (111.7), 
Hε21 (6.909), Hε22 (7.613) 
E72 8.795 122.6 179.47 58.71 30.09  
F73 8.843 122.6 177.27 60.34 39.40  
M74 8.269 118.9 179.24 55.13 29.30  
A75 7.535 123.4 180.63 55.13 17.53  
F76 7.640 121.5 176.68 60.07 38.08  
V77 8.578 120.0 179.69 66.92 31.08  
A78 8.466 124.9 179.25 56.35 17.74  
M79 7.989 120.4 178.77 59.50 33.84  
V80 8.430 118.5 177.71 66.58 32.02  
T81 8.717 117.7 177.28 68.24 68.30  
T82 8.125 117.3 176.39 68.04 67.92  
A83 7.637 124.2 179.93 55.35 18.09  
C84 8.410 117.0 175.75 63.48 26.29  
H85 8.247 118.9 176.21 59.87 29.85  
E86 7.690 116.6 177.96 58.56 29.87  
F87 7.979 117.4 176.39 58.95 39.84  
F88 8.125 116.2 177.01 57.36 38.92  
E89 8.072 117.0 175.53 57.14 33.37  
H90 8.147 120.0 175.53 56.84 30.18  
E91 8.188 120.0 176.49 57.03 29.88  
L92 7.915 120.7 177.38 56.24 (4.139) 42.19  
D93 8.173 118.8 176.75 54.86 (4.507) 40.90  
L94 7.815 120.8 177.39 55.88 (4.073) 42.15  
F95 8.013 118.4 175.76 58.30 (4.493) 39.14  
Q96 7.946 119.6 175.86 55.79 (4.355) 29.75 Cγ (33.90), Nε2 (111.7) 
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Hε21 (6.792), Hε22 (7.466) 
G97 7.830 108.7  44.71  Hα2 (4.044), Hα1 (4.000) 
P98   177.80 63.71 31.95  
G99 8.530 109.3  45.54   
G100   174.73 45.46   
G101       
G102 8.236 108.6 174.22 45.29   
T103 8.084 113.9 174.55 61.91 69.88  
R104 8.393 123.5 176.09 56.15 (4.486) 31.03  
T105 8.173 117.0 173.30 62.03 (4.304) 69.95  
K106 8.049 121.9 176.05 55.46 (4.415) 34.46  
I107 8.335 121.9 174.34 61.75 (3.956) 38.18  
D108 7.821 124.9 176.98 52.89 (4.502) 42.87  
W109 8.489 122.7 178.36 61.19 29.35 Cγ (176.27), Nε1 (129.5) 
Hε1 (10.283) 
N110 8.664 116.9 177.55 56.09 (4.558) 37.73 Nδ2 (112.9), Hδ21 (6.901) 
Hδ22 (7.752) 
K111 7.736 118.8 178.26 57.79 (4.163) 32.05  
I112 7.355 117.0 176.39 62.87 (3.808) 38.13  
L113 8.086 115.8 176.59 55.14 (4.436) 42.05  
S114 7.710 113.5 174.61 58.50 (4.445) 63.06  
L115 8.031 123.8 176.43 55.21 (4.370) 42.27  
E116 7.773 125.4  58.06 (4.110) 31.28  
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Figure 2.13. Backbone amide assignments of S100A10-annexin A2 complex. 
 
1H-15N HSQC spectrum of 0.5 mM (monomer) uniformly 15N, 13C-labeled S100A10 
protein bound to 0.5 mM annexin A2 peptide at pH 7.0 acquired on a Varian INOVA 600 
MHz spectrometer at 35 ºC. Assigned backbone amide cross peaks are indicated with 
their one letter amino acid code and number. Pairs of resonances for sidechain amide 
cross peaks are connected by horizontal lines. Peaks visible at lower contour levels are 
indicated by boxes. 
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Figure 2.14. Comparison of the changes in chemical shift of the A10A2 hybrid 
protein and S100A10 in complex with individual annexin A2 peptide.  
 
Chemical shift changes (∆δ) were normalized in both 1HN and 15N using the formula 
[{HN2 + (N/5)2}/2]1/2. The dashed line indicates the average change in chemical shift at 
0.09 ppm. Proline residues are shown as “P” and asterisks indicate missing assignments 
in either or both proteins. 
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TRTK12 segments was not observed in the absence of calcium (data not shown). 
However, upon calcium addition to BT12, a spectrum was obtained (Figure 2.12) that 
was nearly identical to that for Ca2+-S100B in complex with a synthetic TRTK12 peptide 
(Figure 2.15). As shown in Figure 2.12, for BT12 all resonances in the linker (L92-G102) 
and TRTK (T103-E116) sequences were identified with the exception of three glycine 
residues (G99-G101) in the linker that were absent from the spectra due to the fast 
exchange with the solvent. Once more, backbone assignment of the BT12 and S100B in 
complex with individual TRTK12 peptide allowed measuring the chemical shift changes 
of each residue between the two complexes (Figure 2.16) as well as that for other Ca2+-
bound S100 proteins indicating that little structural change occurred in the S100B protein 
as the result of incorporating the C-terminal linker and TRTK12 sequences. 
One advantage of the A10A2 and BT12 hybrid proteins is that they allow in situ 
cleavage of the linker using TEV or PreScission enzymes, respectively. Figure 2.17 
shows the 1H-15N HSQC spectrum of the A10A2 hybrid protein following TEV cleavage. 
The positions of the amide resonances for the S100A10 and annexin A2 components in 
this spectrum are nearly identical to those found in the presence of the linker (Figure 
2.10). Importantly, the NMR spectrum shows a tight complex is maintained between 
S100A10 and annexin A2 despite the absence of N-terminal acetylation of the annexin 
protein. Parallel experiments for the BT12 hybrid protein following cleavage with 
PreScission protease yielded similar results (Figure 2.18).  
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Figure 2.15. Backbone amide assignments of S100B-TRTK12 complex.  
 
1H-15N HSQC spectrum of 0.7 mM (monomer) uniformly 15N, 13C-labeled S100B protein 
bound to 0.7 mM TRTK12 peptide in the presence of 6 mM CaCl2 at pH 7.0 acquired on 
a Varian INOVA 600 MHz spectrometer at 35 ºC. Assigned backbone amide cross peaks 
are indicated with their one letter amino acid code and number. Pairs of resonances for 
sidechain amide cross peaks are connected by horizontal lines. 
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Figure 2.16. Comparison of the changes in chemical shift of the BT12 hybrid protein 
and S100B in complex with individual TRTK12 peptide.  
 
Chemical shift changes (∆δ) were normalized in both 1HN and 15N using the formula 
[{HN2 + (N/5)2}/2]1/2. The dashed line indicates the average change in chemical shift at 
0.17 ppm. The asterisks indicate missing assignments in either or both proteins.   
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Figure 2.17. 1H-15N HSQC spectrum of A10A2 cleaved with TEV protease.  
 
0.5 mM (monomer) uniformly 15N, 13C-labeled A10A12 protein 48 h following cleavage 
with TEV protease at pH 7.0 acquired on a Varian INOVA 600 MHz spectrometer at 35 
ºC. Assigned backbone amide cross peaks are indicated with their one letter amino acid 
code and number. Pairs of resonances for sidechain amide cross peaks are connected by 
horizontal lines. Peaks visible at lower contour levels are indicated by boxes. 
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Figure 2.18. 1H-15N HSQC spectrum of BT12 hybrid protein cleaved with 
PreScission protease.  
 
0.7 mM (monomer) uniformly 15N, 13C-labeled BT12 protein 48 h following cleavage 
with PreScission protease at pH 7.0 acquired on a Varian INOVA 600 MHz spectrometer 
at 35 ºC. Assigned backbone amide cross peaks are indicated with their one letter amino 
acid code and number. Pairs of resonances for sidechain amide cross peaks are connected 
by horizontal lines. Peaks visible at lower contour levels are indicated by boxes. 
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 The assignments of Hα, Cα and C’ resonances of the annexin A2 and 
TRTK12 regions in the A10A2 and BT12 hybrid proteins allowed their secondary 
structures to be determined using the chemical shift index (Wishart et al. 1992). This 
analysis (Figure 2.19) shows that residues T102-S108 of annexin A2 form a well-defined 
α-helix. This compares very well with the crystal structure of S100A10 with the N-
terminal peptide from annexin A2 (1BT6) that shows residues T2-K9 (T102-K109 in 
A10A2) adopt an α-helical structure (Rety et al. 1999). The secondary structure of 
TRTK12 in the BT12 hybrid protein shows an unstructured N-terminus and a single turn 
of α-helix from D108-K111.  The position of the α-helix in BT12 agrees well with the 
previously reported crystal and NMR structures of Ca2+-S100B in complex with TRTK12 
(1MWN and 3IQO) (Inman et al. 2002; Charpentier et al. 2010).  
 
2.4          Discussion 
2.4.1       High Yield Bacterial Expression of S100-Target Hybrid Proteins  
Bacterial expression of peptides is a challenging task since unstructured 
peptides are prone to degradation by proteases during purification. This results in very 
low yields of purified peptides and can lead to inhomogeneity of the peptide due to non-
specific proteolysis. Although successful methods have been developed using GB1-
tagged (Lindhout et al. 2003) or His-tagged (Lee et al. 2008) peptides for S100B and 
S100A6 respectively, in our hands previous attempts to biosynthetically prepare annexin 
A1 and A2 peptides using GST- or GB1 constructs lead to <1 mg peptide/L culture and 
the isolated peptides were prone to proteolysis (Rintala-Dempsey, unpublished results). In 
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Figure 2.19. Secondary structure determinations for annexin A2 and TRTK12 
peptides in the A10A2 and BT12 hybrid constructs using the chemical shift index 
(Wishart et al. 1992) for Cα, C’ and Hα atoms.  
 
The secondary structure identified for each atom is shown as α-helix (●), β-strand (■) or 
coil conformation (○). 
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the current work, a successful method has been developed for bacterial expression of 
annexin A2 and TRTK12 peptides by linking them to S100A10 and S100B, respectively. 
In essence the target protein is used as a carrier for the target peptide. Similar approaches 
have been described previously to produce hybrid molecules of calmodulin bound to the 
26-residue binding region of myosin light-chain kinase (M13) (Porumb et al. 1994; Hayes 
et al. 2004), and peptides from the calmodulin-binding domains of calcineurin (Renigunta 
et al. 2006), the olfactory nucleotide-gated ion-channel (Chyan et al. 2005), tobacco 
MAPK phosphatase-1 (Ishida et al. 2009), and chromogranin A (Kang et al. 2007). In all 
of these studies, the linker was composed of only glycine residues in order to maintain 
flexibility in the linker connecting the carrier protein to the target peptides. Here, it was 
demonstrated that this is not a necessary requirement and that alternate amino acids can 
be used. This is particularly important for the incorporation of proteolytic cleavage sites 
such as TEV or PreScission protease used in this work to obtain complete digestion of the 
target sites. In principle, this method would allow purification of the target peptides 
(annexin A2 or TRTK12). For NMR studies, this would provide a rapid and facile 
method to obtain reasonable quantities of 15N, 13C-labeled peptides. Alternatively, it was 
chosen not to purify the cleaved peptides and examine the intact hybrid protein or the 
complex after in situ cleavage. This further simplifies the procedure and in the case of 
protein-peptide complexes offers the advantage of perfect 1:1 stoichiometry.  
One requirement for the interaction between some S100 proteins and target 
peptides is the N-terminal acetylation of the peptides (Johnsson et al. 1986; Johnsson et 
al. 1988; McClintock and Shaw 2003). For example, both annexins A1 and A2 are 
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naturally acetylated. Although, crystal structures of S100A10 in complex with annexin 
A2 and Ca2+-S100A11 bound to annexin A1 do not illustrate direct contact between the 
S100 protein and the peptide acetyl groups (Rety et al. 1999; Rety et al. 2000), 
unacetylated peptides show ~1000-fold decreased binding affinity for the respective S100 
proteins (Johnsson et al. 1988). It has been suggested that the acetyl group acts to 
stabilize the α-helical conformation of the peptide. In the A10A2 hybrid protein 
acetylation of the annexin A2 moiety is not possible. However, an acidic residue was 
incorporated at the N-terminus of the annexin A2 sequence to neutralize the helical dipole 
and stabilize the helix structure. The result clarified that A10A2 hybrid maintains a tight 
association between the S100A10 and the annexin peptide indicating the acidic residue is 
sufficient to stabilize the interaction. In support of this approach, a GST-annexin A2 
fusion protein also shows tight binding to S100A10 presumably because the annexin N-
terminus is extended (by GST) in place of acetylation (Mailliard et al. 1996). Similarly, 
an interaction between TRTK12 and S100B is enhanced upon acetylation of the TRTK12 
peptide (McClintock et al. 2002), even though the α-helix forms further down the peptide 
sequence (Inman et al. 2002). The hybrid BT12 protein would support this enhanced 
interaction by mimicking the neutralized TRTK12 sequence. 
 
2.4.2       Applications and Limitations in utilizing S100-Target Hybrid Proteins 
One of the limitations that could be associated with biosynthesis of hybrid 
proteins method is that the hybrid proteins might suffer from reduced solubility in the 
unbound form. This was not a problem for A10A2 because binding of annexin A2 to 
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S100A10 is not calcium sensitive. However, for BT12 the hybrid showed poorer 
solubility in the absence of calcium and exhibited NMR spectra suggestive of protein 
oligomerization. This is perhaps not surprising given that the TRTK12 peptide motif or 
accompanying linker could result in non-specific interactions in the absence of calcium. 
However, upon calcium binding the BT12 showed excellent solubility and provided 1H-
15N HSQC spectra that were better compared to the individual protein peptide complexes.  
In summary, the approach presented here demonstrated a successful method of 
high yield bacterial expression of S100 hybrid proteins. Two different protease cleavage 
sites were successfully incorporated into the linker regions and can be used in situ to form 
the S100-peptide complex. This method could be applied for the synthesis of S100 
binding peptides for biophysical or biological characterization by X-ray crystallography 
or NMR. Further, the S100-target hybrid proteins may prove useful for the assembly and 
examination of larger S100 complexes. In the following chapters, A10A2 hybrid protein 
is used to study the ternary complex involving S100A10, annexin A2 and AHNAK 
proteins. 
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Chapter 3 
 
The S100A10-Annexin A2 Complex Provides a Novel Asymmetric 
Platform for AHNAK Recruitment 
 
 
3.1          Introduction 
A requisite for plasma membrane repair is calcium-regulated exocytosis, 
controlled by a number of proteins that coordinate resealing of the membrane. One 
exocytotic compartment implicated in membrane fusion is the enlargeosome, 
characterized by the large scaffolding protein AHNAK, that relocates to the plasma 
membrane immediately following membrane damage (Zhang et al. 2004). In addition to 
AHNAK, calcium-sensors such as dysferlin and annexin family members are involved in 
membrane repair. Upon membrane rupture, these sensor proteins respond to the calcium 
influx by localizing near the inner membrane surface.  
Membrane repair and membrane-receptor protein trafficking can be modulated 
by the association of an S100A10 dimer with the calcium- and phospholipid-binding 
protein annexin A2. This heterotetrameric complex (Rety et al. 1999) has the ability to 
form larger multiprotein assemblies such as those with AHNAK and members of the 
transmembrane ferlin family (ie. dysferlin). In vitro and in vivo experiments have shown 
that the C-terminal domain of AHNAK (van de Graaf et al. 2003; Borthwick et al. 2008) 
interacts with S100A10 while bound to annexin A2 (Shtivelman and Bishop 1993).  
 
Parts of this chapter have been taken from the submitted article: Rezvanpour, A., and 
Shaw, G. S. 2011. The S100A10-annexin A2 complex provides a novel asymmetric 
platform for AHNAK recruitment. J. Biol. Chem.  
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Available structural information about the arrangement and mechanisms 
used by multi-protein complexes such as those involved in membrane repair is very 
limited. In this chapter, peptide array analysis was used to uncover the binding region(s) 
of different proteins within the complexes formed between S100A10, annexin A2, the C-
terminal region of AHNAK and the C2A domain of dysferlin proteins. For instance, the 
designed S100A10-annexin A2 (A10A2) hybrid protein (described in Chapter 2) in which 
S100A10 was linked in tandem to the N-terminal 15 residues of annexin A2, was used in 
peptide array experiments, to identify the regions of interaction within the C-terminus of 
AHNAK. Of the eight consensus regions observed, one of the sequences (referred to as 
AHNAK5) having a strong interaction was used as a synthetic peptide to identify the 
binding region(s), stoichiometry and affinity with the A10A2 complex. Using NMR 
spectroscopy, non-denaturing electrospray mass spectrometry and fluorescence 
spectroscopy a novel asymmetric ternary arrangement between a single AHNAK5 
peptide, an S100A10 dimer and two annexin A2 peptides was described. These results 
provide the first structural model of a multi-protein assemblage necessary during the 
membrane repair. To examine the possibility for the formation of other ternary complexes 
involving S100A10 and annexin A2, the interaction between S100A10 or A10A2 with the 
transient receptor potential cation channel protein, TRPV5, was also investigated by 
peptide array analysis.  
Furthermore, the interaction between other components of the membrane repair 
machinery was tested. For instance, to identify potential binding sites other than the 12 
residue N-terminal region of annexin A2 with the S100A10 protein, peptide arrays of full 
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length annexin A2 were probed with S100A10 or A10A2 proteins. Finally, the 
interaction between the apo- and calcium-bound C2A domain of dysferlin with the 
S100A10 and C-terminal domain of AHNAK was examined by NMR spectroscopy. 
 
3.2          Materials and Methods 
3.2.1       Source of Materials 
The expression vector for human S100A10 (pGEX-6P-1-derived vector, GE 
Healthcare) was a generous gift from Dr. Michael Walsh (University of Calgary, Alberta, 
Canada). All forward and reverse oligonucleotides described within this chapter were 
synthesized by Sigma-Genosys (Mississauga, ON, Canada). T4 DNA ligase was 
purchased from Fermentas Life Sciences (Burlington, ON, Canada). Pfu Turbo DNA 
polymerase was purchased from Stratagene (La Jolla, CA, USA). All other chemicals 
used in cloning were purchased from BioShop Canada (Burlington, ON, Canada). All 
DNA sequencing was performed at Robarts Research Institute Sequencing Facility 
(London, ON, Canada). 
15NH4Cl and 13C6-glucose were obtained from Cambridge Isotope Laboratories, 
Inc. (Andover, MA). Puratronic grade CaCl2 (99.9995% purity) was purchased from 
Johnson-Matthey (Ward Hill, MA). Peptide arrays were produced at Dr. Shawn Li’s 
laboratory (University of Western Ontario, ON, Canada). All other reagents used in the 
following experiments were of the highest purity commercially available. 
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3.2.2       Construction of S100A10C82S and A10A2C82S in E. coli Expression Vectors  
DNA fragments encoding either rabbit S100A10 or the S100A10-annexin A2 
(A10A2) hybrid proteins (Rezvanpour et al. 2009) were contained in pGEX-6P-1 vectors. 
QuikChange site-directed mutagenesis (Wang and Malcolm 1999) was performed to 
convert the cysteine codon (Cys82) to a serine in both plasmids using forward (5’ GCCG 
GCCTCACCATTGCATCCAATGACTATTTTGTAGTGC 3’) and reverse (5’ GCACT 
ACAAAATAGTCATTGGATGCAATGGTGAGGCCGGC 3’) primers. PCR products 
were treated with DpnI (Nebgen et al.) restriction enzyme for 1 hr at 37º C to digest the 
methylated template DNA and transformed into E. coli strain JM-109. The single point 
mutations in the resulting vectors were confirmed by DNA sequencing. 
 
3.2.3       Expression and Purification of the Wild-Type and C82S Substituted Forms of 
S100A10 and A10A2 
Unlabeled and uniformly 15N, 13C-labeled wild-type and C82S substituted forms 
of human GST-S100A10 and/or GST-A10A2 were overexpressed in the BL21 (DE3)-
RIL E. coli strain as previously described in Section 2.2.6 (Rezvanpour et al. 2009) using 
1 L of 2xYT, or M9 minimal medium supplemented with 1 g 15NH4Cl and 2 g 13C6-
glucose as the sole nitrogen and carbon sources, respectively. MALDI-TOF mass data for 
unlabeled S100A10C82S (MWcalc = 11598.6 Da; MWobs = 11599.4 Da) and A10A2C82S 
(MWcalc = 13733.8 Da; MWobs = 13733.5 Da) confirmed the protein identities. 
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3.2.4       Construction of a Short C-Terminal Fragment of AHNAK Expression Vector 
An expression vector containing a short C-terminal fragment of AHNAK was 
synthesized by DNA 2.0 (Menlo Park, CA). This vector was composed of a His7 tag and a 
TEV cleavage site at the N-terminus of the AHNAK coding gene sequence (5362-5434). 
The DNA was extracted from the GFC filter by incubating the filter in 100 µL of 10 mM 
Tris-HCl at pH 7.5 for 2 min, followed by spinning the sample in a tabletop centrifuge at 
full speed. The integrity of the AHNAK DNA fragment was checked by Pst1 restriction 
enzyme digestion on a 1% agarose gel. The DNA was transformed into the JM-109 E. 
coli strain.  
 
3.2.5       Expression and Purification of the Wild-Type C-Terminal Fragment of AHNAK 
Expression vector containing the C-terminal fragment of AHNAK (5362-5434) 
was transformed into E. coli strain BL21 (DE3) Codon Plus expression cells (Invitrogen), 
which contain extra copies of the argU, ileY, and leuW tRNA genes to recognize AGA, 
AGG, AUA, and CUA codons. An overnight culture (25 mL) was used to inoculate 1 L 
of pre-warmed LB media supplemented with 30 µg/mL kanamycin. The culture was 
grown at 37 ºC to a density of (A600) 0.8 AU, when it was induced with 1 mM IPTG. 
Induction continued for another 4 h with constant shaking at 37 ºC. Cells were harvested 
by centrifugation at 6,000 rpm for 15 min at 4 ºC. Following addition of one complete-
mini protease inhibitor tablet, PMSF (1 mM final concentration) and leupeptin (1 µL of 
100 µM stock per 1 mL of lysate), the cells were lysed by French Pressure at 20,000 psi. 
Ultracentrifugation of the lysed cells was performed using a Beckman ultracentrifuge at 
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38,000 rpm for 90 min. All fractionation steps were performed at 4 °C. The 
supernatant was filtered through 0.45 micron low protein binding Millipore syringe filters 
to remove the particulate matter. The protein was subsequently applied to a 5 mL Ni-
NTA column pre-equilibrated in 20 mM Tris-HCl, 10 mM imidazole, 150 mM NaCl, and 
5% glycerol at pH 7.5. The column was washed with the same buffer containing 20 mM 
imidazole until the OD280 returned to baseline. Bound protein was then eluted with a 30 
mL, 20-500 mM imidazole gradient in the elution buffer. Fractions containing the protein 
were pooled and extensively dialyzed against TEV protease cleavage buffer (20 mM Tris-
HCl, 150 mM NaCl, 10 mM imidazole, 1 mM DTT, and 5% glycerol at pH 7.5) for 6 h 
with multiple buffer exchanges. The His7 tag was cleaved from the N-terminus of 
AHNAK using 250 units of TEV protease in 48 h with gentle agitation. Cleaved protein 
was purified on a second 5 mL Ni-NTA column as described above. Cleaved AHNAK 
was eluted in the flow-through fractions. The integrity of the protein was verified on 
16.6% SDS-PAGE gel and electrospray ionization mass spectrometry (Biological Mass 
Spectrometry Laboratory, University of Western Ontario). MALDI-TOF mass data for 
unlabeled AHNAK (MWcalc = 7827.0 Da; MWobs = 7827.4 Da) confirmed the protein 
identity. 
 
3.2.6       Expression and Purification of Dysferlin C2A Domain 
Unlabeled and uniformly 15N, 13C-labeled wild-type human C2A domain of 
dysferlin (simply referred to as dysferlin) (residues 1-138) were overexpressed in the 
BL21 (DE3) E. coli strain using 1 L of pre-warmed LB or M9 minimal medium 
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supplemented with 30 µg/mL kanamycin. 15NH4Cl (1 g) and 13C6-glucose (2 g) were 
used as the sole nitrogen and carbon sources in the M9 minimal media. Briefly, the 
cultures were grown at 37 ºC to a density of (A600) 0.7 AU. Expression was induced by 
the addition of 1 mM IPTG and allowed to continue for another 4 or 8 h with constant 
shaking at 37 ºC. Cells were harvested by centrifugation at 6,000 rpm for 15 min, lysed 
by French Pressure at 20,000 psi and centrifuged at 38,000 rpm for 90 min. All 
fractionation steps were performed at 4 °C. The supernatant was filtered through 0.45 
micron low protein binding Millipore syringe filters. The protein was subsequently 
applied to a 5 mL Ni-NTA column pre-equilibrated in 20 mM MES, 10 mM imidazole, 
150 mM NaCl, and 5% glycerol at pH 6.7. The column was washed with the same buffer 
containing 20 mM imidazole until the OD280 returned to baseline. Bound protein was then 
eluted with a 30 mL, 20-500 mM imidazole gradient in the elution buffer. Fractions 
containing the protein were pooled and extensively dialyzed against TEV protease 
cleavage buffer (25 mM MES, 100 mM NaCl, 1 mM DTT, pH 5.5) for 6 h with multiple 
buffer exchanges. The His6 tag was cleaved from the N-terminus of dysferlin using 250 
units of TEV protease in 48 h with gentle agitation. Cleaved protein was purified on a 5 
mL HiTrap SP FF column (GE Healthsciences) equilibrated in the binding buffer (25 mM 
MES, 100 mM NaCl, 1 mM EDTA, and 1 mM DTT, at pH 5.5). Bound dysferlin was 
eluted with gradual increase in salt concentration over 30 min using 25 mM MES, 250 
mM NaCl, 1 mM EDTA, and 1 mM DTT at pH 5.5. Fractions containing the protein were 
pooled and stored at -80 ºC. The protein was extensively dialyzed against appropriate 
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buffers to remove EDTA from the sample particularly before calcium titration 
experiments. 
 
3.2.7       Fluorescent Labeling of S100A10C82S, A10A2C82S and Dysferlin C2A Domain 
Freshly reduced S100A10C82S, A10A2C82S or dysferlin C2A domain was loaded 
onto a pre-equilibrated Sephadex G-25 PD-10 column (GE-Healthcare) in 20 mM Tris-
HCl and 1 mM EDTA at pH 7.0 in order to remove excess DTT in the protein samples. 
Acrylodan or Alexa Fluor 680 maleimide (Invitrogen) was dissolved in acetonitrile to a 
concentration of 100 mM. The acrylodan or Alexa Fluor 680 solution (100 µL) was added 
to 1 mL of 80 µM S100A10C82S, A10A2C82S or dysferlin and the reactions continued for 2 
hr at room temperature until quenched with the addition of 5 mM DTT. The unreacted 
dye was removed by chromatography through a Sephadex G-25 PD-10 column which 
was pre-equilibrated in TBS buffer (50 mM Tris-HCl, and 120 mM NaCl at pH 7.4). The 
protein samples were exhaustively dialyzed against 20 mM Tris-HCl, 120 mM NaCl, and 
1 mM DTT at pH 7.4 to eliminate all noncovalently linked dye. ESI-MS indicated a 
single dye molecule was covalently linked to each protein. 
 
3.2.8       Peptide Array Experiments 
Peptide arrays were produced using the SPOT technology on cellulose 
membranes (Dr. Shawn Li, University of Western Ontario). Peptide arrays of AHNAK 
contained 330 spots of 18-residue peptides that shifted by 3 residues through the C-
terminal sequence of AHNAK (residues 4884-5890). A similar array of annexin A2 was 
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also synthesized with 18-residue peptides that shifted by either 2 or 3 residues through 
the entire sequence of annexin A2 protein. The peptide arrays of annexin A2 were 
acetylated at the N-terminus of the peptides as acetylation of the N-terminus of annexin 
A2 has been shown to be a requirement for the interaction (Seemann et al. 1996; Rety et 
al. 2000). The peptide arrays of TRPV5 contained 18-residue peptides that shifted by 1 or 
2 residues through the C-terminal sequence of TRPV5 (residues 577-729). S100A10C82S 
and A10A2C82S were both uniformly labeled at Cys61, while dysferlin was uniformly 
labeled at Cys23 with Alexa Fluor 680 maleimide as described in Section 3.2.7. 
Membranes were hydrated using anhydrous methanol and then washed three times with a 
buffer containing TBS + 0.05% Tween for 10 min at room temperature. Subsequently, 
membranes were incubated with TBS + 0.05% Tween and skim milk blocking buffer for 
1 hour, followed by a final rinse for 10 min with TBS + 0.05% Tween wash buffer. 
Alexa-S100A10C82S, -A10A2C82S or -dysferlin (0.2-2 µM of each) in TBS + 0.05% Tween 
and skim milk was used to probe each array for 2 hr. The arrays were then rinsed with 
TBS + 0.05% Tween buffer three times for 10 min each. To eliminate background 
fluorescence, the arrays were treated three times with a solution of 8 M urea, 1% SDS and 
0.5% β-mercaptoethanol at pH 7.0 in a sonication bath at 40º C, and washed with 10% 
acetic acid, 50% ethanol and 40% distilled and deionized H2O. The spots on the arrays 
were visualized using the Odyssey Infrared Imaging System (LI-COR Biosciences) at 700 
nm. 
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3.2.9       Peptide Synthesis 
The AHNAK (GKVTFPKMKIPKFTFSGREL) (referred to as AHNAK5) and 
annexin A2 (STVHEILSKLSLEGD) (Bio Basic Inc, ON, Canada) peptides were 
synthesized using solid-phase peptide synthesis employing the Fmoc chemistry strategy 
(Grant 2002). The N-termini of the peptides were acetylated while the C-termini were 
amidated. The synthesized peptides were purified by C18 reversed-phase HPLC, and 
lyophilized. The MALDI-TOF mass data for the acetylated AHNAK (MWcalc = 2353.8 
Da; MWobs = 2352.5 Da) and annexin A2 (MWcalc = 1669.8 Da; MWobs = 1668.6 Da) 
confirmed the peptides identities. 
  
3.2.10     Mass spectrometry 
Mass spectrometry analyses were carried out using a quadrupole time-of-flight 
mass spectrometer (Q-TOF, micromass) equipped with a nano electrospray (ES) source 
by Dr. Suya Liu in Dr. Gilles A. Lajoie’s laboratory (University of Western Ontario, ON, 
Canada). Samples were loaded on a gold-coated capillary (Protona) with the tip manually 
opened to produce an orifice of approximately 10 µm. Positive ES was performed at a 
capillary voltage of 1.5 to 2 kV and cone voltage of 50V. CID experiments were carried 
out with collision energy of 80V using argon as the collision gas. Average molecular 
masses were calculated using Mass Lynx 4.0 (Micromass).  
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3.2.11     Fluorescence Spectroscopy 
A10A2C82S was purified and labeled with acrylodan as described in Section 
3.2.7. The concentrations of the protein stock solutions were determined using the 
Bradford protein assay and triplicate amino acid analysis (Advanced Protein Technology 
Centre, Toronto, Canada). Fluorescence experiments were conducted in duplicate using 
acrylodan-labeled A10A2C82S (300 nM) in 20 mM Tris-HCl, 120 mM NaCl, and 1 mM 
DTT at pH 7.4 (3 mL). A Fluorolog-3 steady-state fluorometer (Horiba Scientific) was 
used for all measurements. Solutions were excited at 375 nm and emissions were 
monitored between 400-600 nm using an emission band-pass of 1 nm and an integration 
time of 1 sec. 
Titrations of A10A2C82S (300 nM) with the AHNAK peptide were carried out at 
room temperature in a stirred cell holder. A solution of AHNAK peptide was added in 3 
µL increments using a calibrated 10 µL Hamilton syringe followed by three 30 µL 
additions to insure protein saturation. After each AHNAK addition, the sample was 
stirred for 2 min before scanning. Titrations were continued until a final S100 
protein:AHNAK ratio of 10:1 was achieved. The dissociation constant (Kd) (Morigasaki 
et al.) was determined by plotting the normalized change in fluorescence (∆F) intensity, 
monitored at 500 nm for acrylodan-labeled A10A2C82S (Pt), as a function of AHNAK 
concentration (Lt). Data were fit using GraphPad Prism5 to equations 1 and 2 where 
∆Fmax is the maximum normalized change in fluorescence and PL is the concentration of 
the A10A2C82S-AHNAK complex. 
 
   
117 
[PL] = [(Pt + Lt + Kd) – {(Pt + Lt + Kd) 2 – (4PtLt)} 0.5]/2  (1) 
 ∆F = [∆Fmax][PL]/[Pt]       (2) 
 
3.2.12     NMR Titration Experiments  
All NMR experiments were acquired at 35 ºC on a Varian INOVA 600 MHz 
spectrometer equipped with a pulse field gradient triple resonance probe. A10A2C82S, 
S100A10, the C-terminal fragment of AHNAK, the AHNAK5 peptide and dysferlin 
concentrations were determined by triplicate amino acid analysis (Advanced Protein 
Technology Centre, Toronto, Canada). The concentration of the CaCl2 stock solution was 
determined by ICP (University of Western Ontario, ON, Canada). NMR samples of 
uniformly 15N, 13C-labeled A10A2C82S (143 ± 6 µM) were prepared in 10% D2O, 20 mM 
MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, and 100 mM 
NaCl buffer at pH 7.0, using DSS as an internal standard. AHNAK peptide (3320 ± 16.4 
µM) was added from a stock solution to give a final AHNAK concentration of 584.6 µM. 
Samples were equilibrated for 15 min after each peptide addition. 1H-15N HSQC spectra 
were collected using carrier frequencies of 4.699 (1H) and 114.0 ppm (15N) and spectral 
widths of 8000.0 and 1700.0 Hz, respectively. Intensities of peaks undergoing slow 
exchange were measured after each addition and fit to Equation 1 using the software 
Prism 5.  
For the NMR samples of uniformly 15N-labeled dysferlin C2A domain (200 ± 7 
µM), the protein was prepared in 10% D2O, 10 mM HEPES, 1 mM DTT, and 150 mM 
NaCl buffer at pH 7.5, using DSS as an internal standard. CaCl2 (37 mM) was titrated 
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from a stock solution in 1.2 µL increments for 7 additions to a calcium concentration 
of 1296 µM. The NMR sample of apo-dysferlin and AHNAK (5362-5434) proteins 
contained ~138 µM 15N-labeled apo-dysferlin and ~200 µM unlabeled AHNAK. After 
collecting a 1H-15N HSQC spectrum of this sample, calcium (37 mM) was titrated in 1.2 
µL increments for 7 additions to a calcium concentration of 850 µM. Samples were 
equilibrated for 15 min after each addition. 1H-15N HSQC spectra were collected using 
carrier frequencies of 4.772 (1H) and 117.0 ppm (15N) and spectral widths of 6982.6 and 
1940.0 Hz, respectively.  
 An NMR sample of uniformly 15N, 13C-labeled S100A10 (350 ± 7 µM dimer) 
was prepared in 10% D2O, 20 mM MOPS, 1 mM DTT, 50 mM arginine, 50 mM glutamic 
acid, and 100 mM NaCl buffer at pH 7.0, using DSS as an internal standard. 1H-15N 
HSQC spectra were collected using carrier frequencies of 4.750 (1H) and 114.0 (15N) 
ppm. Sequential assignment of the polypeptide backbone resonances for S100A10 was 
achieved by the HNCACB (Wittekind and Mueller 1993), CBCA(CO)NH (Grzesiek and 
Bax 1992), HNCA (Kay et al. 1990), and HNCO (Kay et al. 1990) experiments. The 
number of complex data points and the spectral widths were set to 512 and 8000.0 Hz for 
the 1H (F3) dimension, and 64 and 2100.0 Hz for the 15N (F2) dimension, respectively. 
For the HNCACB and CBCA(CO)NH experiments, 32 increments and a spectral width of 
7840.0 Hz in the 13C (F1) dimension were used. For the HNCA and HNCO experiments, 
32 increments and a spectral width of 4524.0 Hz were used in the 13C (F1) dimension.  
For the NMR sample of 15N, 13C-labeled apo-dysferlin with unlabeled S100A10, 
1:1 (200 µM of each protein) and 1:2 (200 µM:400 µM) molar ratios of 
   
119 
dysferlin:S100A10 were used, respectively. After collecting a 1H-15N HSQC spectrum 
of this sample, calcium (37 mM) was titrated in 3.5 µL increments for 6 additions to a 
calcium concentration of 1296 µM. Samples were equilibrated for 15 min after each 
addition. 1H-15N HSQC spectra were collected using carrier frequencies of 4.774 (1H) and 
117.0 ppm (15N) and spectral widths of 6982.6 and 1940.0 Hz, respectively. All data were 
processed using NMRPipe and NMRDraw (Delaglio et al. 1995) and analyzed by 
NMRView (Johnson and Belvins 1994).
 
 
 
3.3          RESULTS 
3.3.1       A10A2 Binds to Multiple Consensus Regions on AHNAK 
To identify the AHNAK residues involved in the interaction with annexin A2-
bound S100A10 complex, Alexa-A10A2C82S protein was used in a separate peptide array 
experiment covering the C-terminus of AHNAK (residues 4884-5890). This approach 
identifies the sequence dependent but structurally independent interactions between 
A10A2C82S and a series of 18-residue peptides spanning the C-terminal sequence of 
AHNAK. Overlapping sequences in the arrays that fluoresced upon Alexa-A10A2C82S 
binding were used to identify the AHNAK binding sites (Figure 3.1). Blotting of the 
arrays with Alexa-A10A2C82S revealed that A10A2C82S associates with eight distinct 
regions within the C-terminus of AHNAK. Using the Blocks Server (blocks.fhcrc.org) to 
analyze these regions, a nine residue consensus sequence was identified for AHNAK that 
could best be represented as +X+XPKφXφ (X – variable; φ – hydrophobic residue; + – 
positively charged residue; P – proline; K – lysine).  
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Figure 3.1. Mapping the A10A2C82S binding site on the C-terminal region of 
AHNAK by peptide array analysis.  
 
A peptide array of the Asp4884-Glu5890 region of AHNAK was synthesized on a 
cellulose membrane. Each spot contained an 18-residue peptide shifted by 3 residues 
from its predecessor until the C-terminus was reached. The array was probed with Alexa 
Fluor 680-A10A2C82S and imaged at 700 nm. The sequences of AHNAK that showed the 
best interaction with A10A2C82S are listed beside and below the array; sequence a 
(Thr4917 - Gly4940), sequence b (Asp4959 - Pro4994), sequence c (Pro5220 - Ile5243), 
sequence d (Asn5607 - Ile5633), sequence e (Gly5652 - Gly5675), sequence f (Ser5703 - 
Thr5729), sequence g (Ala5757 - Ser5780), sequence h (Leu5808 - Glu5837). These 
sequences were used to define a consensus sequence showing positively charged (+), 
hydrophobic (φ) and variable (X) residues using the Blocks Server (blocks.fhcrc.org). 
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Examination of the sequences that interact with A10A2C82S allowed for the 
identification of some general trends. For example, sequences b, e and f show the highest 
sequence similarity while the most intense binding at any one spot was observed within 
sequences b and e (4968-4985, 5652-5669). Since the residues of the conserved motif for 
these sequences are identical, the differences in the binding intensities for A10A2C82S 
could indicate that the variable residues in the motif or residues on the periphery may be 
important for the interaction. For instance the presence of a methionine and an isoleucine 
with rather smaller sidechains at the respective second and fourth positions of the 
conserved motif of sequence e, instead of a phenylalanine with a ring in the sidechain at 
the second position or a lysine with a long, charged sidechain at the fourth position of 
sequence b, could enhance the interaction.  
Sequences a, d and g showed weaker interactions with the A10A2C82S protein 
likely due to one or more substitutions within the consensus region. For example, 
sequences a and d have a histidine at the first position instead of lysine, while sequences 
d and g have a small non-polar residue (G/S) at the last position in place of a larger 
hydrophobe. Sequence c is unusual due to the presence of two possible consensus 
sequences, the first as shown in Figure 3.1 and an alternate sequence starting at K5228, 
five residues prior to the indicated consensus sequence. 
In general, these results agree with a previous study in which the S100A10-
annexin A2 binding region within the C-terminus of AHNAK was mapped utilizing a 
series of GST-AHNAK deletion mutants by pull-down assays (De Seranno et al. 2006). A 
20-residue region in the C-terminus of AHNAK corresponding to residues 5654-5673 
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(lying within sequence e, residues 5652-5675) was shown to be sufficient for binding 
to the S100A10-annexin A2 complex. Further deletions from the N- or C-terminal 
extremity of this 20-residue peptide abolished the interaction with the S100A10-annexin 
A2 complex, confirming that these residues are crucial for the interaction (De Seranno et 
al. 2006). 
 
3.3.2       Unique Interactions of AHNAK with the S100A10-Annexin A2 Complex 
A 20-residue AHNAK peptide (5654-5673; referred to as AHNAK5) that 
displayed a strong interaction with A10A2C82S based on the peptide array experiments, 
and was consistent with GST-AHNAK pull-down assays (De Seranno et al. 2006) was 
synthesized and used in NMR titration experiments. Initially, the AHNAK5 peptide was 
titrated into 15N-labeled S100A10C82S in complex with an unlabeled annexin A2 peptide 
(residues 1-15) (Figure 3.2, black). In the absence of AHNAK5, a single resonance was 
observed in the 1H-15N HSQC spectrum for each residue in S100A10C82S, consistent with 
the symmetric structure of the S100A10C82S-annexin A2 complex where only the 15N-
labeled S100A10C82S is visible (black spectrum). Titration of unlabeled AHNAK5 peptide 
to this solution led to the gradual disappearance of many of the S100A10C82S resonances 
in the S100A10C82S-annexin A2 complex and the reappearance of new peaks, indicative 
of a slow exchange process (Figure 3.2, pink). Remarkably, the 1H-15N HSQC spectrum 
of the 15N-labeled S100A10C82S in the presence of annexin A2 and AHNAK5 resulted in 
an increased number of peaks that did not change even in the presence of a four-fold 
excess of AHNAK5 peptide. In addition, many of the new resonances appeared in pairs 
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Figure 3.2. An overlay of 1H-15N HSQC spectrum of annexin A2-bound S100A10C82S 
in complex with the AHNAK5 peptide.  
 
1H-15N HSQC spectrum of 0.5 mM 15N-labeled S100A10C82S (protomer concentration) 
bound to 0.5 mM unlabeled annexin A2 peptide (Ac-STVHEILSLKQLEGD) (black) and 
in complex with 0.25 mM AHNAK5 (Ac-GKVTFPKMKIPKFTFSGREL) (pink). Peaks 
that exhibited obvious multiplicity in the AHNAK5 complex are labeled according to 
their one-letter amino acid code and residue number. Spectra were collected on a Varian 
Inova 600 MHz spectrometer at 35 ºC in 90% H2O/10% D2O at pH 7.0. 
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with each peak having approximately 50% of the intensity of the original peak (Figure 
3.2). For example, Phe13, Val66, Ala76 and Gly77 in 15N-labeled S100A10C82S all 
appeared as two peaks in the 1H-15N HSQC spectrum of S100A10C82S-annexin A2 in 
complex with AHNAK5.  
To examine the effects of AHNAK5 binding on the annexin A2 portion of 
S100A10-annexin A2 complex, NMR titration experiments were repeated using the 15N-
labeled A10A2C82S hybrid protein. The 1H-15N HSQC spectrum of A10A2C82S (Figure 
3.3, black) was very similar to that of the S100A10C82S-annexin A2 complex (Figure 3.2) 
indicating the structures and interactions of the S100A10 and annexin A2 are similar in 
the two complexes (Rezvanpour et al. 2009). In addition, since the annexin A2 portion of 
A10A2C82S was also 15N-labeled, resonances from this segment of the hybrid protein (ie. 
Leu112, G114) were clearly visible in the spectrum. Similar to the S100A10C82S-annexin 
A2 peptide complex, addition of AHNAK5 to the 15N-labeled A10A2C82S protein led to 
the disappearance of peaks from S100A10C82S and annexin A2 and the appearance of new 
resonances on the slow exchange time scale. Upon saturation, the 1H-15N HSQC spectrum 
of 15N-labeled A10A2C82S bound to unlabeled AHNAK5 (Figure 3.3, cyan) bore a strong 
resemblance to that of 15N-labeled S100A10C82S in complex with both unlabeled annexin 
A2 and AHNAK5 peptides (Figure 3.2). This included an increased number of peaks in 
the A10A2C82S spectrum where several resonances from the S100A10C82S protein 
appeared as pairs (Phe13, Val66, Ala76, Gly77). Interestingly, some resonances from the 
annexin A2 portion of A10A2 also exhibited peak doubling upon addition of AHNAK5
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Figure 3.3. An overlay of 1H-15N HSQC spectrum of A10A2C82S hybrid protein 
bound to the AHNAK5 peptide.  
 
1H-15N HSQC spectrum of 0.5 mM uniformly 15N-labeled A10A2C82S hybrid protein 
(protomer) (black) and in complex with 0.25 mM AHNAK5 peptide (Ac-GKVTFPKMKI 
PKFTFSGREL) (cyan). Peaks that exhibited multiplicity in the AHNAK5 complex are 
labeled according to their one-letter amino acid code and residue number. Spectra were 
collected on a Varian Inova 600 MHz spectrometer at 35 ºC in 90% H2O/10% D2O at pH 
7.0. 
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 (L112, G114), indicating that binding of AHNAK5 affected both the S100A10C82S 
and annexin A2 portions of the hybrid protein in a similar fashion.  
The increased number of resonances and multiplicity of some peaks in both the 
S100A10C82S-annexin A2 and A10A2C82S complexes with AHNAK5 is in contrast to 1H-
15N HSQC spectra of many other S100-target peptide complexes including Ca2+-S100B 
with CapZ, p53 or NDR kinase, S100A6 with Siah1-interacting protein, and S100A1 in 
complex with CapZ or RyR (Rustandi et al. 2000; Inman et al. 2002; McClintock and 
Shaw 2003; Lee et al. 2008; Wright et al. 2008; Wright et al. 2009). NMR spectra from 
these complexes all display a similar number of resonances in the presence or absence of 
target, indicating a symmetric relationship in the dimer is maintained. This is borne out in 
three-dimensional structures of the complexes. In order to account for the unique spectral 
observations made for the S100A10C82S-annexin A2 complex with AHNAK5 several 
models were considered including displacement of annexin A2 by AHNAK5, multiple 
orientations of AHNAK5 binding and asymmetric binding of a single AHNAK5 peptide 
to the S100A10C82S-annexin A2 complex. 
 
3.3.3       Asymmetric Binding of AHNAK to the A10A2 Dimer 
Titrations of 15N-labeled S100A10C82S with AHNAK5 in the absence of annexin 
A2 peptide did not show an interaction between S100A10C82S and AHNAK5 and resulted 
in precipitation of the sample. Analysis of the NMR experiments using 15N-labeled 
A10A2C82S titrated with unlabeled AHNAK5 peptide were carried out to investigate the 
stoichiometry and affinity of the interaction (Figure 3.4). The change in the peak
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Figure 3.4. Titration of A10A2C82S with the AHNAK5 peptide.  
 
Representative 1H-15N HSQC spectra from the AHNAK5 titration are illustrated. Small 
additions of AHNAK5 peptide were made into a sample of uniformly 15N, 13C-labeled 
A10A2C82S (143 µM dimer concentration). Spectra shown are at (A) 0 equivalents, (B) 
0.29 eq., (C) 0.58 eq., (D) 0.78 eq., (E) 0.97 eq., and (F) 1.07 eq. of AHNAK5 peptide 
relative to the protein concentration. Many of the new resonances appeared in pairs with 
each peak having approximately 50% of the intensity of the original peak. 
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intensities of Gly40, Val51, Gly77 in S100A10C82S, and Leu112 in annexin A2 were 
plotted as a function of AHNAK5 and A10A2C82S concentrations (Figure 3.5). The data 
show near linear decreases for the peak intensities in 15N-labeled A10A2C82S (Figure 
3.5A) and concomitant increases in the peaks intensities in the AHNAK5 complex 
(Figure 3.5B). The inflection point for the data sets occurs near a stoichiometry of one 
AHNAK5 peptide to one A10A2C82S dimer. Fitting for this interaction indicated a Kd less 
than 1 µM although a precise determination was not possible by this method due to the 
high A10A2C82S protein concentrations used in the NMR experiments. The data were also 
fit for the interaction of two AHNAK5 peptides per A10A2C82S dimer, similar to other 
S100-target peptide complexes that display symmetric binding (Figure 3.5C). This 
resulted in obvious disagreement with the data, indicating the 2:1 
AHNAK:A10A2C82S(dimer) model was incorrect.  
To provide further evidence for a 1:1 AHNAK:A10A2C82S(dimer) stoichiometry 
and to show that both proteins are required for the recruitment of AHNAK5, a mixture of 
A10A2C82S and AHNAK5 was subjected to non-denaturing electrospray mass 
spectrometry (ES-MS) (Figure 3.6) (Loo 2000). This data showed three major peaks in 
the spectrum corresponding to the A10A2C82S protomer (MWobs = 13731.8 Da, MWcalc = 
13733.8 Da), A10A2C82S dimer (MWobs = 27462.4 Da, MWcalc = 27467.6 Da) and the 
A10A2C82S dimer in complex with a single AHNAK5 peptide (MWobs = 29815.5, MWcalc 
= 29820.4 Da). The ES-MS spectrum also showed the absence of a peak at 32173.2 Da 
that would be expected for the mass of the A10A2C82S dimer in complex with two 
AHNAK5 peptides. This result corroborated the NMR titration experiments that showed
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Figure 3.5. Binding plots of A10A2C82S with AHNAK5 peptide measured from 1H-
15N HSQC experiments. 
  
Aliquots of the unlabeled AHNAK5 peptide were added to a solution of 143 µM 15N, 13C-
labeled A10A2C82S (dimer concentration) and the resulting changes in peak intensities 
were monitored. The binding between AHNAK5 and A10A2C82S is shown as the plot of 
(A) decrease, and (B) increase in peak intensities for Gly40 (●), Val51 (♦) and Gly77 (▲) 
in S100A10C82S and Leu112 (▼) in annexin A2 as a function of the AHNAK5:A10A2C82S 
ratio. (C) The normalized change in peak intensities are shown as a function of AHNAK5 
concentration. Data sets for Gly40 (●), Val51 (♦), Gly77 (▲), and Leu112 (▼) were 
globally fit for 1:1 (–––) and 2:1 (-----) AHNAK5:A10A2C82S stoichiometries. Data fitting 
is described in the Materials and Methods Section 3.2.12. 
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Figure 3.6. Mass spectrum showing the complex formed between A10A2C82S hybrid protein and AHNAK5 peptide. 
 
A10A2C82S protein mixed with the AHNAK5 peptide illustrating masses attributed to the A10A2C82S protomer (M), 
A10A2C82S dimer (D), and A10A2C82S dimer complexed with a single AHNAK5 peptide. The spectrum was obtained under  
non-denaturing conditions as described in the Materials and Methods Section 3.2.10. 
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only one AHNAK5 peptide is bound to the A10A2C82S dimer. In separate experiments, 
S100A10C82S was mixed with both the annexin A2 and AHNAK5 peptides (Figure 3.7). A 
representative ES-MS spectrum showed peaks representing the S100A10C82S protomer 
(MWobs = 11598.2 Da, MWcalc 11598.6 Da), S100A10C82S dimer (MWobs = 23196.3 Da, 
MWcalc = 23197.2 Da) and S100A10C82S dimer bound to two annexin A2 peptides (MWobs 
= 26530.4 Da, MWcalc = 26531.4). There was little evidence for a peak corresponding to 
an S100A10C82S protomer bound to a single annexin A2 peptide (MWcalc = 13266.8 Da) 
in agreement with the crystal structure that shows the annexin A2 binding site comprises 
regions from both subunits of the S100A10 dimer (Rety et al. 1999).  The second most 
intense peak in the ES-MS spectrum corresponded to the S100A10C82S dimer in complex 
with two annexin A2 peptides and a single AHNAK5 peptide (MWobs =28883.9 Da, 
MWcalc = 28884.2 Da). Repeated experiments showed no evidence of complexes with 
masses corresponding to the S100A10C82S dimer complexed with either one or two 
AHNAK5 peptides (MWcalc = 25549.9 Da, 27901.9 Da). Similarly, a mixture of 
S100A10C82S and AHNAK5 was subjected to non-denaturing ES-MS (Figure 3.8). This 
data showed three major peaks in the spectrum representing the S100A10C82S protomer 
(MWobs = 11598.7 Da, MWcalc = 11598.6 Da), S100A10C82S dimer (MWobs = 23196.5 Da, 
MWcalc = 23197.2 Da), and S100A10C82S dimer in complex with a single AHNAK5 
peptide (MWobs = 25547.3, MWcalc = 25549.9 Da). In addition, a small peak 
corresponding to mass of the S100A10C82S dimer in complex with two AHNAK5 peptides 
(MWobs = 27899.9, MWcalc = 27902.7 Da) was present on the spectrum. These 
experiments indicate that the S100A10-annexin A2 complex has a stronger interaction
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Figure 3.7. Mass spectrum depicting complexes of S100A10C82S, annexin A2 and AHNAK5 peptides.  
 
S100A10C82S mixed with annexin A2 and AHNAK5 peptides showing masses corresponding to the S100A10C82S 
protomer (M) S100A10C82S dimer (D), S100A10C82S dimer complexed with two annexin A2 peptides and, S100A10C82S  
dimer complexed with two annexin A2 peptides and a single AHNAK5 peptide. The spectrum was obtained under non- 
denaturing conditions as described in Section 3.2.10. 
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Figure 3.8. Mass spectrum depicting complexes of S100A10C82S, and AHNAK5 peptide.  
 
S100A10C82S mixed with AHNAK5 peptide showing masses corresponding to the S100A10C82S protomer (M), 
S100A10C82S dimer (D), S100A10C82S dimer complexed with a single AHNAK5 peptide and, S100A10C82S 
dimer complexed with two AHNAK5 peptides. The spectrum was obtained under non-denaturing conditions as 
described in Section 3.2.10. 
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with AHNAK5, while in the absence of annexin A2, a weak interaction could exist 
between the S100A10C82S protein and AHNAK5. 
Fluorescence spectroscopy was used to calculate the binding affinity of 
AHNAK5 for the A10A2C82S complex and S100A10C82S. Since AHNAK5, A10A2C82S or 
S100A10C82S do not possess a good intrinsic fluorescence probe, S100A10C82S and the 
A10A2C82S hybrid proteins were covalently labeled with acrylodan at Cys61 in the second 
EF-hand loop. Initial fluorescence experiments using acrylodan-labeled S100A10C82S in 
the absence of the annexin A2 peptide showed less than 12% change in fluorescence and 
little wavelength shift suggestive of a poor interaction (Figure 3.9A). The normalized 
change in fluorescence intensity for this titration was plotted as a function of the 
AHNAK5:S100A10C82S(dimer) ratio (Figure 3.9B). The points were globally fit with a 
1:1 ligand binding curve yielding a dissociation constant of 1.75 ± 0.2 µM. In contrast, 
fluorescence experiments of acrylodan-labeled A10A2C82S had a fluorescence maximum 
near 495 nm (Figure 3.10A) that decreased in intensity and gradually shifted to 500 nm 
upon addition of AHNAK5, indicative of a much tighter interaction. The normalized 
change in fluorescence intensity for this titration was plotted as a function of the 
AHNAK5:A10A2C82S(dimer) ratio (Figure 3.10B). Global fitting of duplicate data sets 
with a 1:1 ligand binding curve yielded a dissociation constant of 3.15 ± 0.6 nM. This 
data confirms that the interaction of AHNAK5 with the A10A2C82S hybrid is markedly 
stronger than that with S100A10C82S protein alone.   
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Figure 3.9.  The interaction of AHNAK5 with the S100A10C82S protein monitored by fluorescence  spectroscopy.  
 
(A) Fluorescence spectra of acrylodan-S100A10C82S (300 nM) showing the change in acrylodan fluorescence with 
increasing AHNAK5 peptide concentration. (B) Binding curve for Acrylodan-S100A10C82S titrated with the AHNAK5 
peptide showing the normalized change in fluorescence measured at 500 nm as a function of AHNAK5 concentration. 
Data was collected from duplicate titrations and curves were fit globally with a 1:1 ligand binding function (solid line).   
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Figure 3.10. The interaction of AHNAK5 with the A10A2C82S hybrid protein monitored by fluorescence 
spectroscopy.  
 
(A) Fluorescence spectra of acrylodan-A10A2C82S (300 nM) depicting the change in acrylodan fluorescence with 
increasing AHNAK5 peptide concentration. (B) Binding curve for Acrylodan-A10A2C82S titrated with the AHNAK5 
peptide showing the normalized change in fluorescence measured at 500 nm as a function of AHNAK5 concentration. 
Data was collected from duplicate titrations and curves were fit globally with a 1:1 ligand binding function (solid line).    
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3.3.4       Mapping S100A10 and A10A2 Binding Sites on C-terminal Region of TRPV5 
Recent two-hybrid and co-immunoprecipitation experiments provided evidence 
for interaction of the transient receptor potential cation channel protein TRPV5 and 
TRPV6 with the S100A10 protein (van de Graaf et al. 2003; Borthwick et al. 2008). In 
this case, the S100A10-annexin A2 complex is thought t o  mediate trafficking of the 
TRPV5 and TRPV6 proteins to the plasma membrane where they act as calcium-
selective channels. Although S100A10 forms a ternary complex with annexin A2 and 
either TRPV5 or TRPV6, a direct interaction between the annexin and TRPV proteins 
have not been observed. To examine the possible formation of a ternary complex 
involving S100A10 and annexin A2 proteins, the interaction between TRPV5 with 
S100A10 alone and the A10A2 complex was tested by peptide array analysis. Peptide 
arrays containing 18-residue peptides spanning the C-terminal sequence of human 
TRPV5 (residues 577-730) were synthesized as described in Section 3.2.8. S100A10C82S 
or A10A2C82S were labeled with Alexa Fluor 680 maleimide at their unique cysteine 
(C61) in the sequence for peptide array blotting. Cys61 is located in the second calcium-
binding loop of S100A10, and is not known to be involved in target-binding. As a result, 
the Alexa dye should not interfere with the interaction of Alexa-S100A10C82S or -
A10A2C82S with any of the peptides.  
Alexa-S100A10C82S and -A10A2C82S were used for blotting the peptide arrays to 
determine whether the N-terminal peptide of annexin A2 in the S100A10-annexin A2 
complex is required for the interaction of S100A10 with TRPV5/TRPV6. Peptide array 
analysis identifies the sequence dependent but structurally independent interactions 
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between S100A10C82S or A10A2C82S with the series of 18-residue peptides spanning 
the C-terminal sequence of human TRPV5. The binding regions on TRPV5 were 
identified by comparing the overlapping TRPV5 peptide sequences on the array that were 
fluorescent (Figure 3.11A and B). For instance, the sequences for the peptides at position 
2G, 2H, and 2I on the TRPV5 18-2 array are WPRSGICGCEFGLGDRWF, 
RSGICGCEFGLGDRWFLR, and GICGCEFGLGDRWFLRVE, respectively. Thus, each 
spot on the array differs from the previous one by losing two residues from the N-
terminus, while gaining two residues at the C-terminus of the peptide by moving along 
the protein sequence. Peptide array spots that decreased in fluorescence after a 
consecutive string of fluorescence spots, specify the importance of the deleted residues 
for the S100A10C82S interaction. In all of the arrays the amino acid residues important for 
the interactions are shown in red (Figures 3.11-3.14). 
On the TRPV5 18-1 array, S100A10C82S associated with five regions of the C-
terminal sequence of TRPV5 (Figure 3.11A), while the protein bound to 4 sites on the 
TRPV5 18-2 array (Figure 3.11B). The binding sequences for both arrays were very 
similar. One of the observed differences was that the two sequences spanning S669-W701 
(10G-11H) and L688-E720 (12B-13G) on the TRPV5 18-1 array, appeared as one long 
stretch of residues covering S669-E720 (5A-6D) on the TRPV5 18-2 array. The first 
interaction site in TRPV5 was located at R594-G620 (2H-3G) in both arrays, which is 
localized to its intracellular C-terminal tail. This region contains residues 598-603 
(VATTV) that is a highly conserved region in both TRPV5/TRPV6 channel proteins. 
These arrays uncovered specific sequences within TRPV5 that are recognized by  
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Figure 3.11. Mapping the S100A10 binding site on TRPV5 protein through peptide 
array analysis.  
 
A peptide array of the C-terminal sequence of human TRPV5 (577-730) was synthesized. 
Each spot contained an 18-residue peptide shifted by 1 (A) or 2 (B) residues from its 
predecessor until the C-terminus was reached. The arrays were probed with Alexa Fluor 
680-S100A10C82S and imaged at 700 nm. The sequences of TRPV5 corresponding to the 
peptides that showed the interaction with S100A10C82S are listed below the array, with the 
residues important in the interaction in red. 
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S100A10C82S. Furthermore, since the TRPV5 18-1 array shifted by only a single 
residue at each spot, it allowed to examine the importance of every residue in the protein 
sequence. These residues are indicated in red in Figure 3.11.    
To determine whether the interaction of S100A10 with the N-terminal region of 
annexin A2 alters the binding of S100A10 on the TRPV5 protein, similar peptide arrays 
were probed with Alexa-A10A2C82S (Figure 3.12A and B). A10A2C82S associated with 
five regions on the C-terminal sequence of TRPV5 on the 18-1 array (Figure 3.12A), 
while the protein bound to 4 sites on the TRPV5 18-2 array (Figure 3.12B). The two 
sequences spanning D590-G620
 
(2D-3G) and R615-V633 (4I-4J) on the TRPV5 18-1 
array, appeared as one extended sequence covering E591-D638
 
(1H-2K) on the TRPV5 
18-2 array. Interestingly, the interaction sites found on the arrays blotted with Alexa-
A10A2C82S, were similar to those probed with Alexa-S100A10C82S (Figure 3.11A and B). 
This suggests that association of S100A10C82S with TRPV5 is not modified when 
S100A10C82S is in complex with the N-terminal peptide of annexin A2. This shows the 
binding site of TRPV5 on the S100A10C82S is different from that of the N-terminal 
peptide of annexin A2 protein. Consequently, the interaction of TRPV5 with the 
S100A10C82S-annexin A2 complex is unlike the AHNAK protein, whereby residues from 
both the S100A10C82S and annexin A2 are required for the strong interaction of the 
AHNAK with the complex.   
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Figure 3.12. Identification of the A10A2C82S binding region on TRPV5 protein. 
  
A peptide array scanning the C-terminal sequence of human TRPV5 (577-730) was 
synthesized with each spot containing an 18-residue peptide that moves through the 
sequence by 1 (A) or 2 (B) residues for each spot. The arrays were blotted with Alexa 
Fluor 680-A10A2C82S and imaged at 700 nm. The sequences of TRPV5 corresponding to 
the peptides that were found to interact with A10A2C82S are listed below the array, with 
the residues important for the interaction in red. 
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3.3.5       S100A10 Binds to Specific Regions on Annexin A2 
The crystal structure of apo-S100A10 in complex with annexin A2 is only 
comprised of the first twelve N-terminal residues of the annexin A2 protein (Rety et al. 
1999). Consequently, this structure does not show other potential binding sites of 
S100A10 on the annexin A2 protein. To identify additional regions of annexin A2 that are 
involved in S100A10 binding, two peptide arrays containing 18-residue peptides 
spanning the entire sequence of human annexin A2 were synthesized as described in 
Section 3.2.8. The arrays were blotted with Alexa-S100A10C82S or -A10A2C82S, and 
stripped to eliminate the background fluorescence and non-specific interactions. 
On the annexin A2 18-2 array, S100A10C82S associated with eleven regions of 
annexin A2 protein (Figure 3.13A). The first interaction site (1A-1A) was found in the 
first 18 residues of the N-terminal tail of annexin A2 (M1-S18), which had shown a 
strong interaction with the S100A10 protein in the crystal structure (Rety et al. 1999). 
This interaction did not seem as strong compared to some other spots on the array, 
indicating the presence of other regions on the annexin A2 sequence that have stronger 
binding with S100A10C82S. The second and third binding regions, L13-D34
 
and V51-H94, 
(1G-1I and 2J-3G) encompass the linker that connects the N-terminus of annexin A2 to 
repeat I (refer to Section 1.5, Figure 1.5) as well as helices A-D of repeat I, respectively. 
These two regions are located on one side of the annexin A2 protein, however, only the 
linker and helices A and B of repeat I are accessible to interact with residues of S100A10. 
A closer look at the structure of annexin A2 indicates that binding regions comprised of 
E125-E142 (4O-4O), I129-K148 (5A-5B), S161-A180 (6A-6B), I191-T208 (6P-6P), and
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Figure 3.13. Mapping the S100A10C82S binding site on annexin A2 protein through 
peptide array analysis.  
 
A peptide array of the entire sequence of human annexin A2 was synthesized on a 
cellulose membrane. Each spot contained an 18-residue peptide shifted by 2 (A) or 3 (B) 
residues from its predecessor until the C-terminus was reached. The arrays were probed 
with Alexa Fluor 680-S100A10C82S and imaged at 700 nm. The sequences of annexin A2 
corresponding to the peptides that showed the best interaction with S100A10C82S are 
listed below the array, with the residues important in the interaction in red.  
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 G250-K281 (8N-9F) are all located at the core of annexin A2 molecule and are not 
available for interaction with S100A10C82S. The fact that all of these regions appeared as a 
short or single fluorescence spot on the array is an indication for non-specific interactions 
of the protein to these peptides. It is noteworthy that some of the interactions observed 
could also be due to sequence similarity of the helices within each repeat unit of annexin 
A2. One of the strongest binding regions, P211-V248 (7J-8D), includes helix C of repeat 
III (Figure 1.5) where the N-terminal tail of annexin A2 is packed against. Therefore, it is 
not surprising to observe the association of S100A10C82S with this region. Finally, the 
binding sites encompassing L288-E307 (10A-10B) and M300-K336 (10G-11A) contain 
the linker connecting helices B to C, as well as helices C, D, and E of repeat IV of 
annexin A2. These sites are located at the same side as the N-terminal tail of annexin A2, 
and are accessible for binding to S100A10.  
Comparable results were observed for the annexin A2 18-3 array. However, 
S100A10C82S associated with ten regions of annexin A2 protein (Figure 3.13B). Two of 
the interaction sites, E125-E139 (4O-4O), and I191-T208 (6P-6P), present in the annexin 
A2 18-2 array, were not observed on this array confirming that the single fluorescence 
spots were indeed non-specific. An additional weak interaction was also noted at L91-
S117 (4A-4D) that is not available for interaction with S100A10. 
 In order to determine whether the interaction of S100A10C82S with the N-
terminal tail of annexin A2 alters the binding of S100A10C82S to other regions of annexin 
A2, similar peptide arrays were probed with Alexa Fluor 680-labeled A10A2C82S protein 
(Alexa-A10A2) (Figure 3.14A and B). In the A10A2C82S hybrid protein, the S100A10C82S 
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Figure 3.14. Identification of the A10A2C82S binding region on annexin A2 protein.  
 
A peptide array scanning the entire sequence of human annexin A2 was synthesized. Each 
spot contained an 18-residue peptide shifted by 2 (A) or 3 (B) residues from its 
predecessor until the C-terminus was reached. The arrays were blotted with Alexa Fluor 
680-A10A2C82S and imaged at 700 nm. The sequences of annexin A2 corresponding to 
the peptides that were found to interact with A10A2C82S are listed below the array, with 
the residues important for the interaction in red. 
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 is in complex with the N-terminal tail of annexin A2. As expected, Alexa-A10A2C82S 
did not interact with the spots containing the N-terminal tail of annexin A2 on the array. 
In addition, some of the non-specific bindings such as E125-E139 (4O-4O), I129-K148 
(5A-5B), and I186-T208 (6P-6P) observed on the arrays blotted with Alexa-S100A10C82S, 
were absent.  
 Some of the interaction sites on the arrays blotted with Alexa-A10A2C82S were 
analogous to those probed with Alexa-S100A10C82S (Figure 3.13A and B), signifying that 
A10A2C82S associates with similar sequences on the annexin A2 protein. Thus, these 
interactions are not modified when S100A10C82S is bound to the N-terminal tail of 
annexin A2. Due to the high number of fluorescent spots on these arrays, it was difficult 
to identify the stronger binding sites.   
 
3.3.6       Expression and Purification of the Wild-Type Dysferlin C2A Domain 
Wild-type forms of human dysferlin C2A domain (simply referred to as 
dysferlin) (residues 1-138) were overexpressed in the BL21 (DE3) E. coli strain. 
Following the first run on the Ni-NTA column, the His6 tag was cleaved from the N-
terminus of dysferlin. The cleaved protein was not stable in buffer containing imidazole, 
which is used to elute the protein from Ni-NTA columns. Therefore, cleaved dysferlin 
was purified on a HiTrap SP FF column. Figure 3.15 shows the SDS-PAGE of the last 
purification step, indicating a single band at an apparent molecular weight of 
approximately 14.8 kDa. This roughly corresponds to the calculated molecular weight for 
human dysferlin (1-138) of 14805.9 Da. Since dysferlin is a calcium-binding protein,
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Figure 3.15. Coomassie-stained SDS-PAGE gel (16.5%) depicting the purification of 
wild-type C2A domain of dysferlin.  
 
Lane 1 contains the protein molecular weight markers, with molecular weights labeled on 
the left of the gel. Lanes 2-12 contain elution profile of every fraction following removal 
of His6 tag on the HiTrap SP FF column. The arrowhead on the right indicates dysferlin 
protein at molecular weight of approximately 14.8 kDa. 
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some of the early NMR spectra indicated that after the last purification step the protein 
was partially bound to calcium. To ensure that dysferlin was in the apo form, 1 mM 
EDTA was present in the buffers used in the second column run. Before calcium titration 
experiments, the protein was extensively dialyzed against EDTA-free buffers to remove 
excess EDTA as it could bind to calcium ions. 
 
3.3.7       Sequential Backbone assignment of S100A10 
The structure of S100A10 in the apo state and complexed with the N-terminal 
peptide of annexin A2 has been solved by X-ray crystallography (Rety et al. 1999). The 
lack of an NMR assignment of apo-S100A10 makes it difficult to determine the details of 
the interaction of this protein with target peptides. Thus, the NMR assignment of 
S100A10 was completed. Wild-type S100A10 was purified. However, concentrating this 
protein to a usable concentration for NMR samples resulted in rapid precipitation of 
S100A10. To overcome this problem, dilute S100A10 was dialyzed against a buffer 
containing equimolar concentrations (50 mM) of arginine and glutamic acid prior to 
concentration, which was previously shown to stabilize proteins during concentration 
(Golovanov et al. 2004). Sufficient quantities of wild-type 15N, 13C-labeled S100A10 for 
NMR samples at a concentration of 1 mM were prepared. However, the 1H-15N HSQC 
spectrum of this sample showed that the concentrated sample was too viscous which 
resulted in increasing the line-width of the peaks. Diluting the sample to 500 µM allowed 
better spectra to be collected for the resonance assignment of the protein. Chemical shift 
assignments (1H, 15N, and 13C) for S100A10 were accomplished using standard 
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heteronuclear multiple dimensional NMR spectroscopy (HNCA, HNCACB, 
CBCA(CO)NH, and HNCO) (Figure 3.16 and 3.17). Figure 3.17 shows a representative 
1H-15N HSQC spectrum of S100A10 that is well dispersed, indicating that the protein is 
well folded. The 1H and 15N backbone amide resonances of S100A10 for 78 out of 93 
non-proline residues were assigned (Table 3.1). There were 5 residues on the 1H-15N 
HSQC spectrum that did not appear on any of the three-dimensional NMR spectra and 
thus could not be assigned. Most of the remaining residues were not visible on the spectra 
due to fast exchange with the solvent and could not be assigned.  
 
3.3.8       Interaction Study of Apo- and Calcium Bound Dysferlin C2A Domain with 
S100A10 
To further examine the arrangement of multi-protein complexes involved in 
membrane repair, the binding region(s) of different proteins within the complexes such as 
those formed between S100A10 and dysferlin must be uncovered. Sequence alignments 
of dysferlin with other members of the ferlin family such as synaptotagmin have proposed 
six potential calcium binding sites in the C2A domain of dysferlin (Britton et al. 2000). 
Recently, it was shown that the C2A domain of synaptotagmin (Syt1) associates with 
fibroblast growth factor protein (FGF) as well as one of the members of the S100 family, 
S100A13, in the presence of calcium (Mohan et al. 2009; Mohan et al. 2010).  
The assigned spectra (1H, 15N, and 13C) for the apo-C2A domain of dysferlin 
(Chantal Forristal, data not published, University of Western Ontario, ON, Canada) and 
S100A10 would allow the interaction of sites between dysferlin and S100A10 proteins to
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Figure 3.16. Selected regions of 600 MHz NMR spectra used for the backbone 
assignment of the wild-type S100A10 protein.  
 
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the 
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of 
the three dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i) 
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous 
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for 
sequential assignment of residues E28-E31 of the S100A10. 
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Figure 3.17. Backbone amide assignment of S100A10 protein.  
 
1H-15N HSQC spectrum of 0.5 mM (monomer) uniformly 15N, 13C-labeled S100A10 
protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was collected 
in 20 mM MOPS, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 100 mM NaCl, pH 
7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated with their one letter 
amino acid code and number. The “?” indicates the peaks that appeared on the 1H-15N 
HSQC spectrum, however, were absent on the three-dimensional NMR experiments used 
for assignment purposes. Pairs of resonances for side chain amide cross peaks are 
connected by horizontal lines. 
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Table 3.1. 15N, 13C and 1H resonance assignments for human S100A10. 
 
Residue HN N C’ Cα  Cβ 
P1      
S2    175.17 57.79 64.85 
Q3  9.265 121.4 180.01 59.55 28.39 
M4  9.023 120.1 178.81 57.92 32.02 
E5  8.522 121.0 179.42 60.17 29.53 
H6  8.497 118.4 178.09 59.56 29.90 
A7  8.330 123.8 178.61 55.74 18.24 
M8  8.410 117.1  57.83 32.02 
E9  
 
  60.03 29.40 
T10  8.423 116.7  66.80 68.51 
M11      
M12      
F13  8.050 124.1 178.44 58.23 41.46 
T14  7.840 117.2 176.98 62.70 62.55 
F15  8.053 124.1  58.31 41.57 
H16      
K17     177.70 59.24 32.17 
F18  7.173 114.4 176.05 60.36 40.74 
A19  8.506 122.7  53.92 18.77 
G20  7.454 100.9  44.78  
D21     177.98 56.56 40.63 
K22  8.305 117.1 178.25 57.65 31.15 
G23  7.354 104.0  46.49  
Y24      
L25     178.16 53.20 43.47 
T26  9.218 112.8 175.89 60.72 71.85 
K27  9.098 120.1 178.46 60.70 31.95 
E28  8.196 118.4 178.71 59.79 29.09 
D29  7.723 120.1 177.97 57.22 42.70 
L30  8.352 118.3  57.5 41.80 
R31  7.980 119.7 178.16 60.26 29.78 
V32  7.610 118.3 177.32 66.31 31.91 
L33  8.026 122.0 179.34 59.42 42.02 
M34  8.505 117.6 177.96 59.06 31.64 
E35  8.084 117.3 178.76 59.26 30.11 
K36  8.179 114.9 178.86 57.93 33.68 
E37  8.767 114.5  56.22 30.58 
F38      
P39     179.62 65.63 31.07 
G40  9.256 111.8 172.46 46.46  
F41  6.882 113.6 171.81 55.60 40.14 
L42  8.892 117.6 179.47 52.90  
E43  8.284 119.3 177.35 58.48 29.64 
N44  7.681 116.1 175.11 53.99 39.40 
Q45  7.602 118.0 177.57 55.97 28.99 
K46  8.090 119.7  57.20 32.81 
D47      
P48     177.77 64.28 32.44 
L49  8.238 119.00 177.60 54.91 41.30 
A50  7.625 122.7 178.84 55.69 18.92 
V51  8.230 116.6 174.88 66.42 31.44 
D52  7.896 120.2 178.81 57.61 40.75 
K53  7.961 118.4 178.87 59.75 32.64 
I54  7.605 119.6 178.10 64.22 38.21 
   
153 
M55  8.074 116.8 178.30 57.89 32.20 
K56  7.771 118.9 178.17 58.88 32.26 
D57  7.721 118.7 177.47 56.06 40.88 
L58  7.659 120.2 177.87 55.82 42.06 
D59  8.220 121.5 177.29 56.04 40.85 
Q60  8.254 117.1 176.36 56.89 28.81 
C61  8.050 118.0  58.95 27.54 
R62     176.48 57.91 29.55 
D63  8.527 118.8 176.51 54.32 40.69 
G64  8.352 107.1 173.56 46.04  
K65  7.491 118.8 175.49 55.66 34.21 
V66  9.271 124.4 176.08 62.43 32.73 
G67  8.467 114.4 173.72 44.31  
F68  8.734 119.7  62.13 39.33 
Q69      
S70      
F71      
F72      
S73      
L74      
I75     179.04 62.83  
A76  8.043 124.9 179.19 55.54 18.11 
G77  7.871 104.7 176.04 47.07  
L78  8.175 122.4  59.72 39.09 
T79     175.65 61.72 63.33 
I80  8.605 122.8  60.86 39.06 
A81     178.96 54.11 19.08 
C82  7.793 115.0  59.22 28.24 
N83      
D84      
Y85      
F86     176.63 60.00 39.65 
V87  8.029 118.5 177.20 64.66 32.04 
V88  7.761 120.0 177.14 64.50 32.30 
H89  7.974 119.7 176.23 57.76 30.00 
M90  8.016 118.8 176.94 56.51 32.62 
K91  7.965 120.5 177.00 57.15 32.76 
Q92  8.128 119.8 176.17 56.20 29.30 
K93  8.166 121.8 177.07 56.79 32.94 
G94  8.345 109.6 173.79 45.32  
K95  8.035 121.1  56.28 33.32 
K96  7.974 128.0  57.84 33.75 
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be identified using chemical shift perturbations. To determine whether the interaction 
between S100A10 and dysferlin was dependent upon calcium binding to dysferlin, a 1H-
15N HSQC spectrum of apo-C2A domain of dysferlin was collected (Figure 3.18A). A 
similar NMR sample containing excess amount of S100A10 was also prepared and a 
second 1H-15N HSQC was then obtained (Figure 3.18B). Comparison between the two 
spectra of C2A domain of dysferlin in the presence and absence of S100A10 showed that 
the peaks are in nearly identical positions. This could suggest that the interaction between 
C2A domain of dysferlin and S100A10 is calcium dependent. 
   Small additions of calcium from a stock with known concentration 
(determined by ICP) were made to the NMR sample of apo-C2A domain of dysferlin and 
1H-15N HSQC spectra were collected at each point (Figure 3.19). Calcium additions 
resulted in the gradual disappearance of a subset of dysferlin C2A domain resonances and 
the reappearance of new peaks at each step of the titration. This shows the sequential 
association of the calcium ion to each calcium-binding loop of the protein in a slow 
exchange process with dissociation constants of less than 20 µM for all calcium-binding 
sites. The C2A domain of dysferlin was saturated when the calcium concentration was 
equivalent to 6 times the protein concentration (Figure 3.19F). Comparable titrations were 
made into the NMR sample containing the mixture of apo-C2A domain of dysferlin and 
S100A10 (Figure 3.20B). The 1H-15N HSQC of this sample was identical to the spectrum 
of calcium-bound dysferlin protein (Figure 3.20A), demonstrating a lack of interaction 
between C2A domain of dysferlin and S100A10 under the conditions used. 
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Figure 3.18. Interaction study of dysferlin C2A domain and S100A10 in the absence of calcium.  
 
1H-15N HSQC spectrum of 200 mM  uniformly 15N, 13C-labeled dysferlin C2A domain alone (A) and mixed with 400 
mM wild-type S100A10 protein (B) in 10 mM HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5 acquired at 35 ºC on a 
Varian INOVA 600 MHz spectrometer. 
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Figure 3.19. Titration of dysferlin C2A domain with calcium ions.  
 
Representative 1H-15N HSQC spectra from the calcium titration are illustrated. Small 
additions of calcium were made into a sample of uniformly 15N, 13C-labeled dysferlin 
C2A domain (200 µM). Spectra shown are at (A) 1 equivalent, (B) 2 eq., (C) 3 eq., (D) 4 
eq., (E) 5 eq., and (F) 6 eq. of calcium relative to the protein concentration. The C2A 
domain of dysferlin binds to 6 calcium ions. 
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Figure 3.20.  Interaction study of dysferlin C2A domain and S100A10 in the presence of calcium.  
 
1H-15N HSQC spectrum of 200 mM  uniformly 15N, 13C-labeled calcium-bound dysferlin C2A domain alone (A) and 
mixed with 400 mM wild-type S100A10 protein (B) in 10 mM HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5 
acquired at 35 ºC on a Varian INOVA 600 MHz spectrometer. 
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3.3.9       Expression and Purification of the C-terminal Fragment of Human AHNAK 
Protein 
Recombinant C-terminal fragment of human AHNAK (residues 5362-5434) was 
expressed and purified from E. coli strain BL21 (DE3) Codon Plus expression cells. Since 
the protein degraded very quickly, purification procedures were performed at 4 °C in the 
presence of one complete-mini protease inhibitor tablet, PMSF and leupeptin. The protein 
was purified on two consecutive Ni-NTA columns. Figure 3.21 shows the SDS-PAGE of 
fractions from the second column run. The AHNAK protein appears as a band at 
approximately 9 kDa, which roughly corresponds to the calculated monomer molecular 
weight for the C-terminal fragment of AHNAK of 7827.0 Da. Fractions containing a 
single band corresponding to the mass of AHNAK were pooled and stored at -80 °C. ESI 
mass spectrometry was used to verify the purity, integrity and molecular weight of the 
protein. Figure 3.22 shows a mass spectrum of unlabeled AHNAK with two peaks. The 
first peak appears at 7827.4 Da, which is in agreement with the calculated mass of 
monomeric AHNAK. The second peak at 15652.87 Da corresponds to the molecular 
weight of a dimeric AHNAK protein. Fresh DTT as a reducing agent was required to 
prevent formation of an intermolecular disulfide bond between Cys5382 of the AHNAK.  
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Figure 3.21. Coomassie-stained SDS-PAGE for the purification of short C-terminal 
fragment of AHNAK.  
 
Lane 1 contains the protein molecular weight markers, with molecular weights labeled on 
the left. Lanes 2-13 contain elution profile of every fraction following removal of His7 tag 
on the Ni-NTA column. The arrowhead on the right indicates monomeric AHNAK at 
molecular weight of approximately 9 kDa. 
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Figure 3.22. Mass spectrum of an unlabeled C-terminal domain construct of AHNAK protein.  
 
After purification of the protein, excess salt was removed. The protein was subjected to mass spectrometric analysis to 
verify the molecular weight of the protein. The analysis resulted in two peaks. The peak at 7827.4 Da is in agreement 
with the calculated mass of monomer AHNAK (7827.0 Da). The peak at 15652.9 Da corresponds to the mass of a 
dimer AHNAK when a disulfide bond is formed between cysteines at position 5382. 
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3.3.10     Interaction Study of Apo- and Calcium Bound Dysferlin C2A Domain with 
the C-terminal Fragment of AHNAK 
Recent three-hybrid and co-immunoprecipitation experiments have provided 
some evidence on the interaction between the C-terminal domain of AHNAK and the N-
terminal C2A domain of dysferlin. Further, it was also shown that calcium binding to the 
dysferlin C2A domain is not a requirement for its interaction with AHNAK (Huang et 
al. 2007). To identify the residues involved in this interaction, dysferlin C2A domain was 
labeled with Alexa Fluor 680 maleimide at the only cysteine (Cys23) in the sequence for 
peptide array blotting. Alexa-dysferlin protein was used in a peptide array experiment 
covering the C-terminus of AHNAK (residues 4884-5890). This approach identifies the 
structurally independent interactions between dysferlin and a series of 18-residue peptides 
spanning the C-terminal sequence of AHNAK. Overlapping sequences in the arrays that 
fluoresced upon Alexa-dysferlin C2A domain binding were used to identify the AHNAK 
binding sites (Figure 3.23). Blotting of the arrays with Alexa-dysferlin revealed that the 
apo-dysferlin C2A domain associates with four distinct regions within the C-terminus of 
AHNAK. Using the Blocks Server (blocks.fhcrc.org) to analyze these regions, a six 
residue consensus sequence was identified for AHNAK that could best be represented as 
XPKφ±φ (X – variable; φ – hydrophobic residue; ± – charged residue; P – proline; K – 
lysine).  
The most intense binding at any one spot was observed within sequences b 
(Gly5367 - Ser5393), while sequences a (Met5025 - Phe5042), c (Leu5394 - Ser5414) 
and d (Phe5619 - His5649) showed weaker interactions with the dysferlin C2A
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Figure 3.23. Mapping apo-dysferlin C2A domain binding site on the C-terminal 
region of AHNAK by peptide array analysis.  
 
A peptide array of the Asp4884-Glu5890 region of AHNAK was synthesized. Each spot 
contained an 18-residue peptide shifted by 3 residues from its predecessor until the C-
terminus was reached. The array was probed with Alexa Fluor 680-dysferlin and imaged 
at 700 nm. The sequences of AHNAK that were found to bind dysferlin C2A domain (red 
fluorescent spots) are listed and indicated with arrows; sequence a (Met5025 - Phe5042), 
sequence b (Gly5367 - Ser5393), sequence c (Leu5394 - Ser5414), sequence d (Phe5619 - 
His5649). These sequences were used to define a consensus sequence showing charged 
(±), hydrophobic (φ) and variable (X) residues using the Blocks Server (blocks.fhcrc.org). 
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domain. This could be due to the presence of certain residues upstream of the 
consensus sequence. For example, when residues L5370-G5372 were eliminated from the 
second fluorescent spot of sequences b, the fluorescent signal of the next spot was 
dramatically reduced.  
Previous GST-pull down assays of AHNAK indicated that the binding site for 
dysferlin C2A domain is located between residues M5146-V5643 (Huang et al. 2007). 
However, the peptide array experiment identified an extra binding region, specified as 
sequence a (Met5025 - Phe5042). This interaction could be explained by sequence 
similarity of this region with the remaining binding sites. It would be interesting to repeat 
a similar array in the presence of calcium to observe whether calcium-bound dysferlin 
C2A domain would bind to different regions on the AHNAK.  
To further examine and locate the interaction sites between dysferlin and 
AHNAK proteins, both the C-terminal fragment of AHNAK and the C2A domain of 
dysferlin proteins were purified as described in Sections 3.2.5 and 3.2.6, respectively. A 
1H-15N HSQC spectrum of apo-C2A domain of dysferlin was collected (Figure 3.24). A 
similar NMR sample containing an excess amount of AHNAK was also prepared and a 
second 1H-15N HSQC was obtained (Figure 3.24). The overlay of the two 1H-15N HSQC 
spectra did not show significant changes in chemical shifts of C2A domain of dysferlin in 
the presence and absence of AHNAK.  
   To test whether this interaction is calcium dependent, small additions of 
calcium were made to the NMR sample of apo-C2A domain of dysferlin. Once more, the 
C2A domain of dysferlin was saturated when the calcium concentration was equivalent to
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Figure 3.24. Interaction study of C2A domain of dysferlin and C-terminal fragment 
of AHNAK in the absence of calcium.  
 
Overlay of 1H-15N HSQC spectra of apo-dysferlin (black) and apo-dysferlin mixed with 
C-terminal fragment of AHNAK protein (blue). Two NMR samples of 138 µM uniformly 
15N, 13C-labeled apo-dysferlin alone and mixed with 200 µM AHNAK protein in 10 mM 
HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5 were used to collect the respective HSQC 
spectra. No significant changes in chemical shifts were observed in the absence of 
calcium. 
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6 times the protein concentration (Figure 3.25). Similar titrations were made into the 
NMR sample containing the mixture of apo-C2A domain of dysferlin and AHNAK 
(Figure 3.25). The 1H-15N HSQC of this sample perfectly superimpose the spectrum of 
calcium-bound dysferlin protein. This indicates that under the conditions used, C2A 
domain of dysferlin does not interact with the AHNAK protein in the presence or absence 
of calcium. Similar results were obtained when analogous experiments in different buffer 
conditions (ie. 50 and 100 mM NaCl) were repeated (data not shown).  
 
3.4          Discussion 
Proteomic studies have indicated that a large number of proteins are involved in 
membrane repair processes (de Morree et al. 2010; Cacciottolo et al. 2011). Included in 
this group is the EF-hand protein S100A10, the phospholipid-binding protein annexin A2 
and the enlargeosome protein AHNAK, all proposed to participate in a multi-protein 
complex near the plasma membrane. This chapter provides the first details of the 
architecture for a ternary complex between these three proteins.  
 
3.4.1       Evidence for a Scaffolding Role of the AHNAK C-terminus 
Peptide array experiments show eight potential binding regions within the C-
terminal domain of AHNAK for the A10A2C82S hybrid protein. Not surprisingly, these 
sequences all have some similarity forming a consensus sequence +X+XPKφXφ. The 
repeating nature of these sequences is not unique to the C-terminus of AHNAK. The 
central region of the protein includes 24 repeat motifs (165-residues each) suggested to
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Figure 3.25. Interaction study of C2A domain of dysferlin and C-terminal fragment 
of AHNAK in the presence of calcium.  
 
Overlay of 1H-15N HSQC spectra of calcium-bound dysferlin (black) and calcium-bound 
dysferlin mixed with C-terminal fragment of AHNAK protein (pink). Two NMR samples 
of 138 µM uniformly 15N, 13C-labeled apo-dysferlin alone and mixed with 200 µM 
AHNAK protein were titrated with 850 µM of calcium. The two samples were in 10 mM 
HEPES, 1 mM DTT, 150 mM NaCl at pH 7.5. 1H-15N HSQC spectra did not show any 
significant changes in chemical shifts when calcium was added. 
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adopt a series of β-propeller structures similar to RCC1 (Shtivelman et al. 1992; 
Shtivelman and Bishop 1993). The nature of the AHNAK consensus sequence differs 
from other S100 binding motifs such as those found in the N-terminus of annexins A1 
and A2 (A/VXXφLXXφXφ) and CapZ (R/KL/IXWXXIL). The single-residue spacing of 
the hydrophobic residues in the AHNAK sequence suggests it does not have amphipathic 
character similar to the α-helical structure found in the annexin-binding sequences. In 
addition, a central proline residue would not favor helix formation upon binding. The 
possibility for eight binding regions in the C-terminus of AHNAK for the S100A10-
annexin A2 complex is consistent with a scaffolding role for AHNAK. In principle, this 
would allow up to eight S100A10-annexin A2 heterotetramers to assemble on the C-
terminus. Since binding of the complex to the phospholipid surface is governed by 
calcium binding to the annexin moiety, this would allow a highly cooperative association 
of the complex with the membrane. Despite this potential, other experiments have shown 
that only the Gly5654 - Gly5673 region within the C-terminus of AHNAK displays a 
strong interaction with the S100A10-annexin A2 (De Seranno et al. 2006). This could 
indicate that other sequences identified in the peptide array are masked by the AHNAK 
tertiary structure. Similarly, the Gly5654 - Gly5673 region had the strongest binding spot 
in the peptide array suggesting it could have a much stronger affinity than the other 
sequences.  
The ability of the S100A10-annexin A2 heterotetrameric complex to participate 
in the assembly of other larger multiprotein complexes was also examined for transient 
receptor potential cation channel proteins TRPV5. Peptide array experiments uncovered 
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five potential binding sequences within the C-terminus of TRPV5, including residues 
598-603 (VATTV) that forms a highly conserved region in both TRPV5/TRPV6 
channel proteins. However, regions such as D627-V648 (ie. in Figure 3.11A, 6A-6E) 
showed stronger binding than that observed with the conserved VATTV sequence, to 
both the S100A10C82S and A10A2C82S proteins. The S100A10C82S and A10A2C82S 
associated to the same region on TRPV5 protein, suggesting that the N-terminal peptide 
of annexin A2 may not be required for the interaction of S100A10 to TRPV5. 
Consequently, the interaction site between TRPV5 with S100A10 or annexin A2-bound 
S100A10 is different from the complex formed with the AHNAK, where residues from 
both S100A10 and annexin A2 are required for the strong interaction of the peptide. 
Further experiments such as the binding affinity assays are necessary to determine 
whether a difference exists for the binding affinity of TRPV5 to the S100A10 or annexin 
A2-bound S100A10 protein, similar to that observed for the AHNAK. This experiment 
would indicate that although TRPV5 may use a binding mechanism different from the 
AHNAK protein, strong interaction of TRPV5 requires the complex formed between 
S100A10 and annexin A2 proteins.   
 
3.4.2       An Asymmetric S100A10-Annexin A2-AHNAK Complex  
A representative sequence (AHNAK5) identified from the peptide array was 
used to identify the arrangement of the S100A10-annexin A2-AHNAK5 ternary complex. 
Using both the A10A2C82S hybrid protein and complex of S100A10C82S with an N-
terminal peptide of the annexin A2, a single AHNAK5 peptide was found to coordinate in 
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an asymmetric fashion to the S100A10-annexin A2 heterotetramer. Although it is a 
ternary complex, an asymmetric arrangement within an S100-target protein complex has 
not been observed to date. For example, multiple S100-peptide complexes such as those 
between S100B and CapZ (Inman et al. 2002; McClintock and Shaw 2003; Charpentier et 
al. 2010), p53 (Rustandi et al. 2000) or Ndr kinase (Lee et al. 2008), S100A1 with RyR 
(Wright et al. 2008) and CapZ (Wright et al. 2009) and S100A6 with Siah1 interacting 
protein (Lee et al. 2008) all display symmetric arrangements. In S100A10-annexin A2 the 
addition of AHNAK acts to break the symmetry of the heterotetramer. In contrast the EF-
hand calcium-binding protein calmodulin (CaM) can form asymmetric complexes with 
the dimeric targets glutamate decarboxylase and Cdc42-WASP. In these cases, binding of 
calcium-activated CaM to the symmetric, dimeric arrangements of glutamate 
decarboxylase and Cdc42-WASP results in an overall asymmetric arrangement essential 
for enzyme activity (Yuan and Vogel 1998; Kim et al. 2000; Yap et al. 2003). 
In the A10A2-AHNAK5 complex, significant changes in chemical shift occur 
mainly for residues in helix IV of the S100A10 (Gly77, Ala81) as well as the N-terminus 
of the annexin A2 (Leu112, G114) peptides. In the S100A10-annexin A2 structure helices 
IV and IV’ from S100A10 form a portion of the dimer interface oriented roughly 180˚ 
from each other on one face of the protein (Rety et al. 1999). The two annexin A2 
peptides in the heterotetramer are both oriented such that their C-termini lie on the same 
side of the complex as helices IV and IV’. Thus the interaction of AHNAK5 with the 
S100A10-annexin A2 is consistent with binding that utilizes one face of the dimeric 
protein comprising helices IV and IV’ and the adjacent annexin A2 C-termini.  
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The tight binding between AHNAK5 and S100A10-annexin A2 (~3 nM) 
requires initial formation of the heterotetramer since experiments lacking the annexin A2 
peptide yield a much poorer (~1000 fold) interaction. This observation is in excellent 
agreement with yeast triple-hybrid and in vitro binding assays that show both S100A10 
and annexin A2 are required for strong association with the C-terminal domain of 
AHNAK (De Seranno et al. 2006). This requirement indicates there are two calcium-
regulated steps for AHNAK delivery to the membrane surface both mediated by annexin 
A2. The first is the extrusion of N-terminus of annexin A2 upon calcium binding to the 
protein core domain allowing formation of the heterotetramer and subsequent recruitment 
of AHNAK. The second step is the localization of the entire complex to the phospholipid 
surface through calcium bridging between annexin A2 and the membrane. It is interesting 
that several other proteins have also shown an association with the S100A10-annexin A2 
heterotetramer including TRPV5/6 (van de Graaf et al. 2003; Borthwick et al. 2008), 
TASK-1 (Girard et al. 2002; Renigunta et al. 2006) and NS3 (Beaton et al. 2002). While 
the calcium regulation of these interactions is less known, it is possible that the 
asymmetric interaction proposed here for AHNAK is a general feature for trafficking of 
these proteins to the cell membrane.  
 
3.4.3       Interaction between Other Proteins in the Membrane Repair Complexes  
In addition to the 12 residue N-terminal peptide of annexin A2, other potential 
binding sites for S100A10 were identified on the peptide array of full length annexin A2. 
In fact, interaction with the 12 residue N-terminal peptide of annexin A2 appeared as one 
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of the weakest binding sites for S100A10. Except for annexin A6, the remaining 11 
different annexin proteins contain a core domain consisting of four conserved structural 
repeat sequences (I-IV) (Huber et al. 1990; Concha et al. 1993; Sopkova et al. 1993). 
Each repeat unit is formed from five α-helices (A-E) arranged such that helices A, B, D 
and E are roughly anti-parallel to each other while helix C is nearly perpendicular to these 
helices (Figure 1.5) (Weng et al. 1993; Rosengarth et al. 2001). Due to sequence 
similarity of the helices within each repeat unit of annexin A2 (Barton et al. 1991), it is 
not surprising to observe the binding of S100A10 to all four structural repeats on the 
peptide array. Peptide array analysis identifies the sequence dependent but structurally 
independent interactions between a protein and a series of peptides spanning a particular 
region of a protein. Consequently, some of the annexin A2 repeat units that showed 
binding with S100A10 in the peptide array will be excluded as they are buried in an intact 
annexin A2. In addition, the amount of protein used in probing the peptide arrays of 
annexin A2 with S100A10 or A10A2 was about 2 µM, which could result in non-specific 
interaction of the protein to these peptides particularly when the Kd of binding is low. A 
low dissociation constant of approximately 30 nM for the interaction of the 12 residue N-
terminal peptide of annexin A2 with S100A10 was previously determined (Johnsson et al. 
1988). Thus, to prevent the non-specific interactions, lower amount of proteins must be 
used for probing the peptide arrays.  
S100A10, annexin A2 and AHNAK have been identified as binding partners of 
dysferlin, a central protein in the membrane repair complex (Huang et al. 2007). This 
multiprotein complex is proposed to facilitate wound repair of damaged epithelial, 
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auditory and muscle cells upon extracellular calcium influx. A better understanding of 
the arrangement or assembly of the proteins in the membrane repair complex allows 
proposing a model in which this process takes place. It has been shown that the 
association of annexins A1 and A2 with a dysferlin-containing vesicle and damaged 
plasma membranes (Doherty and McNally 2003; Glover and Brown 2007; Han and 
Campbell 2007) is calcium dependent. Previous GST-pull down assay (Huang et al. 2007) 
as well as the peptide array experiment in this work, identified the interaction of the C-
terminus of AHNAK with the apo-C2A domain of dysferlin (aa 2-130), while NMR 
spectroscopy experiments did not indicate any interaction between the two proteins in the 
presence or absence of calcium. The AHNAK protein used in the NMR experiments was 
composed of amino acid residues 5362-5434, which is much shorter than the AHNAK 
protein used in the GST-pull down (5146-5643) (Huang et al. 2007) or peptide array 
(4884-5890) experiments. Consequently, it is possible that the binding site for AHNAK 
on dysferlin C2A domain is indeed located in residues 5435-5643.  
NMR spectroscopy of S100A10 and the dysferlin C2A domain did not suggest a 
direct interaction between these two proteins in the presence or absence of calcium. In 
contrast, S100A13 interacts with the synaptotagmin C2A domain (Mohan et al. 2009; 
Mohan et al. 2010). In this case, synaptotagmin was shown to mediate the interaction 
between S100A10 and fibroblast growth factor (FGF1). Synaptotagmin is a synaptic 
vesicle protein that belongs to the fer-1 family of proteins. The Dysferlin C2A domain 
has the highest level of homology with the C2A domain of rat synaptotagmin (Britton et 
al. 2000). Furthermore, proteomic analyses identify both annexin A2 and AHNAK as 
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members of the dysferlin complex (de Morree et al. 2010; Cacciottolo et al. 2011). 
Consequently, it is possible that the interaction between S100A10, annexin A2 and 
dysferlin is mediated through AHNAK, the largest protein within the complex. The 
identification of a ternary asymmetric complex between S100A10-annexin A2 and 
AHNAK provides an initial framework for understanding the intricate assembly of these 
membrane repair proteins. 
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Chapter 4 
 
Novel Structure of S100A10-Annexin A2 in Complex with the AHNAK 
Peptide 
 
4.1          Introduction 
The crystal structures of S100A10 and calcium-bound S100A11 in complex 
with the N-terminal regions of the phospholipid-binding proteins annexin A2 (Rety et al. 
1999) and annexin A1 (Rety et al. 2000), respectively, illustrate the heterotetrameric 
nature of these complexes. The symmetric arrangement and stoichiometry of these 
complexes are characteristic of every S100 protein-target peptide structure examined to 
date, including those of Ca2+-S100B in complex with peptides from the C-terminal region 
of p53 (Rustandi et al. 2000), the N-terminal regulatory domain of the Ndr kinase 
(Bhattacharya et al. 2003) and the actin-capping protein CapZ (TRTK12) (Inman et al. 
2002; McClintock and Shaw 2003; Charpentier et al. 2010); Ca2+-S100A1 in complex 
with peptides from the cytosolic regions of the ryanodine receptor (RyR) (Wright et al. 
2008) and CapZ (Wright et al. 2009), and Ca2+-S100A6 in complex with the C-terminus 
of the Siah-1 Interacting Protein (SIP) (Lee et al. 2008).  These structures show that some 
variation in the target peptide binding-site exists (Rezvanpour and Shaw 2009), although 
a symmetric arrangement is always maintained comprising two S100 protomers and two 
target peptides. Structural information on the architecture of higher order complexes such 
as that involving S100A10, annexin A2 and AHNAK are unknown and would be 
important for understanding how this group of proteins assemble to participate in the cell 
membrane repair process. To examine how S100A10 and annexin A2 recruit AHNAK, a 
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hybrid protein complex was designed (described in Chapter 2) in which S100A10 was 
linked in tandem to the fifteen N-terminal residues of annexin A2 (referred to as A10A2), 
separated by a nine-residue spacer sequence. Previous work has shown that the linker 
does not perturb the structures of S100A10 or the bound annexin A2 and allows an 
interaction similar to the one observed with separate molecules (Rezvanpour et al. 2009). 
Peptide array experiments identified eight binding regions within the C-terminus of 
AHNAK for the interaction with the A10A2 hybrid protein (described in Chapter 3). Of 
the eight consensus regions observed, one of the sequences (referred to as AHNAK5) 
having a strong interaction was used as a synthetic peptide to identify the binding 
region(s), stoichiometry and affinity with the A10A2 complex. NMR spectroscopy, non-
denaturing electrospray mass spectrometry and fluorescence spectroscopy identified a 
novel asymmetric ternary arrangement between a single AHNAK5 peptide, and an 
S100A10-annexin A2 heterotetramer (described in Chapter 3). In this chapter, the A10A2 
hybrid protein was used to investigate the binding region of the S100A10-annexin A2 
complex with the AHNAK5 peptide. Using both chemical shift mapping by NMR 
spectroscopy and X-ray crystallography, the three-dimensional structure of the AHNAK5 
peptide on the surface of A10A2 was determined, showing that this interaction required 
residues from helices IV and IV’ of dimeric S100A10 as well as the C-terminal portion of 
the N-terminal peptides of annexin A2.  
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4.2          Materials and Methods 
4.2.1       Source of Materials 
15NH4Cl and 13C6-glucose were obtained from Cambridge Isotope Laboratories, 
Inc. (Andover, MA). 15N-methionine, 15N-phenylalanine, 15N-valine, 15N-leucine, and 
15N-isoleucine were obtained from Sigma-Aldrich (St. Louis, MO). All other reagents 
used in the following experiments were of the highest purity commercially available. 
The auxotrophic bacterial strains CT19 (avtA::Tn5/ trpB83::Tn10/ dcm omT lon 
λDE3 ilvE12 tyrB507 aspC13) and B834 (F- ompT hsdSB(rB- mB-) gal dcm met DE3) were 
kindly provided by Dr. L. Mcintosh (University of British Columbia, Canada) and Dr. H. 
Ling (University of Western Ontario, Canada) and were utilized in the selective 15N- 
labeling of specific amino acids. 
 
4.2.2       Expression and Purification of the Wild-Type and the C82S Substituted A10A2 
Unlabeled wild-type and uniformly 15N, 13C-labeled C82S substituted 
(A10A2C82S) GST-tagged human A10A2 were overexpressed in the BL21 (DE3)-RIL E. 
coli strain using 1 L of 2xYT, or 1 L of M9 minimal medium supplemented with 1 g 
15NH4Cl and 2 g 13C6-glucose as the sole nitrogen and carbon sources, respectively, as 
described in Sections 2.2.6 and 3.2.3 (Rezvanpour et al. 2009). The purification 
procedures were modified for the unlabeled wild-type A10A2 protein. After the last 
purification step, fractions containing this protein were pooled and dialyzed against a 
buffer containing 50 mM Tris, 100 mM NaCl at pH 7.0 and 4 ºC. This protein was 
concentrated and further purified by gel filtration on a HiLoad 16/60 Superdex-75 (GE 
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Healthcare) column using FPLC. Fractions containing wild-type A10A2 were pooled 
and dialyzed against 50 mM Tris, and 1 mM DTT at pH 7.5 and 4 ºC. The purity of the 
protein was assessed by SDS-PAGE analysis.  
 
4.2.3       Selective 15N-Labeling of A10A2C82S Protein 
Selectively 15N-labeled A10A2C82S proteins were obtained by growing E. coli 
strain CT19 (avtA::Tn5/ trpB83::Tn10/ dcm omT lon λDE3 ilvE12 tyrB507 aspC13) in 
M9 minimal media supplemented with either 15N-phenylalanine, 15N-valine, 15N-leucine 
or 15N-isoleucine in addition to the remaining 19 unlabeled amino acids. Similarly, 
selective 15N-methionine labeling of A10A2C82S protein was achieved by growing E. coli 
strain B834 (F- ompT hsdSB(rB- mB-) gal dcm met DE3) in M9 minimal media containing 
15N-methionine and the remaining 19 unlabeled amino acids. The purification of the 
selectively 15N-labeled A10A2C82S proteins followed the same protocol as described in 
Sections 2.2.6 and 3.2.3 (Rezvanpour et al. 2009) of the Materials and Methods.  
 
4.2.4       Peptide Synthesis 
The AHNAK5 peptide (GKVTFPKMKIPKFTFSGREL) was purchased from 
Bio Basic Inc (Toronto, Canada), synthesized using solid-phase peptide synthesis 
employing the Fmoc chemistry strategy (Grant 2002). The N-terminus of the peptide was 
acetylated while the C-terminus was amidated. The synthesized peptides were purified by 
C18 reversed-phase high performance liquid chromatography (HPLC), and lyophilized. 
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The MALDI-TOF mass data for the acetylated AHNAK5 (MWcalc = 2353.8 Da; 
MWobs = 2352.5 Da) confirmed the identity of the peptide. 
 
4.2.5       NMR Spectroscopy of A10A2C82S and A10A2C82S-AHNAK5 Complex  
All NMR experiments were acquired at 35 ºC on a Varian INOVA 600 MHz 
spectrometer equipped with a pulsed-field gradient triple resonance probe. The 
concentration of A10A2C82S was determined by amino acid analysis in triplicate 
(Advanced Protein Technology Centre, Toronto, Canada). Two NMR samples of 
uniformly 15N, 13C-labeled A10A2C82S (400 ± 8 µM dimer) were prepared in 10% D2O, 
20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, and 
100 mM NaCl buffer at pH 7.0, using DSS as an internal standard. The AHNAK5 peptide 
was added to one of the samples to a final concentration of 550 µM. Similarly, samples of 
30-100 µM selectively 15N-labeled A10A2C82S proteins containing 40-110 µM unlabeled 
AHNAK peptide were prepared. 1H-15N HSQC spectra were collected using carrier 
frequencies of 4.691 (1H) and 114.0 (15N) ppm. Sequential assignment of the polypeptide 
backbone resonances for A10A2C82S alone and A10A2C82S in complex with the AHNAK5 
peptide were achieved by the HNCACB (Wittekind and Mueller 1993), CBCA(CO)NH 
(Grzesiek and Bax 1992), and HNCA (Kay et al. 1990) experiments. The number of 
complex data points and the spectral widths were set to 512 and 8000.0 Hz for the 1H 
(F3) dimension, and 32 and 1700.0 Hz for the 15N (F2) dimension, respectively. For the 
HNCACB and CBCA(CO)NH experiments, 32 increments and a spectral width of 7840.0 
Hz in the 13C (F1) dimension were used. For the HNCA experiment, 32 increments and a 
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spectral width of 4500.0 Hz were used in the 13C (F1) dimension. All data were 
processed using NMRPipe and NMRDraw (Delaglio et al. 1995) and analyzed by 
NMRView (Johnson and Belvins 1994).  
 
4.2.6       Crystallization of the Wild-Type A10A2 in Complex with the C-Terminal Peptide 
of AHNAK 
Prior to crystallization, an excess amount of the AHNAK5 peptide was added to 
a solution of purified A10A2 to ensure that all A10A2 molecules formed a complex with 
the AHNAK5 peptide. The excess/unbound AHNAK5 peptide was removed from the 
sample using a HiPrep 26/10 Desalting column (GE Healthcare) equilibrated in 50 mM 
Tris, and 1 mM DTT at pH 7.5. The solution of the A10A2-AHNAK5 complex was 
concentrated to 8 mg/mL. Screening for crystallization conditions was done using several 
commercial screens such as the Cryo Kit (Sigma-Aldrich), the Crystal Magic Screens I 
and II (BioGenova), the PEG/Ion Plus Screen (BioGenova), and the Nucleix Suite 
(QIAGEN). Diffraction-quality crystals were grown in five days at 20°C by the hanging-
drop vapor diffusion method, with drops containing 1 µL of the solution of the A10A2-
AHNAK5 complex (8 mg/mL in 50 mM Tris-HCl, 1 mM DTT at pH 7.5), 1 µL of the 
precipitant (QIAGEN Nucleix Suite condition #85: 100 mM sodium chloride, 200 mM 
magnesium chloride, 0.05 M sodium cacodylate (CH3)2AsO2Na), 20 % (w/v) 
polyethylene glycol (PEG) 1000, pH 6.5) and 0.2 µL of the crystallization additive 
(Hampton Research Additive Screen condition #68: 0.15 mM CYMAL-7). The reservoir 
contained 500 µL of 1.5 M ammonium sulfate. 
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4.2.7       X-ray Diffraction Data Collection and 3-D Structure Determination 
X-ray diffraction data were collected at Beamline X25 (equipped with an ADSC 
Q315 CCD detector) of the National Synchrotron Light Source in Brookhaven National 
Laboratory. The data set was indexed, scaled and merged using HKL-2000 (Otwinowski 
and Minor 1997). 
Initial phases were obtained by the molecular replacement method, using the 
structure of the complex of S100A10 with an N-terminal peptide from annexin A2 
(molecules B and D from PDB 1BT6) as the search model (Rety et al. 1999). Molecular 
replacement was done, and the structural model was built and refined using PHENIX 
(Adams et al. 2010). During refinement, the structural model was adjusted manually 
when needed using Coot (Emsley et al. 2010). The stereochemical quality of the 
structural model was assessed using PROCHECK (Laskowski et al. 1993). Graphical 
representations of the structural model were prepared using PyMOL (Version 1.2r2, 
Schrödinger, LLC.). The interaction between A10A2 and the AHNAK5 peptide were 
analyzed using LIGPLOT (Wallace et al. 1995). 
 
4.2.8       Buried Surface Area Calculation Using VADAR 
The overall change in the buried surface area upon peptide binding was 
determined using the program VADAR (Volume Area Dihedral Angle Reporter) (Willard 
et al. 2003). The coordinates of the X-ray structural model of A10A2 in complex with the 
AHNAK5 peptide were utilized for the analysis. Further, the coordinates of the AHNAK5 
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peptide were removed from the A10A2-AHNAK5 complex to monitor the changes in 
the buried surface area of the A10A2 alone.    
 
4.3          RESULTS 
4.3.1       The C82S Substitution in the A10A2 Protein Does Not Alter Its Structure 
To locate the A10A2 residues involved in the interaction with AHNAK5 
peptide, backbone assignments of the protein in the absence and presence of the peptide 
were completed. Although the chemical shift assignment for the wild-type A10A2 was 
previously completed (Rezvanpour et al. 2009), to keep the experiments consistent with 
those performed in Chapter 3, the C82S substituted form of A10A2 was used for all NMR 
experiments. Due to similar properties of cysteine and serine residues, this mutation was 
not expected to make a dramatic conformational change in the structure of the A10A2 
protein. Using standard heteronuclear multiple dimensional NMR spectroscopy (HNCA, 
HNCACB, and CBCA(CO)NH), chemical shift assignments (1H, 15N, and 13C) for 90% 
non-proline residues of A10A2C82S (Figure 4.1 and 4.2) (Table 4.1) protein was 
completed. Figure 4.3 compares the 1H-15N HSQC spectra of the wild-type and C82S 
substituted A10A2 proteins. Except for a few residues including I75-V88 that are 
adjacent to the C82S substitution site, the two spectra are superimposable, indicating that 
comparable geometry and chemistry are maintained in the secondary structure of both 
forms of A10A2 proteins. 
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Figure 4.1. Selected regions of 600 MHz NMR spectra used for the backbone 
assignment of the A10A2C82S protein.  
 
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the 
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of 
the three dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i) 
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous 
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for 
sequential assignment of residues M55-L58 of the A10A2C82S.  
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Figure 4.2. Backbone amide assignments of A10A2C82S hybrid protein. 
  
1H-15N HSQC spectrum of 0.4 mM (monomer) uniformly 15N, 13C-labeled A10A2C82S 
hybrid protein acquired on a Varian INOVA 600 MHz spectrometer. The spectrum was 
collected in 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic 
acid, 100 mM NaCl, pH 7.0 at 35 ºC. Assigned backbone amide cross peaks are indicated 
with their one letter amino acid code and number. The residues from 15N, 13C-labeled 
annexin A2 are presented in pink and those from the linker region in cyan. Pairs of 
resonances for sidechain amide cross peaks are connected by horizontal lines.  
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Table 4.1. 15N, 13C and 1H resonance assignments for human A10A2C82S. 
Residue HN N Cα  Cβ Other 
G-5     63.24 32.39  
P-4  8.495 122.3 55.47 42.37  
L-3      
G-2  8.390 109.6 45.43   
S-1  8.201 115.7 58.06 64.26  
M0  8.193 122.3 53.23 32.83  
P1     62.44 31.62  
S2  8.902 118.9 56.85 65.67  
Q3  9.566 
 
120.9 59.54 28.19 Cγ (34.78), Nε2 (113.1),  
Hε21 (6.873), Hε22 (7.778) 
M4  8.979 119.7 56.75 30.84  
E5     59.68 29.94  
H6  8.375 117.9 59.41 29.63  
A7  8.522 124.9 55.90 18.45  
M8  8.493 118.3 60.47 35.27  
E9  8.281 120.1 60.32 29.78  
T10  8.592 116.5 67.06 68.43  
M11  8.066 122.7 61.25 32.80  
M12  8.164 117.9 59.86 35.14  
F13  9.367 117.4 59.85 37.58  
T14      
F15  7.441 119.2 62.78 38.86  
H16  7.635 115.7 61.23 31.34  
K17  8.440 122.3 59.38 32.11  
F18  7.101 114.5 60.71 40.43  
A19  8.475 122.3 53.70 18.75  
G20  7.495 100.9 44.79   
D21      
K22     57.77 30.94  
G23  7.284 103.6 46.71   
Y24  6.900 114.1 55.61 40.53  
L25  8.976 117.5 52.85 43.53  
T26  9.270 113.1 60.58 71.90  
K27  9.125 120.6 60.59 32.06  
E28  8.091 117.5 59.51 29.08  
D29  7.629 120.0 57.14 42.88  
L30  8.472 118.8 57.59 41.78  
R31  8.172 119.3 60.55 29.67  
V32  7.660 117.9 66.31 31.78  
L33  8.066 122.3 59.32 42.11  
M34  8.566 117.5 59.41 31.87  
E35  8.318 118.3 59.33 29.93  
K36  8.040 115.3 57.77 33.38  
E37  8.792 114.9 56.44 30.34  
F38  8.131 117.9 54.54 39.53  
P39     65.27   
G40  9.115 110.6 46.48   
F41      
L42      
E43     59.29 28.96  
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N44  7.509 115.3 53.82 39.29 Nδ2 (113.9), Hδ21 (6.800), 
Hδ22 (7.593) 
Q45  7.407 117.1 55.39 28.06  
K46  8.133 119.7 57.22 31.95  
D47  7.926 118.4 50.94 42.48  
P48     64.15 32.18  
L49  8.412 119.3 54.09 40.99  
A50  7.567 122.8 56.19 18.72  
V51  8.462 115.7 66.30 31.13  
D52  7.733 120.6 57.70 40.34  
K53  7.975 119.3 59.69 32.29  
I54  7.751 120.0 64.63 38.49  
M55  8.155 117.3 57.68 32.49  
K56  7.622 118.1 59.17 32.17  
D57  7.606 117.6 55.88 41.11  
L58  7.710 118.8 55.79 42.62  
D59  8.266 120.6 54.20 40.31  
Q60     57.72 28.52 Cγ (34.09), Nε2 (111.8),  
Hε21 (6.839), Hε22 (7.563) 
C61  8.471 117.0 59.08 27.38  
R62     57.07 28.26  
D63  8.660 118.8 53.82 41.22  
G64  9.282 109.6 45.93   
K65  7.462 118.4 55.39 34.37  
V66  9.332 124.5 62.69 32.76  
G67  8.479 114.4 44.27   
F68  9.078 121.0 62.95 39.48  
Q69  8.916 117.5 60.50 27.48 Cγ (34.13), Nε2 (112.0),  
Hε21 (6.823), Hε22 (7.569) 
S70  8.060 117.1 61.84 63.19  
F71  8.605 123.6 60.84 39.42  
F72  8.802 120.1 62.67 38.47  
S73  7.901 114.9 61.95   
L74  7.427 125.4 57.93 41.37  
I75  7.126 117.8 62.88 40.84  
A76  8.994 125.8 55.25 18.46  
G77  7.879 104.6 47.43   
L78      
T79      
I80     66.30 38.28  
A81  7.674 120.6 55.34 18.40  
S82      
N83     54.70 40.96  
D84  8.017 121.0 55.49 42.58  
Y85  8.059 120.5 57.57 39.45  
F86  8.950 121.5 61.00   
V87  8.828 117.9 65.04   
V88  7.476 117.4 65.44 32.94  
H89  7.954 113.6 57.95 30.81  
M90  7.878 117.6 57.61 34.88  
K91  7.625 120.1 58.63 32.71  
Q92  8.169 117.9 56.92 28.96 Cγ (34.16), Nε2 (111.5),  
Hε21 (6.724), Hε22 (7.413) 
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E93  7.856 117.9 56.79 30.06  
N94  8.054 117.0 53.83 38.38 Nδ2 (111.9), Hδ21 (6.868), 
Hδ22 (7.538) 
L95  7.918 120.1 55.29 42.63  
Y96  7.845 118.8 57.48 38.96  
F97  7.920 120.6 57.68 39.31  
Q98  8.237 121.4 55.89 29.65 Cγ (33.93), Nε2 (111.6),  
Hε21 (6.776), Hε22 (7.444) 
G99  8.079 110.1 45.70   
D100  8.364 120.5 54.78 41.39  
S101  8.302 113.5 58.34 63.94  
T102  8.918 123.9    
V103  8.876 121.4 67.77 31.67  
H104  8.488 117.8 60.19   
E105  7.738 116.7 58.90 29.42  
I106     66.26   
L107  8.565 118.0 58.21 41.75  
S108  7.086 111.3 60.54 63.67  
K109  7.684 119.7 55.72 33.23  
L110  7.322 119.8 55.69 43.22  
S111  8.352 115.9 57.43 64.22  
L112  8.347 124.9 55.56 42.17  
E113  8.219 120.1 56.68 30.75  
G114  8.188 110.0 45.26   
D115  7.943 125.8 55.94 42.48  
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Figure 4.3. Comparison of the 1H-15N HSQC spectra of the wild-type and C82S 
substituted forms of A10A2 protein.  
 
Overlay of 1H-15N HSQC spectra of wild-type (black) and C82S substituted (aqua) 
A10A2. NMR samples of uniformly 15N, 13C-labeled A10A2 (400 µM dimer) were 
prepared in 10% D2O, 20 mM MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 
mM glutamic acid, and 100 mM NaCl buffer at pH 7.0. Spectra were collected on a 
Varian INOVA 600 MHz spectrometer at 35 ºC. 
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4.3.2       Backbone Assignment of A10A2C82S in Complex with AHNAK5 Peptide 
The 20-residue AHNAK peptide (5654-5673; AHNAK5) that displayed the 
strongest interaction with A10A2C82S on the peptide array, was used in NMR experiments 
to assess structural changes that occur in A10A2C82S upon formation of the complex with 
AHNAK5. As shown in Chapter 3 (Section 3.3.6 and Figure 4.4), titration of unlabeled 
AHNAK5 peptide to the solution of 15N, 13C-labeled A10A2C82S resulted in the gradual 
disappearance of many of the A10A2C82S resonances and the appearance of many new 
peaks. The large number of chemical shift changes in the amide cross peaks of the two 
spectra indicates that AHNAK5 peptide is indeed binding to the A10A2C82S protein. 
Interestingly, the 1H-15N HSQC spectrum of the 15N, 13C-labeled A10A2C82S in the 
presence of AHNAK5 resulted in an increased number of peaks in which many of the 
new resonances appeared in pairs with each peak having approximately 50% of the 
intensity of the original peak (Figure 4.4). As an initial step towards completing the 
assignment of the A10A2C82S-AHNAK5 complex, HNCACB, CBCA(CO)NH and HNCA 
experiments were collected. Analyses of these spectra were quite challenging as the 
doubling of peaks resulted in overlapping of many peaks. Consequently, selective 15N-
labeling of the backbone amides of leucine, isoleucine, methionine, phenylalanine, and 
valine of A10A2C82S in complex with AHNAK5 was performed. This accounted for 36% 
of the amino acid sequence of the A10A2C82S protein. The simplified 1H-15N HSQC 
spectra of selective 15N-labeled A10A2C82S-AHNAK5 complex (Figure 4.5 and 4.6) along 
with the triple-resonance NMR experiments (Figure 4.7 and 4.8) contributed greatly in
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Figure 4.4. 1H-15N HSQC spectrum of A10A2C82S hybrid protein bound to the 
AHNAK5 peptide.  
 
1H-15N HSQC spectrum of 400 µM uniformly 15N-13C labeled A10A2C82S hybrid protein 
(protomer) in complex with 550 µM AHNAK5 peptide (Ac-GKVTFPKMKIPKFTFSGR 
EL). Some of the peaks that exhibited multiplicity in the AHNAK5 complex are shown in 
boxes. Spectra were collected on a Varian INOVA 600 MHz spectrometer at 35 ºC in 
90% H2O/10% D2O at pH 7.0. 
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Figure 4.5. 1H-15N HSQC spectra of selectively 15N-labeled A10A2C82S in complex 
with the AHNAK5 peptide. 
 
The spectra show selectively labeled (A) 15N-leucine, (B) 15N-isoleucine, and (C) 15N-
methionine A10A2C82S in complex with AHNAK5 peptide. The residues are numbered 1-
115 in both protomers. Multiple resonances from the A10A2C82S protein that appeared as 
pairs upon addition of AHNAK5 are presented as “a” and “b” with the corresponding 
residue number in the first or the second protomer.  
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Figure 4.6. 1H-15N HSQC spectra of selectively 15N-labeled A10A2C82S in complex 
with the AHNAK5 peptide.  
 
The spectra show selectively labeled (A) 15N-phenylalanine, and (B) 15N-valine 
A10A2C82S in complex with AHNAK5 peptide. The residues are numbered 1-115 in both 
protomers. Multiple resonances from the A10A2C82S protein that appeared as pairs upon 
addition of AHNAK5 are presented as “a” and “b” with the corresponding residue 
number in the first or the second protomer. 
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Figure 4.7. Selected regions of 600 MHz NMR spectra used for the backbone 
assignment of the A10A2C82S in complex with the AHNAK5 peptide.  
 
For each pair of planes, the CBCA(CO)NH is shown on the left and the HNCACB on the 
right where the x-axis is the amide proton chemical shift and the y-axis is the 13C plane of 
the three dimensional experiments. The Cα and Cβ for the intraresidues (indicated as i) 
are shown on the HNCACB spectra and the corresponding Cα and Cβ for the previous 
residues (i-1) are shown in the CBCA(CO)NH. The spectra illustrate 15N planes for 
sequential assignment of residues E93-L95 of the A10A2C82S bound to the AHNAK5 
peptide. 
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Figure 4.8. AHNAK5 peptide interacts with the A10A2C82S.  
 
Selected regions of the 600 MHz 1H-15N HSQC spectra showing the interaction of the 
AHNAK5 peptide with 15N, 13C-labeled (A-C) A10A2C82S hybrid protein. In all figures, 
the A10A2C82S alone is shown in the absence (black contours) and in the presence of 1 
equivalence (aqua contours) of AHNAK5 peptide. The spectra were collected in 20 mM 
MOPS, 1 mM EDTA, 1 mM DTT, 50 mM arginine, 50 mM glutamic acid, 100 mM 
NaCl, pH 7.0 at 35 ºC. Both spectra were assigned by triple-resonance NMR experiments. 
Spectra are presented at the same contour levels. 
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identification and completion of the assignment of 107 of 112 non-proline residues in 
the protein (Table 4.2).  
 
4.3.3      The Binding surface of AHNAK5 Peptide on A10A2C82S 
Backbone assignments of the A10A2C82S alone and in complex with the 
AHNAK5 peptide allowed for the analysis of chemical shift changes of each residue 
between the two states of the protein (Figure 4.9A and B). Addition of the peptide to the 
A10A2C82S protein resulted in different changes in the 1H-15N HSQC spectrum. While 
some peaks remained in their original positions, others shifted and appeared as single or 
double peak(s) in the spectrum. This suggested that the protein is affected by the peptide 
binding, either through direct interaction of a residue with the peptide or indirectly by a 
secondary effect. The most striking chemical shift perturbations occurred for residue 
E113 of the annexin A2 peptide region in the A10A2C82S hybrid protein of both protomers 
a and b. Both these residues experienced an amide nitrogen chemical shift change of 1.38 
ppm, which was approximately three times the average chemical shift (0.48 ppm). 
Several other residues also had large chemical shift perturbations including I54a, K56a/b 
and D59a/b in helix III, C61a/b, D63a/b and G64a/b in the second calcium binding loop, 
and F72a/b, I75b, G77a/b and D84a in helix IV of the S100A10C82S region in both 
A10A2C82S protomers. Furthermore, residues S108-S111 and G114 of protomer a, and 
L110-S111 of protomer b in the annexin A2 peptide region of A10A2C82S showed 
significant changes in chemical shift. These observations could indicate that these 
residues are either directly at the protein-peptide interface or indirectly affected by
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Table 4.2. 15N, 13C and 1H resonance assignments for A10A2C82S-AHNAK5 
complex.  
Protomer Residue HN N Cα  Cβ 
 P1     62.40 32.08 
 S2  9.080 119.3 56.93 65.34 
 Q3  9.575 120.6 59.62 28.17 
 M4  9.030 119.3 56.62 30.74 
 E5     59.77 29.62 
 H6  8.418 118.1 59.53 29.65 
 A7  8.452 124.4 55.82 18.19 
 M8  8.556 117.9 60.20 35.03 
 E9  8.342 120.5 60.44 29.79 
 T10  8.569 116.2 67.13 68.18 
 M11  8.118 122.7 61.24 33.69 
 M12  8.199 117.9 60.14 34.99 
 F13  9.301 117.5 60.32 37.81 
 T14     
 F15  7.580 119.2 62.77 38.90 
 H16  7.508 115.7 61.15 31.42 
 K17  8.362 122.2 59.33 32.00 
 F18  7.098 114.4 60.59 40.50 
 A19  8.483 122.3 53.79 18.74 
 G20  7.474 100.8 44.78  
 D21     
 K22     57.77 30.81 
 G23  7.308 103.9 46.68  
 Y24  6.918 113.9 55.59 40.05 
 L25  8.897 117.5 52.88 42.95 
 T26  9.298 113.4 60.68 71.87 
 K27  9.162 120.6 60.58 32.28 
 E28  8.059 117.1 59.44 29.03 
 D29  7.633 119.7 57.06 42.70 
 L30  8.616 118.8 57.52 41.46 
 R31  8.246 119.4 60.67 29.97 
 V32  7.789 117.9 66.51 31.81 
 L33  8.111 121.8 59.19 41.76 
 M34  8.582 117.5 59.53 32.23 
 E35  8.528 118.8 59.22 30.06 
 K36  7.928 115.3 57.69 33.37 
 E37  8.750 114.9 56.36 29.91 
 F38  8.182 118.0 56.83 39.31 
 P39     
 G40     48.55  
 F41  8.254 121.9 57.72 40.34 
 L42  7.849 119.7 57.68 40.11 
 E43     59.50 28.89 
 N44  7.357 114.9 53.95 39.30 
 Q45  7.435 115.7 54.50 26.94 
 K46     56.92 31.16 
 D47  7.824 118.0 51.00 42.80 
 P48     64.27 32.48 
 L49  8.544 119.6 53.81 41.02 
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 A50  7.584 122.4 56.45 18.43 
 V51  8.584 114.9 67.29 31.14 
 D52  7.724 120.1 57.57 40.33 
 K53     58.57 29.07 
 I54  8.068 121.0 66.05 38.63 
 M55  8.161 116.0 58.98 32.66 
 K56  7.411 115.7 58.83 32.17 
“a” D57  7.430 118.0 55.27 42.50 
 L58     56.87 40.57 
 D59  8.376 117.1 57.52 40.30 
 Q60  8.156 118.8 59.92 32.66 
 C61  7.696 116.6 58.72 29.24 
 R62     63.24 32.35 
 D63  8.488 122.3 55.53 42.36 
 G64  8.385 109.7 45.43  
 K65  7.445 118.0 55.45 34.60 
 V66  9.438 125.0 62.28 32.30 
 G67  8.342 114.4 44.42  
 F68  9.238 121.4 63.56  
 Q69     60.58 27.19 
 S70  7.992 117.1 61.67 63.56 
 F71  8.762 124.1 60.49 39.08 
 F72  9.087 121.4 62.58 38.75 
 S73     62.31 62.73 
 L74  7.297 123.6 58.31 40.59 
 I75  7.198 117.8 62.77  
 A76  9.045 125.1 55.00 18.53 
 G77  8.497 105.6 48.44  
 L78  7.708 118.8 58.00 42.31 
 T79     67.24 67.68 
 I80  9.100 123.6 66.22 38.22 
 A81  7.417 119.6 55.16 19.91 
 C82  7.767 115.8 62.99  
 N83  8.472 121.8 57.94 39.40 
 D84  8.321 119.2 57.96 40.53 
 Y85     
 F86  8.925 121.3 61.19 40.41 
 V87  8.842 118.0 66.45 31.97 
 V88  7.478 117.5 65.47 32.77 
 H89  7.911 114.0 58.00 31.56 
 M90  7.856 117.4 57.54 34.89 
 K91  7.636 120.1 58.43 32.62 
 Q92  8.178 117.9 56.89 28.90 
 E93  7.869 117.9 56.87 29.95 
 N94  8.060 117.0 53.82 38.43 
 L95  7.912 120.1 55.26 42.61 
 Y96  7.844 118.8 57.46 38.95 
 F97  7.934 120.6 57.68 39.18 
 Q98  8.230 121.0 55.94 29.51 
 G99  8.116 110.1 45.67  
 D100  8.348 120.5 54.74 41.47 
 S101  8.297 113.6 58.27 63.84 
 T102     66.04 69.48 
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 V103  8.927 121.4 61.12  
 H104     
 E105     59.68 32.91 
 I106  8.209 120.5 65.91 37.61 
 L107  8.457 118.0 58.47 42.29 
 S108  6.889 109.6 60.24 63.56 
 K109  7.913 118.4 54.82 33.07 
 L110  7.006 118.4 54.29 43.54 
 S111  8.592 114.4 57.16 66.01 
 L112  8.628 124.6 56.00 42.64 
 E113  8.433 125.8 57.03 30.78 
 G114  8.304 111.9 45.18  
 D115  7.943 126.0 55.94 42.48 
 P1     62.40 32.08 
 S2  9.074 119.3 56.85 65.29 
 Q3  9.577 120.6 59.65 28.20 
 M4  8.980 119.3 56.42 30.99 
 E5     59.77 29.62 
 H6  8.424 118.2 59.58 29.73 
 A7  8.448 124.4 55.80 18.21 
 M8  8.500 117.9 60.18 34.96 
 E9  8.291 120.5 60.51 29.79 
 T10  8.564 116.2 67.08 68.18 
 M11  8.117 122.7 61.25 33.69 
 M12  8.199 117.9 60.16 35.08 
 F13  9.235 117.0 60.28 37.81 
 T14     
 F15  7.387 119.2 62.88 38.70 
 H16  7.513 115.6 61.15 31.42 
 K17  8.360 122.2 59.33 31.94 
 F18  7.099 114.4 60.59 40.50 
 A19  8.483 122.3 53.86 18.74 
 G20  7.465 100.6 44.79  
 D21     
 K22     57.77 30.81 
 G23  7.308 103.9 46.68  
 Y24  6.918 113.9 55.60 40.19 
 L25  8.895 117.5 52.88 42.95 
 T26  9.298 113.4 60.72 71.85 
 K27  9.163 120.6 60.50 32.32 
 E28  8.059 117.1 59.46 29.01 
 D29  7.547 119.7 56.98 42.61 
 L30  8.618 118.8 57.52 41.46 
 R31  8.246 119.4 60.58 30.02 
 V32  7.661 117.5 66.37 31.58 
 L33  8.111 121.9 59.21 41.83 
 M34  8.585 117.5 59.51 32.23 
 E35  8.449 118.3 59.47 29.96 
 K36  8.043 115.3 57.72 33.42 
 E37  8.754 115.0 56.36 29.95 
 F38  8.186 118.0 56.92 39.31 
 P39     
 G40     48.55  
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 F41  8.254 121.9 57.72 40.34 
 L42  7.849 119.7 57.68 40.36 
 E43     59.50 28.89 
 N44  7.359 114.9 53.95 39.30 
 Q45  7.435 115.7 54.50 26.94 
 K46     56.92 31.16 
 D47  7.824 118.0 51.00 42.80 
 P48     64.21 32.24 
 L49  8.546 119.7 53.81 41.05 
 A50  7.622 121.9 56.50 18.43 
 V51  8.486 114.8 67.02 30.87 
 D52  7.724 120.1 57.57 40.33 
 K53     57.53 29.31 
 I54  7.947 120.9 65.69 38.46 
 M55  8.224 116.0 59.32 32.99 
 K56  7.295 115.7 58.69 32.24 
 D57  7.364 118.0 54.56 42.09 
 L58     56.87 40.57 
 D59  8.376 117.1 57.54 40.25 
 Q60  8.025 119.7 59.78 32.49 
 C61  7.647 116.5 58.77 29.29 
 R62     63.17 32.27 
“b” D63  8.491 121.9 55.53 42.36 
 G64  8.385 109.7 45.48  
 K65  7.468 118.2 55.33 34.38 
 V66  9.436 125.3 62.28 32.37 
 G67  8.343 114.4 44.33  
 F68  9.173 121.5 63.19  
 Q69     60.58 27.19 
 S70  7.992 117.1 61.67 63.56 
 F71  8.762 124.1 60.46 39.06 
 F72  9.089 121.5 62.58 38.75 
 S73     62.31 62.73 
 L74  7.288 123.6 57.67 41.19 
 I75  7.373 116.6 63.42 36.07 
 A76  9.106 125.3 55.25 19.16 
 G77  8.444 104.8 48.42  
 L78  7.708 118.8 58.00 42.31 
 T79     67.24 67.68 
 I80  9.074 123.6 66.42 38.24 
 A81  7.380 120.1 55.39 19.93 
 C82  7.753 114.0 63.04 19.96 
 N83  8.472 121.8 57.94 39.36 
 D84  8.093 119.6 57.88 40.21 
 Y85     
 F86  8.876 121.3 61.11 40.15 
 V87  8.844 117.9 66.41 31.87 
 V88  7.550 117.8 65.42 32.30 
 H89  7.928 113.9 57.99 31.58 
 M90  7.787 117.4 57.40 34.82 
 K91  7.609 120.4 58.47 32.56 
 Q92  8.188 117.9 56.87 28.91 
 E93  7.870 117.9 56.79 29.95 
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 N94  8.061 117.0 53.81 38.42 
 L95  7.914 120.1 55.26 42.58 
 Y96  7.848 118.8 57.46 39.06 
 F97  7.930 120.6 57.72 39.15 
 Q98  8.226 121.0 55.94 29.51 
 G99  8.115 110.1 45.64  
 D100  8.327 120.6 54.74 41.45 
 S101  8.305 113.6 58.27 63.84 
 T102     65.89 69.44 
 V103  8.864 121.4 61.13  
 H104     
 E105     59.79 32.15 
 I106  8.046 120.1 65.70 38.29 
 L107  8.352 117.9 58.31 41.72 
 S108  6.938 110.0 60.41 63.48 
 K109  7.951 119.2 54.84 32.71 
 L110  7.139 117.9 54.42 44.61 
 S111  8.975 114.0 57.25 66.01 
 L112  8.628 124.6 56.00 42.64 
 E113  8.433 125.8 56.97 30.85 
 G114  8.366 110.9 45.23  
 D115  7.954 126.1 55.92 42.49 
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Figure 4.9. Comparison of the changes in chemical shift of the A10A2C82S hybrid 
protein and AHNAK5-bound A10A2C82S for both protomers a (A) and b (B) in the 
dimer A10A2C82S.  
 
Chemical shift changes (∆δ) were normalized in both 1HN and 15N using the formula 
[{HN2 + (N/5)2}/2]1/2. The dashed line indicates the average change in chemical shift at 
0.48 ppm. Proline residues are shown as “P” and asterisks indicate missing assignments 
in either or both proteins. Different helices of A10A2C82S (based on the crystal structure 
of the S100A10-annexin A2 complex) are coloured with helix I in pink, helix II in aqua, 
helix III in purple, helix IV in blue, and annexin A2 in light green. 
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residues that were involved in the interaction. The crystal structure of S100A10 in 
complex with the 12-residue N-terminal peptide of annexin A2 (PDB Code:1BT6) (Rety 
et al. 1999) was used to map all of the chemical shift changes greater than the average 
value (0.48 ppm) onto the surface of the A10A2C82S protein (Figure 4.10A). This allowed 
the interaction surface of the AHNAK5 peptide on the A10A2C82S hybrid protein to be 
obtained. The length of annexin A2 peptide in the A10A2C82S hybrid construct is 3 
residues longer than that in the crystal structure. Thus, residues E113a/b and G114a are 
not colored in Figure 4.10A. Regardless, the significant change in the chemical shifts for 
these two residues indicates that E113a/b and G114a are affected by the interaction with 
the AHNAK5 peptide. Several residues including L58a/b in helix III, Q60a/b and R62a/b 
in the second calcium binding loop, and S73a/b, L78a/b-I80a/b, and S82a/b-N83a/b in 
helix IV of the A10A2C82S protomers were lacking chemical shift changes due to missing 
assignments. Since most of these peaks were assigned in the AHNAK5-bound A10A2C82S 
(not in the A10A2C82S), the doubling of peaks corresponding to these residues in the 
complex was considered as a means to identify those affected by the interaction with the 
AHNAK5 peptide. Among them, only residues Q60a/b, S73a/b and I80a/b appeared as 
double peaks on the spectrum and thus are inclined to be involved in AHNAK5 binding. 
In Figure 4.10A, these residues are shaded in a different color to distinguish them from 
the residues with determined and large chemical shift perturbations. A contiguous surface 
containing residues E113a-G114a, S108a-S111a, D84a, S82a, I80a, G77a-A76a, S73a, 
F72a/b, S73b, I75b, A76b-G77b, I80b, L110b-S111b and E113b is formed on the 
A10A2C82S for the interaction with the AHNAK5. With the current data it is difficult to
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Figure 4.10. The A10A2C82S binding surface for the AHNAK5 peptide.  
 
Surface and ribbon representation of A10A2C82S depicting residues affected by the 
interaction with the AHNAK5 peptide. (A) The surface is coloured according to the 
chemical shift changes [{HN2 + (N/5)2}/2]1/2 observed in NMR experiments resulting 
from the interaction with AHNAK5 for both protomers a and b in the dimeric A10A2C82S 
protein. Residues with chemical shift changes greater than the average chemical shift 
change of 0.48 ppm are shown in cyan. Residues Q60, S73 and I80 are shaded in purple 
indicating those that were affected by the binding (doubled peaks in NMR spectrum), 
even though a chemical shift change could not be determined for them due to the lack of 
an amide proton or missing assignments in A10A2C82S in the absence of the AHNAK5 
peptide. Residues are labeled according to their one-letter amino acid code and residue 
number. (B) The same complex is oriented approximately 180 with respect to (A) to show 
that the AHNAK5 peptide binds to one side of the A10A2 dimer. 
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conclude whether residues such as I54a, K56a/b, D59a, Q60a/b, C61a/b, D63a/b and 
G64a/b are in direct contact with the AHNAK5 peptide or are only affected by the 
secondary conformational changes resulted from peptide binding. Overall, these data 
show that the AHNAK5 peptide is bound to only one side of the dimeric A10A2C82S 
protein, comprised of helices IV and IV’ as well as the adjacent C-termini of the annexin 
A2 peptide region (Figure 4.10A and B).    
 
4.3.4       Crystal Structure of the A10A2-AHNAK5 Complex 
4.3.4.1    The Structure of A10A2-AHNAK5 Is Similar to the Non-covalent Complex of 
S100A10 and Annexin A2 
Diffraction quality crystals of the A10A2-AHNAK5 were obtained and the 
structure of this complex was solved by molecular replacement, using the structure of the 
S100A10-annexin A2 N-terminal peptide complex (molecules B and D from PDB 1BT6) 
(Rety et al. 1999) as the search model. The parameters and the statistics of X-ray 
diffraction data collection and structural model refinement are summarized in Table 4.3. 
The A10A2-AHNAK5 complex crystallized in the monoclinic space group C2, with two 
A10A2 molecules (chains a and b) and one AHNAK5 peptide (chain c) in each 
asymmetric unit. Collected X-ray diffraction data allowed for the computation of electron 
density maps at a resolution of 2.97Å. Residues Q3a to M90a and Q3b to H89b of the 
S100A10 regions, T102a to E113a and V103b to E113b of the annexin A2 regions in 
both protomers of the A10A2 protein, and twelve of the twenty residues of the AHNAK5 
were identified. The electron density for some of the residues including C61, I80, A81 
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Table 4.3. Parameters and statistics of X-ray diffraction data collection and 
structural model refinement. 
A10A2-AHNAK5 Complex 
X-ray Diffraction Data Collection 
Wavelength (Å) 1.100 
Resolution limitsa (Å) 28.96 – 2.97 (3.02 – 2.97) 
Space group C2 
Unit-cell constants 
a, b, c (Å) 79.80, 54.99, 62.92 
α, β, γ (°) 90, 113.56, 90 
Number of unique reflections 5,107 (265) 
Redundancy 3.7 (3.7) 
Completeness (%) 97.3 (99.3) 
Rsymb (%) 5.1 (45.5) 
I / σ(I) 22.2 (2.9) 
 
Structural Model Refinement 
Resolution range (Å) 28.96 – 2.97 
Rwork / Rfreec (%) 31.43 / 39.72 
Number of non-hydrogen atoms per asymmetric unit (average B factors, Å2) 
Protein 1,483 (175.81) 
Solvent 0 (---) 
Root-mean-square deviation from ideal geometry 
Bond lengths (Å) 0.006 
Bond angles (°) 1.070 
Ramachandran statistics 
Most favored (%) 70.8 
Additional allowed (%) 25.3 
Generously allowed (%) 3.9 
Disallowed (%) 0.0 
a
 Numbers in the parentheses refer to the highest resolution bins. 
b
 Rsym = ∑hkl∑i|Ihkl,i - <Ihkl>| / ∑hkl∑iIhkl,i, where Ihkl,i and <Ihkl> are the i-th observed intensity and the 
average intensity of the reflection hkl, respectively. 
c
 Rwork = ∑||Fo| - |Fc|| / ∑|Fo|, where |Fo| and |Fc| are the observed and the calculated structure factor 
amplitudes of a particular reflection, respectively. The summation is over 95 % of the reflections in the 
specified resolution range. The remaining 5 % of the reflections were randomly selected before the 
structure refinement and not included in the structure refinement. Rfree was calculated over these 
reflections using the same equation as for Rwork (Brünger 1992). 
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and M90 in the S100A10 region of protomer b, K91, G114-D115 in the annexin A2 
region as well as the nine residues in the linker connecting the S100A10 to the annexin 
A2 peptide of both protomers were not visible. The structural model presented here was 
refined to an Rwork and an Rfree values of 31.43 % and 39.72 %, respectively. A high 
percentage (96.1%) of residues in this structural model lie in the most favored and the 
additionally allowed regions of the Ramachandran Plot. 
The A10A2-AHNAK5 complex contains an A10A2 dimer (Figure 4.11B), 
whose structure is analogous to that of S100A10 in complex with the N-terminal peptide 
of annexin A2 (Figure 4.11A). Similarly, helices I, I’, IV and IV’ of A10A2 comprise the 
dimer interface. In the A10A2 dimer, helices IV and IV’ are roughly antiparallel to each 
other and form a portion of the dimer interface on one side of the protein as in the other 
S100 structures. Further, the two annexin A2 peptide regions of the A10A2 dimer bind in 
nearly the same manner to either side of the S100A10 regions of the dimer such that the 
C-termini of the annexin A2 peptides are positioned on the same side of the complex as 
helices IV and IV’. The hydrophobic surface of the annexin A2 peptide region is made up 
of residues V3a/b, I6a/b, L7a/b and L10a/b. For instance, in protomer a of the A10A2 
dimer, V3a of the annexin A2 peptide region interacts with a large number of residues in 
helix I’ (E5’, M8’, E9’, M12’). The residue at position 6a (I) makes contacts with helix 
IV (C82, Y85, F86, M90). The sidechain of L7a makes numerous contacts with the 
S100A10 region via residues in the linker sequence (F38, F41), helix IV (L78, C82) and 
helix I’ (E5’, M8’). Finally, the residue at position 10a (L) is in close proximity of helix 
IV (A81, C82, Y85). All of these findings are in perfect agreement with the X-ray
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A B 
Figure 4.11. Comparison of the S100A10-annexin A2 structures alone and in complex with the AHNAK5 
peptide.  
 
Ribbon diagrams of (A) S100A10 bound to the N-terminal peptide of annexin A2 (Rety et al. 1999) and (B) A10A2 
in complex with the AHNAK5 peptide are shown in similar orientations to demonstrate the lack of conformational 
changes that occur upon binding to the AHNAK5 peptide. In both structures, protomer a (including its associated 
annexin A2 peptide) is shown in light purple and its helices are numbered I-IV, while protomer b (including its 
corresponding bound annexin A2 peptide) is presented in light blue and its helices are numbered I’-IV’. The single 
AHNAK5 peptide is shown as a yellow strand bound to an A10A2 dimer in (B). Superposition of these two structures 
gives a backbone rmsd value of 0.66 Å. 
I 
I 
I’ I’ 
II II 
II’ 
II’ 
III 
III 
III’ III’ 
IV IV 
IV’ 
IV’ 
Annexin A2 Annexin A2 
Annexin A2 Annexin A2 
C 
C 
C 
C 
C 
N 
AHNAK5 
Protomer a Protomer a Protomer b Protomer b 
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 crystallographic results (Rety et al. 1999) for the S100A10-annexin A2 complex in 
the absence of AHNAK5. Despite the non-covalent complex of S100A10 and the 
individual N-terminal peptide of annexin A2 in the X-ray crystallographic structure (Rety 
et al. 1999), and the covalent linkage between these two proteins in the A10A2-AHNAK5 
complex, these two structures are indeed similar to each other with an rmsd of 0.66 Å. 
This provides further evidence that the linker connecting S100A10 to the N-terminal 
peptide of annexin A2 in the A10A2 hybrid protein has not perturb the structure. 
Comparison between the structures of S100A10 in complex with the individual 
N-terminal peptide of annexin A2, A10A2 and AHNAK5-bound A10A2 with the 
S100A10 protein resulted in small rmsd values of 0.91, 1.11, and 1.37 Å, respectively. 
Once more, these values confirm that the backbone structure of S100A10 does not change 
significantly in any of the complexes when S100A10 binds to either annexin A2 or both 
annexin A2 and AHNAK5 peptides.   
 
4.3.4.2    Binding Region of AHNAK5 on A10A2 
Following fitting for the S100A10 and annexin A2 portions of the A10A2 
structure, outstanding electron densities were clearly observed for the backbone of the 
AHNAK5 peptide in the electron density maps (Figure 4.12A). This electron density was 
only sufficient to fit a single AHNAK5 peptide on helix IV side of the A10A2 complex. 
This stoichiometry of 1:1 for an A10A2(dimer):AHNAK5 complex is in agreement with 
the fluorescence, NMR and non-denaturing mass spectroscopy experiments presented in 
Chapter 3. As explained above and shown in Figure 4.11, interaction of the AHNAK5
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Figure 4.12. Orthogonal views of the A10A2-AHNAK5 complex.  
 
Outstanding electron density of the AHNAK5 peptide are shown in (A) and omitted for 
clarity purposes in (B). In both diagrams, the ribbon representation of the A10A2-AHNAK5 
complex is oriented approximately 90º with respect to each other to show the binding region 
of a single AHNAK5 peptide. Protomer a of the A10A2 dimer is colored in light purple and 
its helices are numbered I-IV, whereas protomer b is shown in light blue and its helices are 
numbered I’-IV’. The single AHNAK5 peptide is represented as sticks, with carbon atoms in 
yellow, nitrogen atoms in blue and oxygen atoms in red.  
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peptide with the A10A2 dimer does not cause a significant conformational change in 
the backbone structure of the A10A2 hybrid protein. Adopting a coil conformation, the 
bound AHNAK5 peptide was located on one face of the dimeric A10A2, comprising 
helices IV and IV’ as well as the adjacent C-termini of the annexin A2 peptide regions 
(Figure 4.11B and 4.12). In the model shown, residues P6 to G17 of the AHNAK5 
peptide (ie. PKMKIPKFTFSG) were modeled in the electron densities. However, the 
sidechain conformations of K9, and F13 could not be determined (Figure 4.13). The PDB 
file for the crystal structure was used in the LIGPLOT program (Wallace et al. 1995) to 
generate schematic 2D representations of the A10A2-AHNAK5 complex, showing 
intermolecular interactions as well as their strengths including hydrogen bonds, 
hydrophobic interactions and atom accessibilities (Figure 4.14). Based on this analysis, 
P6, M8, F15, and S16 of the AHNAK5 peptide are involved in interactions with the 
A10A2 dimer (Figure 4.13 and 4.14). The residue at position 6 (P) of the AHNAK5 
peptide interacts with S111 at the C-terminus of the annexin A2 peptide region of 
protomer a in the A10A2 dimer. M8 of the AHNAK5 makes contacts with helix III (I54, 
L58) of the S100A10 region of also protomer a. F15 of the AHNAK5 peptide interacts 
with L78 of the S100A10 and L112 from the C-terminus of the annexin A2 peptide 
regions of protomer b in the dimeric A10A2 protein. Lastly, a hydrogen bond exists 
between the sidechain of S16 of the bound AHNAK5 with S111 at the C-terminus of the 
annexin A2 peptide region of protomer b in the A10A2 dimer. 
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Figure 4.13. AHNAK5-binding site on the A10A2 dimer. 
 
Close-up stereo views of the (A) N-terminal half and (B) C-terminal half of the bound 
AHNAK5 peptide on the A10A2 dimer are shown. In both diagrams, the two A10A2 
subunits are colored in light purple (protomer a) and light blue (protomer b), and the 
helices are numbered I-IV and I’-IV’ for protomer a and b, respectively. The single 
AHNAK molecule is represented in orange. Residues of A10A2 interacting with the 
AHNAK5 peptide are also presented as sticks, with carbon atoms in the original color, 
nitrogen atoms in blue and oxygen atoms in red. 
   
216 
 
Figure 4.14. Schematic representation of intermolecular interactions in the A10A2- 
AHNAK5 complex.  
 
The LIGPLOT program was used to generate a 2D schematic for the intermolecular 
interactions between the residues from the AHNAK5 peptide and A10A2 protein. The 
hydrogen bonds and their distances are indicated by ( 3.0 ). Covalent bonds in the 
AHNAK5 peptide are shown by ( ), while covalent bonds in the A10A2 dimer 
are presented by ( ). Residues of the A10A2 dimer (protomers a and b) and 
specific atoms involved in Van der Waals contacts are indicated by ( ) and ( ), 
respectively.  
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4.4          Discussion 
4.4.1       Comparison of the Binding Surface of AHNAK5 on A10A2 Determined by X-ray 
Crystallography and NMR Spectroscopy 
In this chapter, the AHNAK5 peptide which had previously shown the strongest 
interaction with A10A2C82S was utilized to identify the arrangement of the S100A10-
annexin A2-AHNAK5 ternary complex. NMR spectroscopy and X-ray crystallography 
were used to determine which residues of A10A2 protein and AHNAK5 peptide are 
involved in the interaction. 1H-15N HSQC spectra were collected to monitor the changes 
made in the A10A2C82S spectra after addition of the AHNAK5 peptide. NMR experiments 
revealed a significant number of chemical shift changes in the amide cross peaks of the 
two spectra confirming that an interaction with the AHNAK5 peptide has taken place. 
Significant changes in chemical shift were observed mainly for residues in helix IV and 
IV’ of protomers a and b of the S100A10 region (D84a, S82a, I80a, G77a-A76a, S73a, 
F72a/b, S73b, L74b, A76b-G77b, I80b), as well as the residues from the annexin A2 
peptide region (E113a-G114a, S108a-S111a, L110b-S111b and E113b) of A10A2C82S 
protein (Figure 4.10). Overall, these results showed that interaction of a single AHNAK5  
peptide with the A10A2C82S protein is consistent with asymmetrical binding to one face of 
the dimeric protein comprising helices IV and IV’ and the adjacent annexin A2 C-termini. 
A number of significant chemical shift changes also occurred in helix III and III’ as well 
as the second calcium-binding loops of both protomers of A10A2C82S protein (Figure 
4.10) either through direct contact with the AHNAK5 peptide or by indirect changes 
resulting from peptide binding. 
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Determining resonance assignments for an unlabeled peptide such as 
AHNAK5 in a protein-peptide complex is difficult by NMR spectroscopy as only proton 
signals of the unlabeled peptide will be observed in the spectra. Consequently, residues 
from the AHNAK5 peptide that are directly involved in the interaction could not be 
determined. X-ray crystallography of the A10A2-AHNAK5 complex was useful in 
obtaining detailed information on the bound peptide. The backbone structure of A10A2-
AHNAK5 complex is similar to that of S100A10 in complex with the N-terminal peptide 
of annexin A2 (Figure 4.11A and B). The hydrophobic surface of the annexin A2 peptide 
region of the A10A2 hybrid protein in the A10A2-AHNAK5 complex was also similar to 
that of the X-ray crystallographic results of the S100A10 bound to individual N-terminal 
peptide of annexin A2. Even though computation of electron density maps was only 
possible to a resolution of 2.97Å, it was still clear that only one AHNAK5 peptide is 
bound to one face of the dimeric A10A2, comprising helices IV and IV’ as well as the 
adjacent C-termini of the annexin A2 peptide regions (Figure 4.11B and 4.12A and B). 
This is in perfect agreement with the results obtained by NMR spectroscopy. Some of the 
important residues for this interaction included I54, L58 and S111 of protomer a, and 
L78, S111 and L112 of protomer b in the A10A2 protein. The X-ray crystallography data 
explains some of the NMR spectroscopy observations. For instance, the significant 
chemical shift of I54a is due to interaction of this residue with the methionine sidechain at 
position 8 of the AHNAK5 peptide. This interaction would explain the large chemical 
shifts of other residues in helix III and the second calcium-binding loop of protomer a in 
the dimeric A10A2 protein. Chemical shift changes could not be determined for residue 
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L58a and L78b of the A10A2 protein by NMR experiments due to the missing 
assignments or lacking chemical shift changes, respectively. However, chemical shift 
changes greater than the average chemical shift values for S111 in both protomers a and b 
was observed. Although, a significant chemical shift for S111a was observed, the change 
in chemical shift (more than twice the average chemical shift value) was more 
pronounced for S111 in protomer b. This could be explained by the hydrogen bond 
formed between the sidechain of S16 of the bound AHNAK5 with S111 at the C-terminus 
of the annexin A2 peptide region of protomer b in the A10A2 dimer. Residue L112 in 
protomer b of the dimeric A10A2 protein was identified as one of the residues involved in 
the interaction with the AHNAK5 peptide by X-ray crystallography, while a chemical 
shift change below the average change in chemical shift was obtained for this residue by 
NMR spectroscopy. Further, the fractional accessible surface area for the sidechains of 
residues of A10A2 in the absence and presence of AHNAK5 peptide were calculated 
from the three-dimensional X-ray crystallography model using the program VADAR 
(Willard et al. 2003). This showed that 558 Å2 of the sidechain surface area in A10A2 
protein was buried upon binding AHNAK5 in A10A2-AHNAK5 complex. Residues in 
the A10A2 protein that decreased their sidechain exposure by greater than 40% upon 
AHNAK5 binding included F41, I54, L58, S73, L74, A76, G77, L78, A81, L110 and 
L112 of protomer a and I54, L58, S73, L74, G77, L78, D84, L110 and L112 of protomer 
b of the A10A2 protein. This method allowed identifying additional residues such as F41 
and A81 in protomer a, as well as I54 and L58 in protomer b of A10A2 that were buried 
by the interaction of AHNAK5. Higher quality crystals allowing higher resolution 
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electron density maps, or complete NMR assignments of A10A2 protein alone and in 
complex with the AHNAK5 peptide could help finding the answer to some of the 
discrepancies observed here.  
X-ray crystallography results complemented the peptide array experiments in 
identifying the important residues of AHNAK5 that were involved in A10A2 binding 
(Chapter 3). Peptide array identified a nine residue consensus sequence for AHNAK, 
represented as +X+XPKφXφ (X – variable; φ – hydrophobic residue; + – positively 
charged residue; P – proline; K – lysine) (Figure 3.1). Proline at position 6 of the 
AHNAK5 peptide that showed interaction with S111 at the C-terminus of the annexin A2 
region of protomer a in the A10A2 dimer, is not included in the consensus sequence. 
However, the binding was abolished as soon as the 3 residues FPK (positions 5-7 of 
AHNAK5) were eliminated from the peptide sequence on the array. Residue M8 of the 
AHNAK5 peptide makes contacts with helix III (I54, L58) of the S100A10 region of 
protomer a. This residue is presented as a variable (X) in the consensus, while peptide 
array sequence analysis showed that smaller sidechain of methionine at this position 
enhances the interaction. The consensus sequence does not include residues F15 and S16 
of the AHNAK5 peptide that associated with L78, S111 and L112 of protomer b in the 
A10A2 protein by X-ray crystallography. However; the strongest interaction was 
observed when these residues became a part of the peptide sequence on the array. 
Interestingly, amino acids F41, I54, L58, S73, L74, A76, G77, L78 and A81 in 
the S100A10 region of A10A2 protein that were the key residues in binding AHNAK5 in 
the X-ray crystallographic structure, are conserved hydrophobic residues in the S100 
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family of proteins (Wilder et al. 2006). While, the possibility of a similar complex 
formed between an S100 dimer, a pair of annexins and a single AHNAK exists, only 
some of the S100 proteins have shown an interaction with annexin family of proteins. 
These include Ca2+-S100A1 with annexin A5 (Garbuglia et al. 1998) and annexin A6 
(Propper et al. 1999; Arcuri et al. 2002); Ca2+-S100A6 with annexin A11 (Watanabe et al. 
1993; Tomas and Moss 2003; Williams et al. 2005), annexin A2 (Zeng et al. 1993; 
Filipek et al. 1995), annexin A5 (Tokumitsu et al. 1992), and annexin A6 (Zeng et al. 
1993); Ca2+-S100A11 with annexin A1 (Rety et al. 2000; Bianchi et al. 2003); Ca2+-
S100B with annexin A6 (Garbuglia et al. 1998; Arcuri et al. 2002); apo-S100A4 with 
annexin A2 (Semov et al. 2005); and apo-S100A10 with annexin A2 (Osborn et al. 1988; 
Johnsson and Weber 1990; Bianchi et al. 1992; Rety et al. 1999). Closer look at the first 
fourteen amino acid residues at the N-terminus of annexin A1, A2, A5, A6, and A11 
reveals that in fact only annexin A1 and A2 have significant sequence similarity. Thus, 
formation of a ternary complex involving an AHNAK protein associated with annexin 
A2-bound apo-S100A10, apo-S100A4 or Ca2+-S100A6; or annexin A1-bound Ca2+-
S100A11 could occur in a similar manner, where any one of these complexes could 
perform a similar function in the appropriate cell type.  
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Chapter 5 
 
SUMMARY 
 
5.1          Introduction 
The S100 proteins are a group of proteins comprising at least 25 members in 
humans including S100B, S100A1, S100A6, S100A10 and S100A11 (Donato 2001; 
Heizmann et al. 2002). These proteins are dimeric, having two “EF-hand” calcium-
binding motifs in each subunit. In vivo experiments have shown that both homo- and 
heterodimeric S100 complexes are formed (Propper et al. 1999; Deloulme et al. 2000; 
Wang et al. 2005). The S100 proteins act as calcium-signaling molecules by converting 
changes in cellular calcium levels to a variety of biological responses. In this manner, 
many of the S100 proteins modulate enzyme activities, oligomerization of cytoskeletal  
protein components (tubulin, glial fibrillary acidic protein), modulate ubiquitination, 
control membrane vesicle formation and participate in trafficking of proteins to the inner 
surface of the plasma membrane (Santamaria-Kisiel et al. 2006).  
Most S100 proteins bind calcium ions and undergo a conformational change 
that allows them to interact with specific target proteins and control a cellular activity 
(Zimmer et al. 2003; Santamaria-Kisiel et al. 2006; Wilder et al. 2006). Three-
dimensional structures of several S100 proteins in the calcium-free (apo) and calcium-
bound states show that the major structural change involves the movement of helix III 
with respect to helix IV. This leads to the exposure of previously buried residues and 
creates a hydrophobic surface. In one S100 protein, S100A10, substitutions in both its 
calcium-binding sites have left this protein with the inability to coordinate calcium. 
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Consequently, S100A10 does not undergo a calcium-induced structural change and 
instead adopts a structure in its calcium-free state that is very similar to the calcium-
bound states of other S100 proteins (Rety et al. 1999; Rety et al. 2000). As a result 
S100A10 interacts and controls the functions of more than a dozen proteins in a calcium-
insensitive manner. 
In the last few years, several proteins (AHNAK, TASK-1, dysferlin, NS3) have 
been found to interact with S100A10 together with annexin A2 as a possible means for 
trafficking of these proteins to the plasma membrane or assemble multiprotein complexes 
important in membrane repair processes. Unfortunately, lack of structural information on 
the arrangement, affinities and structures of these proteins in the complex does not allow 
understanding the mechanisms they are involved in. In this thesis, the focus was on the 
complexes of S100A10 with annexin A2, AHNAK, and dysferlin proteins to provide the 
first structural model of a multi-protein assemblage required for membrane repair.  
 
5.2          Previous Work 
Frequent partners for the S100 proteins are members of the annexin protein 
family. At least 10 different S100-annexin complexes have been characterized 
(Santamaria-Kisiel et al. 2006). Each annexin protein has a core domain comprised of 
four (annexins A1-A5, A7- A11, A13) or eight (annexin A6) structurally conserved 
repeats, each possessing five α-helices and a short 30-reside N-terminal ‘tail’. Calcium 
binding to the annexins promotes association with phospholipid membranes, which leads 
to the release of the N-terminal tail for interaction with the S100 proteins.  
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The first two structures of S100 proteins in complex with the annexins were 
solved by Rety et al. (Rety et al. 1999; Rety et al. 2000) and comprised apo-S100A10 and 
Ca2+-S100A11 in complex with the N-terminal peptides of annexin A2 and A1, 
respectively. Despite the difference in the calcium-bound states of the proteins and that 
the two annexin peptides are from different protein sources, both structures demonstrate 
two annexin peptides per S100 dimer, located in near-identical binding sites on either side 
of the S100 molecule (Figure 1.4). Each peptide makes contacts with both S100 
protomers resulting in the bridging of the two monomers by the annexin protein. Gerke 
and Moss proposed an elegant model in which calcium-binding by an annexin protein 
promotes its association with a phospholipid membrane and facilitates interaction with 
either S100A10 or Ca2+-S100A11, allowing two membrane surfaces to be brought within 
close proximity during a fusion or vesiculation event (Gerke and Moss 2002).  
Recently, a multiprotein complex was identified between S100A10, annexin A2 
and AHNAK (Figure 1.8B) (Benaud et al. 2004; De Seranno et al. 2006). AHNAK is  
important for cell membrane differentiation and membrane repair (Kouno et al. 2004), is 
expressed in epithelial cells and localizes near the plasma membrane. In the absence of 
annexin A2, a weak interaction between S100A10 and the C-terminal portion of AHNAK 
exists. However, the strength of this interaction is increased more than 150-fold in the 
presence of annexin A2. Further, in vitro binding assays demonstrated no detectable 
interactions between annexin A2 and the C-terminus of AHNAK, in the absence of 
S100A10, or S100A10 with AHNAK in the absence of annexin A2. These observations 
suggest that S100A10-annexin A2 tetramer formation is likely a prerequisite for the 
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interaction with AHNAK. Similar to S100A10 and annexin A2, AHNAK protein 
localizes on the plasma membrane (Kouno et al. 2004), where the interaction between 
dysferlin and this complex can mediate the docking and fusion of the patch and sealing of 
the membrane. A high calcium concentration (extracellular, via the wound) causes 
annexin A1 and A2 association with a dysferlin-containing vesicle and damaged plasma 
membranes. The key protein in this process, dysferlin (Doherty and McNally 2003; Shao 
et al. 2006; Glover and Brown 2007), co-localizes and co-immunoprecipitates with 
annexins A1 and A2 (Lennon et al. 2003). In addition, recent experiments have shown 
that the C-terminus of AHNAK is responsible for binding to the N-terminal C2A domain 
of dysferlin. Calcium binding to the dysferlin C2A domain is not required for its 
interaction with AHNAK. The exact mechanisms whereby AHNAK is recruited for 
plasma membrane repair are not clear, however, S100A10 and annexin A2 co-localize 
with AHNAK and dysferlin proteins at the plasma membrane, providing some evidence 
for the function of this multiprotein complex in membrane repair.  
 
5.3          Design of High-Affinity S100-Target Hybrid Proteins 
Due to the presence of multiple proteins in larger complexes, studying the 
arrangement, affinities and mechanisms used by multi-protein complexes is quite 
challenging. This task could be achieved by devising a method in which the number or 
the sizes of the proteins involved in the interactions are reduced. In order to study multi-
protein complexes involved in membrane repair, chapter 2 focused on designing a hybrid 
protein in which the S100A10 was linked in tandem to the N-terminal peptide of annexin 
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A2 (residues 1-15). A similar hybrid molecule was also generated for S100B and the 
central region of CapZ (TRTK12; residues 1-12). These two proteins were selected to test 
this approach for one protein (S100B) that undergoes a calcium-induced conformational 
change in order to interact with a target, and one protein (S100A10) that is calcium-
insensitive. Further advantage of this method was protection of the target peptide from 
degradation to proteases by the S100 protein, which was used as a carrier.  
Analysis of the structures of S100A10 in complex with the N-terminus of 
annexin A2 (1BT6) (Rety et al. 1999), and Ca2+-S100B complexed to a portion of the 
CapZ (TRTK12) (1MWN, 1MQ1) (Inman et al. 2002; McClintock and Shaw 2003), 
allowed determining the length of the linker connecting the S100 protein to the target 
peptide. In both these structures (Figure 2.6), the C-termini of helix IV in the S100 
protein are proximal to the N-terminus of the binding peptide. A nine-residue linker 
comprised of a TEV protease cleavage site (ENLYFQ/G) was introduced to connect the 
S100A10 protein to the N-terminal peptide of annexin A2 (A10A2). Similarly, an eleven-
residue linker containing a PreScission protease cut site (LFQ/GP) and four glycine 
residues were used to connect the S100B protein to the TRTK12 peptide (BT12). High 
yields of isotopically labeled A10A2 and BT12 were purified to prepare the concentrated 
samples required for the collection of heteronuclear NMR experiments. The resonance 
assignments for nearly all of the atoms of each one of the hybrid proteins were completed. 
In situ proteolytic cleavage monitored by 1H-15N HSQC spectra showed the linker did not 
perturb the structures of the S100A10-annexin A2 or S100B-TRTK12 complexes. 
Overall, these results indicated that the structures and interactions of the S100 proteins 
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and the peptides in the A10A2 and BT12 hybrid proteins are nearly identical to those 
obtained for the complexes formed between the individual S100 proteins and synthetic 
peptides. Furthermore, analysis of the chemical shift assignments (1H, 15N, and 13C) 
showed that residues T102-S108 of annexin A2 formed a well-defined α-helix in the 
A10A2 hybrid while the TRTK12 region was unstructured at the N-terminus with a single 
turn of α-helix from D108-K111 in the BT12 hybrid protein. The two S100 hybrid 
proteins provide a simple yet extremely efficient method for obtaining high yields of 
intact S100 target peptides. Since cleavage of the S100 hybrid protein is not necessary for 
structural characterization, this approach may be useful as a scaffold for larger S100 
complexes. 
 
5.4          An Asymmetric Platform for AHNAK Recruitment 
The availability of the A10A2 hybrid protein, designed in previous chapter, 
allowed performing a series of experiments that assisted greatly in understanding the 
arrangement of the novel multi-protein complex formed between the S100A10, annexin 
A2 and AHNAK proteins. Peptide array analysis identified eight potential binding regions 
within the C-terminus of AHNAK for the A10A2 protein. Important amino acids of 
AHNAK for this interaction were characterized by +X+XPKφXφ consensus sequence, 
whereby amino acids with smaller sidechains at the second and forth positions of this 
sequence enhanced the interaction of A10A2. The sequence of AHNAK with the most 
intense binding (residues 5654-5673, AHNAK5) that was consistent with previous GST-
AHNAK pull-down assay (De Seranno et al. 2006), was utilized in NMR titration 
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experiments. Using both the A10A2C82S hybrid protein and complex of S100A10C82S 
with an N-terminal peptide of the annexin A2, a single AHNAK5 peptide was found to 
coordinate in an asymmetric fashion to the S100A10-annexin A2 heterotetramer. Since 
the annexin A2 portion of A10A2C82S was also 15N-labeled and visible in the spectrum, it 
was clear that the binding of AHNAK5 affected both the S100A10C82S and annexin A2 
regions of the hybrid protein. Significant chemical shift changes occurred mainly for 
residues in helix IV of the S100A10C82S (Gly77, Ala81), as well as the N-terminus of the 
annexin A2 (Leu112, G114) peptides. The plot of the change in peak intensities as a 
function of AHNAK5 and A10A2C82S concentrations showed a stoichiometry of one 
AHNAK5 peptide to one A10A2C82S dimer. Further, non-denaturing electrospray mass 
spectrometry results corroborated the NMR titration experiments. The binding affinity 
between AHNAK5 and A10A2C82S was measure to approximately 3 nM. Repeating 
similar experiments using AHNAK5 and S100A10C82S showed a much poorer interaction 
in the absence of annexin A2. Thus, confirming that both S100A10 and annexin A2 are 
required for strong association with the C-terminal domain of AHNAK.  
Consistent with the two-hybrid and co-immunoprecipitation experiments (van 
de Graaf et al. 2003; Borthwick et al. 2008), possible formation of a ternary complex 
involving S100A10, annexin A2 proteins and the transient receptor potential cation 
channel protein, TRPV5 was examined by peptide array analysis. Both, S100A10C82S or 
A10A2C82S associated to the same regions on multiple sites of the TRPV5 peptide array, 
indicating that interaction of TRPV5 with S100A10C82S or annexin A2-bound 
S100A10C82S differs from the complex formed with the AHNAK, where residues from 
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both S100A10C82S and annexin A2 are required for the strong interaction of the 
peptide. Regardless, it is important to repeat these experiments at lower protein 
concentrations in order to reduce the non-specific or weaker interactions.    
     
5.5          Interactions between Other Proteins in the Membrane Repair Complex  
With the aim of identifying secondary binding sites on annexin A2 (other than 
the twelve-residue N-terminal region) by S100A10 protein, peptide array experiments of 
full length annexin A2 were performed. Due to the sequence similarity of the helices 
within each repeat unit of annexin A2 (Barton et al. 1991; Jost et al. 1994), different 
potential binding sites corresponding to all four structural repeats were observed. Some of 
these repeats are buried in the structure of annexin A2 and clearly are not available to 
interact with S100A10. Similar to the TRPV5, the peptide array of annexin A2 was also 
probed at higher protein concentrations and it is important to repeat them using lower 
amount of protein to eliminate the non-specific or weaker interactions. 
Lack of information on the arrangement or assembly of the proteins in the 
membrane repair complex does not allow understanding the membrane repair mechanism. 
To shed light into this, the possible interactions between pairs of proteins in the complex 
were examined. Knowing the backbone assignment of some of these proteins would 
provide the information on how some residues are affected by the binding to other 
proteins in the complex. High yields of unlabeled and isotopically labeled S100A10, 
AHNAK C-terminal domain and dysferlin C2A domain were purified and concentrated 
samples for the collection of heteronuclear NMR experiments were prepared. The 
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resonance assignments of S100A10 were determined. However, NMR spectroscopy of 
S100A10 and dysferlin C2A domain did not indicate a direct interaction between these 
two proteins in the presence or absence of calcium. This result was contradictory to the 
interaction observed between S100A13 and synaptotagmin C2A domain (Mohan et al. 
2009; Mohan et al. 2010). It will be very interesting to test whether optimizing the 
experimental conditions such as the salt concentration in the buffer would change the 
outcome. 
Similarly, no interaction was identified between the C-terminus of AHNAK and 
dysferlin C2A domain in the presence or absence of calcium by NMR spectroscopy, 
contradicting the previous GST-pull down assay (Huang et al. 2007) and peptide array 
experiment performed in this thesis. The AHNAK protein used in the NMR experiments 
was much shorter than the AHNAK fragment used in the GST-pull down assay and it will 
be exciting to repeat this experiment using a larger AHNAK construct in optimized 
experimental conditions. 
No structural information is available for dysferlin C2A domain to date. 
Calcium titrations into the sample of dysferlin C2A domain showed sequential binding of 
six calcium ions to this region. It is important to obtain apo- and calcium-bound structures 
of dysferlin C2A domain to locate the interaction site formed between this protein and 
others in the membrane repair complex.  
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5.6          Structure of S100A10-Annexin A2-AHNAK5 Complex 
The last chapter of this thesis was focused on determining the binding region of 
AHNAK5 on A10A2 protein by NMR spectroscopy and X-ray crystallography methods. 
The resonance assignments for A10A2C82S alone and in complex with the AHNAK5 
peptide were completed. Chemical shift perturbation mapped the binding surface of 
AHNAK5 on helices IV and IV’ of protomers a and b of the S100A10 region (D84a, 
S82a, I80a, G77a-A76a, S73a, F72a/b, S73b, L74b, A76b-G77b, I80b), as well as some 
residues from the annexin A2 peptide region (E113a-G114a, S108a-S111a, L110b-S111b 
and E113b) of the A10A2C82S protein (Figure 4.10).  
X-ray crystallography of the A10A2-AHNAK5 complex showed that the 
backbone structure of A10A2-AHNAK5 complex is similar to that of S100A10 in 
complex with the N-terminal peptide of annexin A2 (Rety et al. 1999). The symmetric 
dimer contained four α-helices per subunit (I-IV), with helices I, I’, IV and IV’ 
comprising the dimer interface of the A10A2. The hydrophobic surface of the annexin A2 
peptide region of the A10A2 hybrid protein in the A10A2-AHNAK5 complex was also 
similar to that of the X-ray crystallographic structure of the S100A10 bound to individual 
N-terminal peptide of annexin A2. Some of the important residues for the interaction with 
the AHNAK5 peptide included I54, L58 and S111 of protomer a, and L78, S111 and 
L112 of protomer b in the A10A2 protein. From the structure, it was clear that only one 
AHNAK5 peptide was bound to a dimeric A10A2 protein. This result was in perfect 
agreement with the results obtained by NMR spectroscopy, however, this mode of 
interaction for AHNAK5 peptide differs from other interaction in S100-target complexes 
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observed to date (Figure 5.1). For instance, in the Ca2+-S100B structures with 
TRTK12 (1MWN, 1MQ1, 3IQO, Figure 5.1A) (Inman et al. 2002; McClintock and Shaw 
2003; Charpentier et al. 2010), Ndr kinase (1PSB, Figure 5.1A) (Bhattacharya et al. 2003) 
and p53 (1DT7) (Rustandi et al. 2000); and the Ca2+-S100A1 structure with TRTK12 
(2KBM, Figure 5.1A) (Wright et al. 2009); the interaction occurs between the target 
peptide and the exposed hydrophobic surface between helices III and IV of the calcium-
bound S100 protein. The second mode of interaction used by the S100 proteins is 
observed in the structures of Ca2+-S100A11 (1QLS, Figure 5.1B) and apo-S100A10 
(1BT6) in complexes with the N-terminal peptides from annexins A1 and A2, 
respectively. In both structures the annexin peptide bridges the two S100 protomers such 
that its C-terminus interacts with the linker and helix IV of one protomer while the 
annexin N-terminus has contacts near the N-terminus of helix I’ of the partner protomer. 
The third mode of interaction utilized by the S100 proteins involves the Ca2+-S100A6 and 
the C-terminal domain from the Siah-1 Interacting Protein (2JTT) (Figure 5.1C). In this 
structure the SIP peptide forms two distinct α-helices oriented nearly perpendicular to 
each other. The first helix (Helix A) occupies the hydrophobic groove between helices III 
and IV, while the second helix in SIP (helix B) lies across helix I’ of the adjacent 
protomer. The binding surface of AHNAK5 on the A10A2 protein is unique, as the 
peptide binds diagonally across helices IV and IV’ of the S100A10 region (Figure 5.1), 
which is on the opposite face of the molecule with respect to other S100-target 
complexes. In addition, AHNAK5 makes contacts with residues on the adjacent C-termini 
of the annexin A2 peptide regions (Figure 5.1D) of the A10A2 hybrid protein. 
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Figure 5.1. Different modes for target protein interaction with S100 proteins.  
 
(A) Binding to the helix III-IV hydrophobic displayed by TRTK12 (pink) bound to Ca2+-
S100A1 (2KBM) (Wright et al. 2009) and NDR kinase (cyan) bound to Ca2+-S100B 
(1PSB) (Bhattacharya et al. 2003). (B) Binding near helix I’ at the dimer interface 
displayed by the N-terminal region of annexin A1 (pink) and Ca2+-S100A11 (1QLS) 
(Rety et al. 2000). (C) Two- site surface mode displayed by the C-terminal region of SIP 
bound to Ca2+-S100A6 (2JTT) (Lee et al. 2008). (D) Binding to the helices IV and IV‘ as 
well as the adjacent C-termini of annexin A2 peptides one face of the A10A2 hybrid 
protein. The diagram in (D) is rotated by 180 alonge the y-axis with respect to (A-C). 
Ribbon diagrams of the calcium-saturated S100 or apo-A10A2 proteins are presented 
with one of the protomers shaded in black (helices labeled as I-IV for the S100 or as I-IV 
and annexin A2 for the A10A2) and the other protomer shown in light grey (helices 
labeled as I’-IV’ for the S100 or as I’-IV’ and annexin A2 for the A10A2). Calcium ions 
are illustrated in yellow spheres. 
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5.7          Membrane Repair mechanism 
Membrane repair involves a complicated assembly of multiple proteins. Strong 
in vivo evidence suggests that S100A10 is an important regulator of plasma membrane 
repair and membrane receptor trafficking. One of the central proteins in these functions is 
the calcium-sensitive annexin A2 protein. Many different experiments including co-
immunoprecipitation and two-hybrid assays supporte the formation of a tight complex 
with the S100A10 protein. The interaction between S100A10 and annexin A2 utilizes the 
N-terminus of annexin A2 similar to that observed in the S100A10-annexin A2 tetramer 
crystal structure (Rety et al. 1999) with a Kd of approximately 30 nM. An S100A10 dimer 
can coordinate a pair of annexin A2 proteins, potentially bridging adjacent phospholipid 
membranes into close proximity during a membrane fusion event (Gerke and Moss 2002). 
This allows for the aggregation of vesicles and formation of an endomembrane patch 
required for membrane repair during calcium flood through the disrupted membrane. The 
endomembrane patch trafficking is facilitated by affixin. Meanwhile, calpain-3 cleaves 
cytoskeletal proteins to mediate disassembly of the damaged actin cytoskeleton at the 
damaged site. The next component involved in membrane repair is the AHNAK protein. 
In this thesis, it was shown that despite the symmetric structure of dimeric S100A10-
annexin A2 complex, only one AHNAK5 peptide was bound asymmetrically to the 
heterotetramer (Figure 5.1) with a Kd of about 3 nM. Simialr to the yeast triple-hybrid and 
in vitro binding assays (De Seranno et al. 2006), it was also shown that both S100A10 
and annexin A2 are required for strong association with the C-terminal domain of 
AHNAK. This requirement indicates there are two calcium-regulated steps for AHNAK 
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delivery to the membrane surface both mediated by annexin A2. The first is the 
extrusion of N-terminus of annexin A2 upon calcium binding to the protein core domain 
allowing formation of the heterotetramer and subsequent recruitment of AHNAK. The 
second step is the localization of the entire complex to the phospholipid surface through 
calcium bridging between annexin A2 and the membrane. Peptide array experiments 
identified the possibility for eight binding regions in the C-terminus of AHNAK for the 
S100A10-annexin A2 complex. This is consistent with a scaffolding role for AHNAK 
where up to eight S100A10-annexin A2 heterotetramers could be assembled on the C-
terminus of AHNAK. Since binding of the complex to the phospholipid surface is 
governed by calcium binding to the annexin moiety, this would allow a highly 
cooperative association of the complex with the membrane. Stronger association of only 
one of the sequences in the array could also imply that some or the remaining binding 
sites are masked by the AHNAK tertiary structure. Regardless of the number of 
S100A10-annexin A2 complexes that could be recruited by one AHNAK onto the plasma 
membrane, the AHNAK protein gets located on the plasma membrane (Kouno et al. 
2004), where the interaction between dysferlin and this complex can mediate the docking 
and fusion of the patch and sealing of the membrane.  
 
5.8          Conclusion 
The work in this thesis has provided valuable information regarding multi-
protein complexes involved in membrane repair. The details on the arrangement of the 
proteins, stoichiometry and affinity of AHNAK for the S100A10-annexin A2 complex, as 
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well as structural information on this ternary complex proposed a novel model for a 
larger protein assembly during the membrane repair. 
 
5.9          Future Work 
The data presented in this thesis demonstrate an assembly of at least four 
proteins involved in membrane repair. Given the essential role of membrane repair in cell 
survival, it is important to invest on understanding the arrangement, affinities and 
structural information of the proteins in the complex. Although the structures of S100 
proteins bound to the target peptides are informative, they lack the overall architecture of 
the proteins in the complex. Thus, it is exciting to obtain more structural information on 
larger protein fragments alone or associated with other proteins in the complex. For 
instance, the apo- and calcium-bound structures of dysferlin C2A domain must first be 
solved in order to locate the binding sites of other members of the repair complex (ie. 
S100A10, annexin A2, and AHNAK). Finally, this structural model and the identified 
protein-protein interactions must be confirmed by site-directed mutation experiments. 
The preliminary work on the association of some of the pair complexes (ie. S100A10 or 
AHNAK with dysferlin) did not indicate an interaction, however, it is important to repeat 
these experiments under optimized experimental conditions.  
These structures could further be used in explaining some of the diseases caused 
by impaired membrane repair. For example, single V67D point mutation in dysferlin C2A 
domain is responsible for limb-girdle form of muscular dystrophy. Dysferlin has been 
shown to co-localize and co-immunoprecipitate with annexins A2 and A1 (Lennon et al. 
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2003) as well as the C-terminal domain of AHNAK. Therefore, it is quite interesting 
to study the effect of this mutation on the stability, structure and interactions of dysferlin 
C2A domain and other proteins in the complex. 
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